RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy14019
         (124 letters)



>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine
           Kinases, Discoidin Domain Receptors.  Protein Tyrosine
           Kinase (PTK) family; Discoidin Domain Receptor (DDR)
           subfamily; catalytic (c) domain. The DDR subfamily
           consists of homologs of mammalian DDR1, DDR2, and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           DDR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular discoidin homology domain, a
           transmembrane segment, an extended juxtamembrane region,
           and an intracellular catalytic domain. The binding of
           the ligand, collagen, to DDRs results in a slow but
           sustained receptor activation. DDRs regulate cell
           adhesion, proliferation, and extracellular matrix
           remodeling. They have been linked to a variety of human
           cancers including breast, colon, ovarian, brain, and
           lung. There is no evidence showing that DDRs act as
           transforming oncogenes. They are more likely to play a
           role in the regulation of tumor growth and metastasis.
          Length = 296

 Score =  146 bits (370), Expect = 2e-44
 Identities = 58/89 (65%), Positives = 66/89 (74%), Gaps = 1/89 (1%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLP-TPQTTK 84
           KFTTKSDVW+FGVTLWEIL L R +PYE LTD +V+EN  H   DDG  IYLP  P   K
Sbjct: 208 KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPK 267

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQR 113
           DI +LM ECW+R   +RP+F EIHLFLQR
Sbjct: 268 DIYELMLECWRRDEEDRPTFREIHLFLQR 296


>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity.
           Phosphotransferases. The specificity of this class of
           kinases can not be predicted. Possible dual-specificity
           Ser/Thr/Tyr kinase.
          Length = 258

 Score =  107 bits (270), Expect = 6e-30
 Identities = 43/117 (36%), Positives = 58/117 (49%), Gaps = 19/117 (16%)

Query: 7   LMRDLTNGRIFKNKNS------------LHRKFTTKSDVWSFGVTLWEILNLARHRPYEG 54
           L RDL +   +K K                 KFT+KSDVWSFGV LWEI  L    PY G
Sbjct: 149 LSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE-EPYPG 207

Query: 55  LTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIHLFL 111
           +++ EVLE +       G  +  P P    ++  LM +CW   P +RP+F+E+   L
Sbjct: 208 MSNAEVLEYL-----KKGYRLPKP-PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258


>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain.
           Phosphotransferases. Tyrosine-specific kinase subfamily.
          Length = 257

 Score =  106 bits (266), Expect = 2e-29
 Identities = 42/117 (35%), Positives = 61/117 (52%), Gaps = 19/117 (16%)

Query: 7   LMRDLTNGRIFKNKNS------------LHRKFTTKSDVWSFGVTLWEILNLARHRPYEG 54
           L RDL +   ++ +                 KFT+KSDVWSFGV LWEI  L   +PY G
Sbjct: 148 LSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE-QPYPG 206

Query: 55  LTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIHLFL 111
           +++ EVLE +      +G  +  P P    ++ DLM +CW   P +RP+F+E+   L
Sbjct: 207 MSNEEVLEYL-----KNGYRLPQP-PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257


>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine
           Kinase, Discoidin Domain Receptor 2.  Protein Tyrosine
           Kinase (PTK) family; mammalian Discoidin Domain Receptor
           2 (DDR2) and homologs; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. DDR2 is a
           member of the DDR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular discoidin
           homology domain, a transmembrane segment, an extended
           juxtamembrane region, and an intracellular catalytic
           domain. The binding of the ligand, collagen, to DDRs
           results in a slow but sustained receptor activation.
           DDR2 binds mostly to fibrillar collagens. More recently,
           it has been reported to also bind collagen X. DDR2 is
           widely expressed in many tissues with the highest levels
           found in skeletal muscle, skin, kidney and lung. It is
           important in cell proliferation and development. Mice,
           with a deletion of DDR2, suffer from dwarfism and
           delayed healing of epidermal wounds. DDR2 also
           contributes to collagen (type I) regulation by
           inhibiting fibrillogenesis and altering the morphology
           of collagen fibers. It is also expressed in immature
           dendritic cells (DCs), where it plays a role in DC
           activation and function.
          Length = 296

 Score =  105 bits (263), Expect = 1e-28
 Identities = 47/88 (53%), Positives = 56/88 (63%), Gaps = 1/88 (1%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KFTT SDVW+FGVTLWEIL L + +PY  L+D +V+EN      D G  +YLP P    D
Sbjct: 208 KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD 267

Query: 86  IL-DLMNECWKRSPTERPSFTEIHLFLQ 112
            L  LM  CW+R+  ERPSF EIH  L 
Sbjct: 268 SLYKLMLSCWRRNAKERPSFQEIHATLL 295


>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase. 
          Length = 258

 Score =  103 bits (259), Expect = 3e-28
 Identities = 39/89 (43%), Positives = 55/89 (61%), Gaps = 9/89 (10%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ-T 82
             KFT+KSDVWSFGV LWEI  L   +PY G+++ EVLE +     +DG    LP P+  
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGE-QPYPGMSNEEVLELL-----EDGY--RLPRPENC 229

Query: 83  TKDILDLMNECWKRSPTERPSFTEIHLFL 111
             ++ +LM +CW   P +RP+F+E+   L
Sbjct: 230 PDELYELMLQCWAYDPEDRPTFSELVEDL 258


>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases.
           Protein Tyrosine Kinase (PTK) family, catalytic domain.
           This PTKc family is part of a larger superfamily that
           includes the catalytic domains of protein
           serine/threonine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. They can be classified
           into receptor and non-receptor tyr kinases. PTKs play
           important roles in many cellular processes including,
           lymphocyte activation, epithelium growth and
           maintenance, metabolism control, organogenesis
           regulation, survival, proliferation, differentiation,
           migration, adhesion, motility, and morphogenesis.
           Receptor tyr kinases (RTKs) are integral membrane
           proteins which contain an extracellular ligand-binding
           region, a transmembrane segment, and an intracellular
           tyr kinase domain. RTKs are usually activated through
           ligand binding, which causes dimerization and
           autophosphorylation of the intracellular tyr kinase
           catalytic domain, leading to intracellular signaling.
           Some RTKs are orphan receptors with no known ligands.
           Non-receptor (or cytoplasmic) tyr kinases are
           distributed in different intracellular compartments and
           are usually multi-domain proteins containing a catalytic
           tyr kinase domain as well as various regulatory domains
           such as SH3 and SH2. PTKs are usually autoinhibited and
           require a mechanism for activation. In many PTKs, the
           phosphorylation of tyr residues in the activation loop
           is essential for optimal activity. Aberrant expression
           of PTKs is associated with many development
           abnormalities and cancers.
          Length = 262

 Score = 99.5 bits (249), Expect = 9e-27
 Identities = 38/90 (42%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ-T 82
              FT+KSDVWSFGV LWEI  L    PY GL++ EVLE +       G    LP P+  
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGAT-PYPGLSNEEVLEYLR-----KGYR--LPKPEYC 232

Query: 83  TKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
             ++ +LM  CW+  P +RP+F+E+   L+
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVERLE 262


>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine
           Kinase, Discoidin Domain Receptor 1.  Protein Tyrosine
           Kinase (PTK) family; mammalian Discoidin Domain Receptor
           1 (DDR1) and homologs; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. DDR1 is a
           member of the DDR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular discoidin
           homology domain, a transmembrane segment, an extended
           juxtamembrane region, and an intracellular catalytic
           domain. The binding of the ligand, collagen, to DDRs
           results in a slow but sustained receptor activation.
           DDR1 binds to all collagens tested to date (types I-IV).
           It is widely expressed in many tissues. It is abundant
           in the brain and is also found in keratinocytes, colonic
           mucosa epithelium, lung epithelium, thyroid follicles,
           and the islets of Langerhans. During embryonic
           development, it is found in the developing
           neuroectoderm. DDR1 is a key regulator of cell
           morphogenesis, differentiation and proliferation. It is
           important in the development of the mammary gland, the
           vasculator and the kidney. DDR1 is also found in human
           leukocytes, where it facilitates cell adhesion,
           migration, maturation, and cytokine production.
          Length = 304

 Score = 96.5 bits (240), Expect = 3e-25
 Identities = 45/87 (51%), Positives = 57/87 (65%), Gaps = 1/87 (1%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT-K 84
           KFTT SDVW+FGVTLWEIL L + +PY  LTD +V+EN      D G  +YL  P    +
Sbjct: 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ 275

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFL 111
            + +LM +CW R   ERPSF++IH FL
Sbjct: 276 GLYELMLQCWSRDCRERPSFSDIHAFL 302


>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain
           Receptor-like Protein Tyrosine Kinases.  Protein
           Tyrosine Kinase (PTK) family; Discoidin Domain Receptor
           (DDR)-like proteins; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. DDR-like
           proteins are members of the DDR subfamily, which are
           receptor tyr kinases (RTKs) containing an extracellular
           discoidin homology domain, a transmembrane segment, an
           extended juxtamembrane region, and an intracellular
           catalytic domain. The binding of the ligand, collagen,
           to DDRs results in a slow but sustained receptor
           activation. DDRs regulate cell adhesion, proliferation,
           and extracellular matrix remodeling. They have been
           linked to a variety of human cancers including breast,
           colon, ovarian, brain, and lung. There is no evidence
           showing that DDRs act as transforming oncogenes. They
           are more likely to play a role in the regulation of
           tumor growth and metastasis.
          Length = 295

 Score = 93.9 bits (233), Expect = 2e-24
 Identities = 41/87 (47%), Positives = 53/87 (60%), Gaps = 1/87 (1%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLP-TPQTTK 84
           KFTT SDVW+FGVTLWE+  L + +PY  L+D +V+EN      + G  IYL  TP    
Sbjct: 207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPS 266

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFL 111
            +  LM  CW R   +RP+F +IH FL
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKIHHFL 293


>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like
           Protein Tyrosine Kinases.  Protein Tyrosine Kinase (PTK)
           family; Insulin Receptor (InsR) subfamily; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). The InsR subfamily
           is composed of InsR, Insulin-like Growth Factor-1
           Receptor (IGF-1R), and similar proteins. PTKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. InsR and
           IGF-1R are receptor tyr kinases (RTKs) composed of two
           alphabeta heterodimers. Binding of the ligand (insulin,
           IGF-1, or IGF-2) to the extracellular alpha subunit
           activates the intracellular tyr kinase domain of the
           transmembrane beta subunit. Receptor activation leads to
           autophosphorylation, stimulating downstream kinase
           activities, which initiate signaling cascades and
           biological function. InsR and IGF-1R, which share 84%
           sequence identity in their kinase domains, display
           physiologically distinct yet overlapping functions in
           cell growth, differentiation, and metabolism. InsR
           activation leads primarily to metabolic effects while
           IGF-1R activation stimulates mitogenic pathways. In
           cells expressing both receptors, InsR/IGF-1R hybrids are
           found together with classical receptors. Both receptors
           can interact with common adaptor molecules such as IRS-1
           and IRS-2.
          Length = 277

 Score = 92.8 bits (231), Expect = 4e-24
 Identities = 41/89 (46%), Positives = 55/89 (61%), Gaps = 9/89 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
            FTTKSDVWSFGV LWE+  LA  +PY+GL++ EVL+ +      DG   +L  P+   D
Sbjct: 197 VFTTKSDVWSFGVVLWEMATLAE-QPYQGLSNEEVLKFVI-----DGG--HLDLPENCPD 248

Query: 86  IL-DLMNECWKRSPTERPSFTEIHLFLQR 113
            L +LM  CW+ +P  RP+F EI   L+ 
Sbjct: 249 KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277


>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Ephrin Receptor (EphR) subfamily; catalytic (c) domain.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). They can be classified into two classes (EphA
           and EphB), according to their extracellular sequences,
           which largely correspond to binding preferences for
           either GPI-anchored ephrin-A ligands or transmembrane
           ephrin-B ligands. Vertebrates have ten EphA and six EhpB
           receptors, which display promiscuous ligand interactions
           within each class. EphRs contain an ephrin binding
           domain and two fibronectin repeats extracellularly, a
           transmembrane segment, and a cytoplasmic tyr kinase
           domain. Binding of the ephrin ligand to EphR requires
           cell-cell contact since both are anchored to the plasma
           membrane. This allows ephrin/EphR dimers to form,
           leading to the activation of the intracellular tyr
           kinase domain. The resulting downstream signals occur
           bidirectionally in both EphR-expressing cells (forward
           signaling) and ephrin-expressing cells (reverse
           signaling). The main effect of ephrin/EphR interaction
           is cell-cell repulsion or adhesion. Ephrin/EphR
           signaling is important in neural development and
           plasticity, cell morphogenesis and proliferation,
           cell-fate determination, embryonic development, tissue
           patterning, and angiogenesis.
          Length = 266

 Score = 85.1 bits (211), Expect = 3e-21
 Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 11/92 (11%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIY-LPTPQT 82
           +RKFT+ SDVWSFG+ +WE+++    RPY  +++ +V++ +     +DG   Y LP P  
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGE-RPYWDMSNQDVIKAV-----EDG---YRLPPPMD 232

Query: 83  TKDIL-DLMNECWKRSPTERPSFTEIHLFLQR 113
               L  LM +CW++   ERP+F++I   L +
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264


>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine
           Kinase, Activated Cdc42-associated kinase.  Protein
           Tyrosine Kinase (PTK) family; Activated Cdc42-associated
           kinase (Ack) subfamily; catalytic (c) domain. Ack
           subfamily members include Ack1, thirty-eight-negative
           kinase 1 (Tnk1), and similar proteins. The PTKc family
           is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ack
           subfamily members are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal catalytic domain, an
           SH3 domain, a Cdc42-binding CRIB domain, and a
           proline-rich region. They are mainly expressed in brain
           and skeletal tissues and are involved in the regulation
           of cell adhesion and growth, receptor degradation, and
           axonal guidance. Ack1 is also associated with
           androgen-independent  prostate cancer progression. Tnk1
           regulates TNFalpha signaling and may play an important
           role in cell death.
          Length = 257

 Score = 83.2 bits (206), Expect = 1e-20
 Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 8/89 (8%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ-T 82
            R F+  SDVW FGVTLWE+       P+ GL+  ++L+ I      D E   L  P+  
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGE-EPWAGLSGSQILKKI------DKEGERLERPEAC 226

Query: 83  TKDILDLMNECWKRSPTERPSFTEIHLFL 111
            +DI ++M +CW  +P +RP+F  +  FL
Sbjct: 227 PQDIYNVMLQCWAHNPADRPTFAALREFL 255


>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine
           Kinases, Tropomyosin Related Kinases.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase (Trk)
           subfamily; catalytic (c) domain. The Trk subfamily
           consists of TrkA, TrkB, TrkC, and similar proteins. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Trk
           subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular region with arrays of
           leucine-rich motifs flanked by two cysteine-rich
           clusters followed by two immunoglobulin-like domains, a
           transmembrane segment, and an intracellular catalytic
           domain. Binding to their ligands, the nerve growth
           factor (NGF) family of neutrotrophins, leads to Trk
           receptor oligomerization and activation of the catalytic
           domain. Trk receptors are mainly expressed in the
           peripheral and central nervous systems. They play
           important roles in cell fate determination, neuronal
           survival and differentiation, as well as in the
           regulation of synaptic plasticity. Altered expression of
           Trk receptors is associated with many human diseases.
          Length = 280

 Score = 83.3 bits (206), Expect = 2e-20
 Identities = 40/91 (43%), Positives = 56/91 (61%), Gaps = 9/91 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           ++RKFTT+SDVWSFGV LWEI    + +P+ GL++ EV+E I       G    L  P+T
Sbjct: 197 MYRKFTTESDVWSFGVVLWEIFTYGK-QPWYGLSNEEVIECI-----TQG--RLLQRPRT 248

Query: 83  -TKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
              ++ D+M  CWKR P +R +  +IH  LQ
Sbjct: 249 CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279


>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Src kinase subfamily; catalytic (c) domain. Src
           subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr,
           Fyn, Yrk, and Yes. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Src (or c-Src) proteins are cytoplasmic (or
           non-receptor) tyr kinases which are anchored to the
           plasma membrane. They contain an N-terminal SH4 domain
           with a myristoylation site, followed by SH3 and SH2
           domains, a tyr kinase domain, and a regulatory
           C-terminal region containing a conserved tyr. They are
           activated by autophosphorylation at the tyr kinase
           domain, but are negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. They were identified as the first
           proto-oncogene products, and they regulate cell
           adhesion, invasion, and motility in cancer cells and
           tumor vasculature, contributing to cancer progression
           and metastasis. Src kinases are overexpressed in a
           variety of human cancers, making them attractive targets
           for therapy. They are also implicated in acute
           inflammatory responses and osteoclast function. Src,
           Fyn, Yes, and Yrk are widely expressed, while Blk, Lck,
           Hck, Fgr, and Lyn show a limited expression pattern.
          Length = 261

 Score = 82.8 bits (205), Expect = 2e-20
 Identities = 37/91 (40%), Positives = 52/91 (57%), Gaps = 9/91 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
            + +FT KSDVWSFG+ L EI+   R  PY G+T+ EVLE +   +        +P P  
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR-VPYPGMTNREVLEQVERGY-------RMPRPPN 228

Query: 83  TKDIL-DLMNECWKRSPTERPSFTEIHLFLQ 112
             + L DLM +CW + P ERP+F  +  FL+
Sbjct: 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259


>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine
           Kinase, Muscle-specific kinase.  Protein Tyrosine Kinase
           (PTK) family; Muscle-specific kinase (Musk); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Musk is a receptor tyr kinase (RTK) containing an
           extracellular region with four immunoglobulin-like
           domains and a cysteine-rich cluster, a transmembrane
           segment, and an intracellular catalytic domain. Musk is
           expressed and concentrated in the postsynaptic membrane
           in skeletal muscle. It is essential for the
           establishment of the neuromuscular junction (NMJ), a
           peripheral synapse that conveys signals from motor
           neurons to muscle cells. Agrin, a large proteoglycan
           released from motor neurons, stimulates Musk
           autophosphorylation and activation, leading to the
           clustering of acetylcholine receptors (AChRs). To date,
           there is no evidence to suggest that agrin binds
           directly to Musk. Mutations in AChR, Musk and other
           partners are responsible for diseases of the NMJ, such
           as the autoimmune syndrome myasthenia gravis.
          Length = 288

 Score = 82.2 bits (203), Expect = 5e-20
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 11/93 (11%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLP--TP 80
            + ++TT+SDVW++GV LWEI +    +PY G+   EV+      +  DG  +  P   P
Sbjct: 205 FYNRYTTESDVWAYGVVLWEIFSYGM-QPYYGMAHEEVIY-----YVRDGNVLSCPDNCP 258

Query: 81  QTTKDILDLMNECWKRSPTERPSFTEIHLFLQR 113
               ++ +LM  CW + P++RPSF  I+  LQR
Sbjct: 259 L---ELYNLMRLCWSKLPSDRPSFASINRILQR 288


>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine
           Kinase-like Protein Tyrosine Kinases.  Protein Tyrosine
           Kinase (PTK) family; Spleen Tyrosine Kinase (Syk)
           subfamily; catalytic (c) domain. The Syk subfamily is
           composed of Syk, ZAP-70, Shark, and similar proteins.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Syk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing two Src homology 2 (SH2) domains
           N-terminal to the catalytic tyr kinase domain. They are
           involved in the signaling downstream of activated
           receptors (including B-cell, T-cell, and Fc receptors)
           that contain ITAMs (immunoreceptor tyr activation
           motifs), leading to processes such as cell
           proliferation, differentiation, survival, adhesion,
           migration, and phagocytosis. Syk is important in B-cell
           receptor (BCR) signaling, while Zap-70 is primarily
           expressed in T-cells and NK cells, and is a crucial
           component in T-cell receptor (TCR) signaling. Syk also
           plays a central role in Fc receptor-mediated
           phagocytosis in the adaptive immune system. Shark is
           exclusively expressed in ectodermally derived epithelia,
           and is localized preferentially to the apical surface of
           the epithelial cells, it may play a role in a signaling
           pathway for epithelial cell polarity.
          Length = 257

 Score = 81.2 bits (201), Expect = 8e-20
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 9/90 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
            KF++KSDVWS+GVTLWE  +    +PY  +   EV+  +            LP P+   
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGA-KPYGEMKGAEVIAMLESGER-------LPRPEECP 224

Query: 85  D-ILDLMNECWKRSPTERPSFTEIHLFLQR 113
             I  +M  CWK  P +RP+F+E+    +R
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSELESTFRR 254


>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine
           Kinase, C-ros.  Protein Tyrosine Kinases (PTK) family;
           C-ros and Drosophila Sevenless proteins; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. The
           proto-oncogene c-ros encodes an orphan receptor tyr
           kinase (RTK) with an unknown ligand. RTKs contain an
           extracellular ligand-binding domain, a transmembrane
           region, and an intracellular tyr kinase domain. RTKs are
           usually activated through ligand binding, which causes
           dimerization and autophosphorylation of the
           intracellular tyr kinase catalytic domain. C-ros is
           expressed in embryonic cells of the kidney, intestine
           and lung, but disappears soon after birth. It persists
           only in the adult epididymis. Male mice bearing inactive
           mutations of c-ros lack the initial segment of the
           epididymis and are infertile. The Drosophila protein,
           Sevenless, is required for the specification of the R7
           photoreceptor cell during eye development.
          Length = 269

 Score = 80.7 bits (199), Expect = 1e-19
 Identities = 39/87 (44%), Positives = 48/87 (55%), Gaps = 7/87 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KFTT+SDVWSFGV +WEIL L   +PY  L + EVL+     H   G  +  P       
Sbjct: 189 KFTTQSDVWSFGVLMWEILTLG-QQPYPALNNQEVLQ-----HVTAGGRLQKP-ENCPDK 241

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFLQ 112
           I  LM  CW + P+ERP+F  I   LQ
Sbjct: 242 IYQLMTNCWAQDPSERPTFDRIQEILQ 268


>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Tyrosine kinase expressed in hepatocellular carcinoma
           (Tec) subfamily; catalytic (c) domain. The Tec subfamily
           is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk
           (Txk), and similar proteins. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tec kinases are
           cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with
           similarity to Src kinases in that they contain Src
           homology protein interaction domains (SH3, SH2)
           N-terminal to the catalytic tyr kinase domain. Unlike
           Src kinases, most Tec subfamily members (except Rlk)
           also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, some
           members contain the Tec homology (TH) domain, which
           contains proline-rich and zinc-binding regions. Tec
           kinases form the second largest subfamily of nRTKs and
           are expressed mainly by haematopoietic cells, although
           Tec and Bmx are also found in endothelial cells. B-cells
           express Btk and Tec, while T-cells express Itk, Txk, and
           Tec. Collectively, Tec kinases are expressed in a
           variety of myeloid cells such as mast cells, platelets,
           macrophages, and dendritic cells. Each Tec kinase shows
           a distinct cell-type pattern of expression. The function
           of Tec kinases in lymphoid cells have been studied
           extensively. They play important roles in the
           development, differentiation, maturation, regulation,
           survival, and function of B-cells and T-cells. Mutations
           in Btk cause the severe B-cell immunodeficiency,
           X-linked agammaglobulinaemia (XLA).
          Length = 256

 Score = 79.4 bits (196), Expect = 4e-19
 Identities = 29/85 (34%), Positives = 50/85 (58%), Gaps = 7/85 (8%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
            + +F++KSDVWSFGV +WE+ +  +  PYE  ++ EV+E++S      G  +Y P    
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESVSA-----GYRLYRPK-LA 226

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
             ++  +M  CW   P +RP+F ++
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKL 251


>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like
           Protein Tyrosine Kinases.  Protein Tyrosine Kinase (PTK)
           family; Human Fyn-related kinase (Frk) and similar
           proteins; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Frk and
           Srk are members of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Frk, also known as Rak, is specifically
           expressed in liver, lung, kidney, intestine, mammary
           glands, and the islets of Langerhans. Rodent homologs
           were previously referred to as GTK (gastrointestinal tyr
           kinase), BSK (beta-cell Src-like kinase), or IYK
           (intestinal tyr kinase). Studies in mice reveal that Frk
           is not essential for viability. It plays a role in the
           signaling that leads to cytokine-induced beta-cell death
           in Type I diabetes. It also regulates beta-cell number
           during embryogenesis and early in life.
          Length = 261

 Score = 78.6 bits (194), Expect = 9e-19
 Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 9/83 (10%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L+ +F+ KSDVWSFG+ L EI+   R  PY G+T+ EVL+ +   +        +P P  
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR-MPYPGMTNAEVLQQVDQGYR-------MPCPPG 228

Query: 83  TKDIL-DLMNECWKRSPTERPSF 104
               L D+M +CWK  P +RP+F
Sbjct: 229 CPKELYDIMLDCWKEDPDDRPTF 251


>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth
           Factor Receptor-like Protein Tyrosine Kinases.  Protein
           Tyrosine Kinase (PTK) family; Epidermal Growth Factor
           Receptor (EGFR) subfamily; catalytic (c) domain. EGFR
           (HER, ErbB) subfamily members include EGFR (HER1,
           ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           The EGFR proteins are receptor tyr kinases (RTKs)
           containing an extracellular EGF-related ligand-binding
           region, a transmembrane helix, and a cytoplasmic region
           with a tyr kinase domain and a regulatory C-terminal
           tail. Unlike other tyr kinases, phosphorylation of the
           activation loop of EGFR proteins is not critical to
           their activation. Instead, they are activated by
           ligand-induced dimerization, resulting in the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Collectively, they can recognize a variety of
           ligands including EGF, TGFalpha, and neuregulins, among
           others. All four subfamily members can form homo- or
           heterodimers. HER3 contains an impaired kinase domain
           and depends on its heterodimerization partner for
           activation. EGFR subfamily members are involved in
           signaling pathways leading to a broad range of cellular
           responses including cell proliferation, differentiation,
           migration, growth inhibition, and apoptosis. Gain of
           function alterations, through their overexpression,
           deletions, or point mutations in their kinase domains,
           have been implicated in various cancers. These receptors
           are targets of many small molecule inhibitors and
           monoclonal antibodies used in cancer therapy.
          Length = 279

 Score = 75.9 bits (187), Expect = 8e-18
 Identities = 33/86 (38%), Positives = 50/86 (58%), Gaps = 9/86 (10%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           LHR +T KSDVWS+GVT+WE++     +PYEG+  +E+ +       + GE   LP P  
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGA-KPYEGIPAVEIPD-----LLEKGE--RLPQPPI 235

Query: 83  -TKDILDLMNECWKRSPTERPSFTEI 107
            T D+  ++ +CW      RP+F E+
Sbjct: 236 CTIDVYMVLVKCWMIDAESRPTFKEL 261


>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine
           Kinase, Colon Carcinoma Kinase 4.  Protein Tyrosine
           Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4);
           pseudokinase domain. The PTKc (catalytic domain) family,
           to which this subfamily belongs, includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. CCK4,
           also called protein tyrosine kinase 7 (PTK7), is an
           orphan receptor tyr kinase (RTK) containing an
           extracellular region with seven immunoglobulin domains,
           a transmembrane segment, and an intracellular inactive
           pseudokinase domain. Studies in mice reveal that CCK4 is
           essential for neural development. Mouse embryos
           containing a truncated CCK4 die perinatally and display
           craniorachischisis, a severe form of neural tube defect.
           The mechanism of action of the CCK4 pseudokinase is
           still unknown. Other pseudokinases such as HER3 rely on
           the activity of partner RTKs.
          Length = 275

 Score = 75.2 bits (185), Expect = 2e-17
 Identities = 37/82 (45%), Positives = 47/82 (57%), Gaps = 8/82 (9%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           F+TKSDVWSFGV +WE+       P+ GL+D EVL     L A   E   LP P+     
Sbjct: 195 FSTKSDVWSFGVLMWEVFTQGE-LPFYGLSDEEVLNR---LQAGKLE---LPVPEGCPSR 247

Query: 87  L-DLMNECWKRSPTERPSFTEI 107
           L  LM  CW  +P +RPSF+E+
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSEL 269


>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase,
           Yes.  Protein Tyrosine Kinase (PTK) family; Yes kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Yes (or c-Yes) is a
           member of the Src subfamily of proteins, which are
           cytoplasmic (or non-receptor) tyr kinases. Src kinases
           contain an N-terminal SH4 domain with a myristoylation
           site, followed by SH3 and SH2 domains, a tyr kinase
           domain, and a regulatory C-terminal region containing a
           conserved tyr. They are activated by autophosphorylation
           at the tyr kinase domain, but are negatively regulated
           by phosphorylation at the C-terminal tyr by Csk
           (C-terminal Src Kinase). Src proteins are involved in
           signaling pathways that regulate cytokine and growth
           factor responses, cytoskeleton dynamics, cell
           proliferation, survival, and differentiation. c-Yes
           kinase is the cellular homolog of the oncogenic protein
           (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma
           viruses. It displays functional overlap with other Src
           subfamily members, particularly Src. It also shows some
           unique functions such as binding to occludins,
           transmembrane proteins that regulate extracellular
           interactions in tight junctions. Yes also associates
           with a number of proteins in different cell types that
           Src does not interact with, like JAK2 and gp130 in
           pre-adipocytes, and Pyk2 in treated pulmonary vein
           endothelial cells. Although the biological function of
           Yes remains unclear, it appears to have a role in
           regulating cell-cell interactions and vesicle
           trafficking in polarized cells.
          Length = 260

 Score = 73.9 bits (181), Expect = 4e-17
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 9/92 (9%)

Query: 22  SLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ 81
           +L+ +FT KSDVWSFG+ L E++   R  PY G+ + EVLE +   +        +P PQ
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR-VPYPGMVNREVLEQVERGYR-------MPCPQ 226

Query: 82  TTKDIL-DLMNECWKRSPTERPSFTEIHLFLQ 112
              + L +LM  CWK+ P ERP+F  I  FL+
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258


>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine
           Kinase, Tropomyosin Related Kinase A.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase A
           (TrkA); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. TrkA is a member of the
           Trk subfamily of proteins, which are receptor tyr
           kinases (RTKs) containing an extracellular region with
           arrays of leucine-rich motifs flanked by two
           cysteine-rich clusters followed by two
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. Binding of TrkA
           to its ligand, nerve growth factor (NGF), results in
           receptor oligomerization and activation of the catalytic
           domain. TrkA is expressed mainly in neural-crest-derived
           sensory and sympathetic neurons of the peripheral
           nervous system, and in basal forebrain cholinergic
           neurons of the central nervous system. It is critical
           for neuronal growth, differentiation and survival.
           Alternative TrkA splicing has been implicated as a
           pivotal regulator of neuroblastoma (NB) behavior. Normal
           TrkA expression is associated with better NB prognosis,
           while the hypoxia-regulated TrkAIII splice variant
           promotes NB pathogenesis and progression. Aberrant TrkA
           expression has also been demonstrated in non-neural
           tumors including prostate, breast, lung, and pancreatic
           cancers.
          Length = 280

 Score = 73.5 bits (180), Expect = 8e-17
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L+RKFTT+SD+WSFGV LWEI    + +P+  L++ E +E I+           L  P+T
Sbjct: 197 LYRKFTTESDIWSFGVVLWEIFTYGK-QPWYQLSNTEAIECITQGRE-------LERPRT 248

Query: 83  T-KDILDLMNECWKRSPTERPSFTEIHLFLQR 113
              ++  +M  CW+R P +R    +IH  LQ 
Sbjct: 249 CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280


>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase,
           Focal Adhesion Kinase.  Protein Tyrosine Kinase (PTK)
           family; Focal Adhesion Kinase (FAK); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FAK is a
           cytoplasmic (or nonreceptor) tyr kinase that contains an
           autophosphorylation site and a FERM domain at the
           N-terminus, a central tyr kinase domain, proline-rich
           regions, and a C-terminal FAT (focal adhesion targeting)
           domain. FAK activity is dependent on integrin-mediated
           cell adhesion, which facilitates N-terminal
           autophosphorylation. Full activation is achieved by the
           phosphorylation of its two adjacent A-loop tyrosines.
           FAK is important in mediating signaling initiated at
           sites of cell adhesions and at growth factor receptors.
           Through diverse molecular interactions, FAK functions as
           a biosensor or integrator to control cell motility. It
           is a key regulator of cell survival, proliferation,
           migration and invasion, and thus plays an important role
           in the development and progression of cancer. Src binds
           to autophosphorylated FAK forming the FAK-Src dual
           kinase complex, which is activated in a wide variety of
           tumor cells and generates signals promoting growth and
           metastasis. FAK is being developed as a target for
           cancer therapy.
          Length = 270

 Score = 72.5 bits (178), Expect = 2e-16
 Identities = 35/84 (41%), Positives = 51/84 (60%), Gaps = 9/84 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           R+FT+ SDVW FGV +WEIL L   +P++G+ + +V   I  +  ++GE   LP P    
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGV-KPFQGVKNNDV---IGRI--ENGE--RLPMPPNCP 234

Query: 85  DIL-DLMNECWKRSPTERPSFTEI 107
             L  LM +CW   P++RP FTE+
Sbjct: 235 PTLYSLMTKCWAYDPSKRPRFTEL 258


>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine
           Kinases, Receptor tyrosine kinase-like Orphan Receptors.
            Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
           kinase-like Orphan Receptor (Ror) subfamily; catalytic
           (c) domain. The Ror subfamily consists of Ror1, Ror2,
           and similar proteins. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Ror proteins are orphan
           receptor tyr kinases (RTKs) containing an extracellular
           region with immunoglobulin-like, cysteine-rich, and
           kringle domains, a transmembrane segment, and an
           intracellular catalytic domain. Ror RTKs are unrelated
           to the nuclear receptor subfamily called
           retinoid-related orphan receptors (RORs). RTKs are
           usually activated through ligand binding, which causes
           dimerization and autophosphorylation of the
           intracellular tyr kinase catalytic domain. Ror kinases
           are expressed in many tissues during development. They
           play important roles in bone and heart formation.
           Mutations in human Ror2 result in two different bone
           development genetic disorders, recessive Robinow
           syndrome and brachydactyly type B. Drosophila Ror is
           expressed only in the developing nervous system during
           neurite outgrowth and neuronal differentiation,
           suggesting a role for Drosophila Ror in neural
           development. More recently, mouse Ror1 and Ror2 have
           also been found to play an important role in regulating
           neurite growth in central neurons. Ror1 and Ror2 are
           believed to have some overlapping and redundant
           functions.
          Length = 283

 Score = 72.1 bits (177), Expect = 3e-16
 Identities = 37/87 (42%), Positives = 48/87 (55%), Gaps = 9/87 (10%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L+ KFTT+SD+WSFGV LWEI +    +PY G ++ EV+E I            LP P+ 
Sbjct: 199 LYGKFTTESDIWSFGVVLWEIFSYGL-QPYYGFSNQEVIEMIR-------SRQLLPCPED 250

Query: 83  T-KDILDLMNECWKRSPTERPSFTEIH 108
               +  LM ECW   P  RP F +IH
Sbjct: 251 CPARVYALMIECWNEIPARRPRFKDIH 277


>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine
           Kinases, Anaplastic Lymphoma Kinase and Leukocyte
           Tyrosine Kinase.  Protein Tyrosine Kinase (PTK) family;
           Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine
           (tyr) Kinase (LTK); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to tyr
           residues in protein substrates. ALK and LTK are orphan
           receptor tyr kinases (RTKs) whose ligands are not yet
           well-defined. RTKs contain an extracellular
           ligand-binding domain, a transmembrane region, and an
           intracellular tyr kinase domain. They are usually
           activated through ligand binding, which causes
           dimerization and autophosphorylation of the
           intracellular tyr kinase catalytic domain. ALK appears
           to play an important role in mammalian neural
           development as well as visceral muscle differentiation
           in Drosophila. ALK is aberrantly expressed as fusion
           proteins, due to chromosomal translocations, in about
           60% of anaplastic large cell lymphomas (ALCLs). ALK
           fusion proteins are also found in rare cases of diffuse
           large B cell lymphomas (DLBCLs). LTK is mainly expressed
           in B lymphocytes and neuronal tissues. It is important
           in cell proliferation and survival. Transgenic mice
           expressing TLK display retarded growth and high
           mortality rate. In addition, a polymorphism in mouse and
           human LTK is implicated in the pathogenesis of systemic
           lupus erythematosus.
          Length = 277

 Score = 71.7 bits (176), Expect = 3e-16
 Identities = 34/84 (40%), Positives = 48/84 (57%), Gaps = 13/84 (15%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENIS---HLHADDGEFIYLPTPQTT 83
           FT+K+DVWSFGV LWEI +L    PY G T+ EV+E ++    L    G     P P   
Sbjct: 198 FTSKTDVWSFGVLLWEIFSLGY-MPYPGRTNQEVMEFVTGGGRLDPPKG----CPGP--- 249

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
             +  +M +CW+ +P +RP+F  I
Sbjct: 250 --VYRIMTDCWQHTPEDRPNFATI 271


>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine
           Kinases, Fyn and Yrk.  Protein Tyrosine Kinase (PTK)
           family; Fyn and Yrk kinases; catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fyn and
           Yrk are members of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Fyn, together with Lck, plays a
           critical role in T-cell signal transduction by
           phosphorylating ITAM (immunoreceptor tyr activation
           motif) sequences on T-cell receptors, ultimately leading
           to the proliferation and differentiation of T-cells. In
           addition, Fyn is involved in the myelination of neurons,
           and is implicated in Alzheimer's and Parkinson's
           diseases. Yrk has been detected only in chickens. It is
           primarily found in neuronal and epithelial cells and in
           macrophages. It may play a role in inflammation and in
           response to injury.
          Length = 260

 Score = 71.6 bits (175), Expect = 3e-16
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 9/92 (9%)

Query: 22  SLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ 81
           +L+ +FT KSDVWSFG+ L E++   R  PY G+ + EVLE +   +        +P PQ
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR-VPYPGMNNREVLEQVERGYR-------MPCPQ 226

Query: 82  TTKDIL-DLMNECWKRSPTERPSFTEIHLFLQ 112
                L +LM +CWK+ P ERP+F  +  FL+
Sbjct: 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258


>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine
           Kinase, Insulin-like Growth Factor-1 Receptor.  Protein
           Tyrosine Kinase (PTK) family; Insulin-like Growth
           Factor-1 Receptor (IGF-1R); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. IGF-1R is
           a receptor tyr kinases (RTK) that is composed of two
           alphabeta heterodimers. Binding of the ligand (IGF-1 or
           IGF-2) to the extracellular alpha subunit activates the
           intracellular tyr kinase domain of the transmembrane
           beta subunit. Receptor activation leads to
           autophosphorylation, which stimulates downstream kinase
           activities and biological function. IGF-1R signaling is
           important in the differentiation, growth, and survival
           of normal cells. In cancer cells, where it is frequently
           overexpressed, IGF-1R is implicated in proliferation,
           the suppression of apoptosis, invasion, and metastasis.
           IGF-1R is being developed as a therapeutic target in
           cancer treatment.
          Length = 277

 Score = 71.2 bits (174), Expect = 6e-16
 Identities = 38/82 (46%), Positives = 49/82 (59%), Gaps = 9/82 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           FTT SDVWSFGV LWEI  LA  +PY+G+++ +VL  +        E   L  P    D+
Sbjct: 198 FTTYSDVWSFGVVLWEIATLA-EQPYQGMSNEQVLRFVM-------EGGLLDKPDNCPDM 249

Query: 87  L-DLMNECWKRSPTERPSFTEI 107
           L +LM  CW+ +P  RPSF EI
Sbjct: 250 LFELMRMCWQYNPKMRPSFLEI 271


>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Fes subfamily; catalytic (c) domain. Fes subfamily
           members include Fes (or Fps), Fer, and similar proteins.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fes
           subfamily proteins are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal region with FCH
           (Fes/Fer/CIP4 homology) and coiled-coil domains,
           followed by a SH2 domain, and a C-terminal catalytic
           domain. The genes for Fes (feline sarcoma) and Fps
           (Fujinami poultry sarcoma) were first isolated from
           tumor-causing retroviruses. The viral oncogenes encode
           chimeric Fes proteins consisting of Gag sequences at the
           N-termini, resulting in unregulated tyr kinase activity.
           Fes and Fer kinases play roles in haematopoiesis,
           inflammation and immunity, growth factor signaling,
           cytoskeletal regulation, cell migration and adhesion,
           and the regulation of cell-cell interactions. Fes and
           Fer show redundancy in their biological functions.
          Length = 251

 Score = 70.6 bits (173), Expect = 8e-16
 Identities = 34/88 (38%), Positives = 52/88 (59%), Gaps = 9/88 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT-K 84
           ++T++SDVWS+G+ LWE  +L    PY G+++ +  E I     + G    +P PQ   +
Sbjct: 171 RYTSESDVWSYGILLWETFSLG-DTPYPGMSNQQTRERI-----ESG--YRMPAPQLCPE 222

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQ 112
           +I  LM +CW   P  RPSF+EI+  LQ
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250


>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src
           kinase-like Protein Tyrosine Kinases.  Protein Tyrosine
           Kinase (PTK) family; C-terminal Src kinase (Csk)
           subfamily; catalytic (c) domain. The Csk subfamily is
           composed of Csk, Chk, and similar proteins. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. To inhibit Src kinases,
           Csk and Chk are translocated to the membrane via binding
           to specific transmembrane proteins, G-proteins, or
           adaptor proteins near the membrane. Csk catalyzes the
           tyr phosphorylation of the regulatory C-terminal tail of
           Src kinases, resulting in their inactivation. Chk
           inhibit Src kinases using a noncatalytic mechanism by
           simply binding to them. As negative regulators of Src
           kinases, Csk and Chk play important roles in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression.
          Length = 256

 Score = 70.5 bits (173), Expect = 8e-16
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 17/95 (17%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPY--EGLTDL-EVLENISHLHADDG--EFIYLP 78
            +KF+TKSDVWSFG+ LWEI +  R  PY    L D+   +E    + A +G    +Y  
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVY-- 229

Query: 79  TPQTTKDILDLMNECWKRSPTERPSFTEIHLFLQR 113
                     +M +CW+  P +RP+F ++   L  
Sbjct: 230 ---------KVMKDCWELDPAKRPTFKQLREQLAL 255


>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine
           Kinase, Ephrin Receptor A10.  Protein Tyrosine Kinase
           (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10
           receptor; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). In general, class EphA receptors bind
           GPI-anchored ephrin-A ligands. There are ten vertebrate
           EphA receptors (EphA1-10), which display promiscuous
           interactions with six ephrin-A ligands. EphRs contain an
           ephrin binding domain and two fibronectin repeats
           extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). EphA10,
           which contains an inactive tyr kinase domain, may
           function to attenuate signals of co-clustered active
           receptors. EphA10 is mainly expressed in the testis.
           Ephrin/EphR interaction results in cell-cell repulsion
           or adhesion, making it important in neural development
           and plasticity, cell morphogenesis, cell-fate
           determination, embryonic development, tissue patterning,
           and angiogenesis.
          Length = 266

 Score = 70.3 bits (172), Expect = 1e-15
 Identities = 31/89 (34%), Positives = 54/89 (60%), Gaps = 9/89 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
            F++ SDVWSFG+ +WE+++    RPY  ++  +V++ +     +DG    LP P+   +
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGE-RPYWDMSGQDVIKAV-----EDG--FRLPAPRNCPN 235

Query: 86  IL-DLMNECWKRSPTERPSFTEIHLFLQR 113
           +L  LM +CW++   ERP F++IH  L +
Sbjct: 236 LLHQLMLDCWQKERGERPRFSQIHSILSK 264


>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase,
           Csk homologous kinase.  Protein Tyrosine Kinase (PTK)
           family; Csk homologous kinase (Chk); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. Chk is also referred to
           as megakaryocyte-associated tyrosine kinase (Matk). To
           inhibit Src kinases, Chk is translocated to the membrane
           via binding to specific transmembrane proteins,
           G-proteins, or adaptor proteins near the membrane. Chk
           inhibit Src kinases using a noncatalytic mechanism by
           simply binding to them. As a negative regulator of Src
           kinases, Chk may play important roles in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression. Chk
           is expressed in brain and hematopoietic cells. Studies
           in mice reveal that Chk is not functionally redundant
           with Csk and that it plays an important role as a
           regulator of immune responses. Chk also plays a role in
           neural differentiation in a manner independent of Src by
           enhancing Mapk activation via Ras-mediated signaling.
          Length = 254

 Score = 70.4 bits (172), Expect = 1e-15
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           H+KF++KSDVWS+GV LWE+ +  R  PY  ++  EV E +   +  +      P     
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGR-APYPKMSLKEVKECVEKGYRME------PPEGCP 223

Query: 84  KDILDLMNECWKRSPTERPSFTEIHLFLQRK 114
            D+  LM  CW+  P +RPSF ++   L+++
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254


>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine
           Kinases, Srm and Brk.  Protein Tyrosine Kinase (PTK)
           family; Src-related kinase lacking C-terminal regulatory
           tyrosine and N-terminal myristylation sites (Srm) and
           breast tumor kinase (Brk, also called protein tyrosine
           kinase 6); catalytic (c) domains. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Srm and
           Brk are a member of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases in general contain an N-terminal SH4 domain with
           a myristoylation site, followed by SH3 and SH2 domains,
           a tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr; they are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Srm and
           Brk however, lack the N-terminal myristylation sites.
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Brk has been found to be overexpressed
           in a majority of breast tumors.
          Length = 261

 Score = 70.2 bits (172), Expect = 1e-15
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 9/86 (10%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTP-QT 82
           H  F+TKSDVWSFG+ L+E+    +  PY G+ + EV + I+           +P P + 
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQ-VPYPGMNNHEVYDQIT-------AGYRMPCPAKC 229

Query: 83  TKDILDLMNECWKRSPTERPSFTEIH 108
            ++I  +M ECW   P +RPSF  + 
Sbjct: 230 PQEIYKIMLECWAAEPEDRPSFKALR 255


>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Fibroblast Growth Factor Receptors.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor (FGFR) subfamily; catalytic (c) domain. The
           FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4,
           and similar proteins. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K).PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. FGFR subfamily members
           are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with three
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding of
           FGFRs to their ligands, the FGFs, and to heparin/heparan
           sulfate (HS) results in the formation of a ternary
           complex, which leads to receptor dimerization and
           activation, and intracellular signaling. There are at
           least 23 FGFs and four types of FGFRs. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. FGF/FGFR signaling is
           important in the regulation of embryonic development,
           homeostasis, and regenerative processes. Depending on
           the cell type and stage, FGFR signaling produces diverse
           cellular responses including proliferation, growth
           arrest, differentiation, and apoptosis. Aberrant
           signaling leads to many human diseases such as skeletal,
           olfactory, and metabolic disorders, as well as cancer.
          Length = 293

 Score = 70.5 bits (173), Expect = 1e-15
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 11/114 (9%)

Query: 5   NDLMRDLTNGRIFKNKNSLH----RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEV 60
            D  R  TNGR+     +      R +T +SDVWSFGV LWEI  L    PY G+   E+
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-GSPYPGIPVEEL 243

Query: 61  LENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIHLFLQRK 114
            + +   +  +           T+++  LM +CW   P++RP+F ++   L R 
Sbjct: 244 FKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291


>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine
           Kinase, Tie1.  Protein Tyrosine Kinase (PTK) family;
           Tie1; catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie1 is a receptor tyr
           kinase (RTK) containing an extracellular region, a
           transmembrane segment, and an intracellular catalytic
           domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie receptors are
           specifically expressed in endothelial cells and
           hematopoietic stem cells. No specific ligand has been
           identified for Tie1, although the angiopoietin, Ang-1,
           binds to Tie1 through integrins at high concentrations.
           In vivo studies of Tie1 show that it is critical in
           vascular development.
          Length = 297

 Score = 70.4 bits (172), Expect = 1e-15
 Identities = 36/88 (40%), Positives = 51/88 (57%), Gaps = 9/88 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD- 85
           +TTKSDVWSFGV LWEI++L    PY G+T  E+ E +        +   +  P+   D 
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLG-GTPYCGMTCAELYEKLP-------QGYRMEKPRNCDDE 246

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFLQR 113
           + +LM +CW+  P ERP F +I + L R
Sbjct: 247 VYELMRQCWRDRPYERPPFAQISVQLSR 274


>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine
           Kinase, Insulin Receptor.  Protein Tyrosine Kinase (PTK)
           family; Insulin Receptor (InsR); catalytic (c) domain.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. InsR is a
           receptor tyr kinase (RTK) that is composed of two
           alphabeta heterodimers. Binding of the insulin ligand to
           the extracellular alpha subunit activates the
           intracellular tyr kinase domain of the transmembrane
           beta subunit. Receptor activation leads to
           autophosphorylation, stimulating downstream kinase
           activities, which initiate signaling cascades and
           biological function. InsR signaling plays an important
           role in many cellular processes including glucose
           homeostasis, glycogen synthesis, lipid and protein
           metabolism, ion and amino acid transport, cell cycle and
           proliferation, cell differentiation, gene transcription,
           and nitric oxide synthesis. Insulin resistance, caused
           by abnormalities in InsR signaling, has been described
           in diabetes, hypertension, cardiovascular disease,
           metabolic syndrome, heart failure, and female
           infertility.
          Length = 288

 Score = 70.0 bits (171), Expect = 1e-15
 Identities = 38/82 (46%), Positives = 52/82 (63%), Gaps = 9/82 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD- 85
           FTT SD+WSFGV LWEI +LA  +PY+GL++ +VL+ +     D G   YL  P    + 
Sbjct: 198 FTTSSDMWSFGVVLWEITSLAE-QPYQGLSNEQVLKFV----MDGG---YLDQPDNCPER 249

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           + DLM  CW+ +P  RP+F EI
Sbjct: 250 VTDLMRMCWQFNPKMRPTFLEI 271


>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine
           Kinases, Bruton's tyrosine kinase and Bone marrow kinase
           on the X chromosome.  Protein Tyrosine Kinase (PTK)
           family; Bruton's tyrosine kinase (Btk) and Bone marrow
           kinase on the X chromosome (Bmx); catalytic (c) domain.
           The PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Btk and
           Bmx (also named Etk) are members of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, Btk
           contains the Tec homology (TH) domain with proline-rich
           and zinc-binding regions. Tec kinases are expressed
           mainly by haematopoietic cells. Btk is expressed in
           B-cells, and a variety of myeloid cells including mast
           cells, platelets, neutrophils, and dendrictic cells. It
           interacts with a variety of partners, from cytosolic
           proteins to nuclear transcription factors, suggesting a
           diversity of functions. Stimulation of a diverse array
           of cell surface receptors, including antigen engagement
           of the B-cell receptor (BCR), leads to PH-mediated
           membrane translocation of Btk and subsequent
           phosphorylation by Src kinase and activation. Btk plays
           an important role in the life cycle of B-cells including
           their development, differentiation, proliferation,
           survival, and apoptosis. Mutations in Btk cause the
           primary immunodeficiency disease, X-linked
           agammaglobulinaemia (XLA) in humans. Bmx is primarily
           expressed in bone marrow and the arterial endothelium,
           and plays an important role in ischemia-induced
           angiogenesis. It facilitates arterial growth, capillary
           formation, vessel maturation, and bone marrow-derived
           endothelial progenitor cell mobilization.
          Length = 256

 Score = 69.5 bits (170), Expect = 2e-15
 Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 7/85 (8%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L+ KF++KSDVW+FGV +WE+ +L +  PYE   + E +E +S      G  +Y P    
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQ-----GLRLYRPH-LA 226

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
           ++ +  +M  CW     ERP+F ++
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQL 251


>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine
           Kinases.  Protein Tyrosine Kinase (PTK) family; Tie
           subfamily; catalytic (c) domain. The Tie subfamily
           consists of Tie1 and Tie2. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie proteins are
           receptor tyr kinases (RTKs) containing an extracellular
           region, a transmembrane segment, and an intracellular
           catalytic domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie receptors are
           specifically expressed in endothelial cells and
           hematopoietic stem cells. The angiopoietins (Ang-1 to
           Ang-4) serve as ligands for Tie2, while no specific
           ligand has been identified for Tie1. The binding of
           Ang-1 to Tie2 leads to receptor autophosphorylation and
           activation, promoting cell migration and survival. In
           contrast, Ang-2 binding to Tie2 does not result in the
           same response, suggesting that Ang-2 may function as an
           antagonist. In vivo studies of Tie1 show that it is
           critical in vascular development.
          Length = 270

 Score = 69.3 bits (169), Expect = 2e-15
 Identities = 37/88 (42%), Positives = 50/88 (56%), Gaps = 9/88 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD- 85
           +TT SDVWS+GV LWEI++L    PY G+T  E+ E +   +        L  P    D 
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLG-GTPYCGMTCAELYEKLPQGYR-------LEKPLNCDDE 239

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFLQR 113
           + DLM +CW+  P ERPSF +I + L R
Sbjct: 240 VYDLMRQCWREKPYERPSFAQILVSLNR 267


>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase,
           Interleukin-2-inducible T-cell Kinase.  Protein Tyrosine
           Kinase (PTK) family; Interleukin-2 (IL-2)-inducible
           T-cell kinase (Itk); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Itk (also
           known as Tsk or Emt) is a member of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. In addition, Itk
           contains the Tec homology (TH) domain containing one
           proline-rich region and a zinc-binding region. Tec
           kinases are expressed mainly by haematopoietic cells.
           Itk is expressed in T-cells and mast cells, and is
           important in their development and differentiation. Of
           the three Tec kinases expressed in T-cells, Itk plays
           the predominant role in T-cell receptor (TCR) signaling.
           It is activated by phosphorylation upon TCR crosslinking
           and is involved in the pathway resulting in
           phospholipase C-gamma1 activation and actin
           polymerization. It also plays a role in the downstream
           signaling of the T-cell costimulatory receptor CD28, the
           T-cell surface receptor CD2, and the chemokine receptor
           CXCR4. In addition, Itk is crucial for the development
           of T-helper(Th)2 effector responses.
          Length = 256

 Score = 69.2 bits (169), Expect = 2e-15
 Identities = 32/80 (40%), Positives = 50/80 (62%), Gaps = 7/80 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           K+++KSDVWSFGV +WE+ +  +  PYE  ++ EV+E I+      G  +Y P    ++ 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGK-TPYENRSNSEVVETIN-----AGFRLYKPR-LASQS 229

Query: 86  ILDLMNECWKRSPTERPSFT 105
           + +LM  CWK  P +RPSF+
Sbjct: 230 VYELMQHCWKERPEDRPSFS 249


>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein
           Tyrosine Kinases.  Protein Tyrosine Kinase (PTK) family;
           Axl subfamily; catalytic (c) domain. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). The Axl subfamily
           consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and
           similar proteins. PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Axl subfamily members
           are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with two
           immunoglobulin-like domains followed by two fibronectin
           type III repeats, a transmembrane segment, and an
           intracellular catalytic domain. Binding to their
           ligands, Gas6 and protein S, leads to receptor
           dimerization, autophosphorylation, activation, and
           intracellular signaling. Axl subfamily members are
           implicated in a variety of cellular effects including
           survival, proliferation, migration, and phagocytosis.
           They are also associated with several types of cancer as
           well as inflammatory, autoimmune, vascular, and kidney
           diseases. Mer is named after its original reported
           expression pattern (monocytes, epithelial, and
           reproductive tissues). It is required for the ingestion
           of apoptotic cells by phagocytes such as macrophages,
           retinal pigment epithelial cells, and dendritic cells.
           Mer is also important in maintaining immune homeostasis.
          Length = 273

 Score = 68.7 bits (168), Expect = 4e-15
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           R +T+KSDVW+FGVT+WEI    +  PY G+ + E+ + + H +        L  P+   
Sbjct: 190 RVYTSKSDVWAFGVTMWEIATRGQ-TPYPGVENHEIYDYLRHGNR-------LKQPEDCL 241

Query: 85  D-ILDLMNECWKRSPTERPSFTEIHLFLQR 113
           D + DLM  CW+  P +RP+FT++   L+ 
Sbjct: 242 DELYDLMYSCWRADPKDRPTFTKLREVLEN 271


>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine
           Kinase, Receptor tyrosine kinase-like Orphan Receptor 1.
            Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
           kinase-like Orphan Receptor 1 (Ror1); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ror
           proteins are orphan receptor tyr kinases (RTKs)
           containing an extracellular region with
           immunoglobulin-like, cysteine-rich, and kringle domains,
           a transmembrane segment, and an intracellular catalytic
           domain. Ror RTKs are unrelated to the nuclear receptor
           subfamily called retinoid-related orphan receptors
           (RORs). RTKs are usually activated through ligand
           binding, which causes dimerization and
           autophosphorylation of the intracellular tyr kinase
           catalytic domain. Ror kinases are expressed in many
           tissues during development. Avian Ror1 was found to be
           involved in late limb development. Studies in mice
           reveal that Ror1 is important in the regulation of
           neurite growth in central neurons, as well as in
           respiratory development. Loss of Ror1 also enhances the
           heart and skeletal abnormalities found in Ror2-deficient
           mice.
          Length = 283

 Score = 68.9 bits (168), Expect = 5e-15
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 9/91 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           ++ KF++ SD+WSFGV LWEI +    +PY G ++ EV+E +            LP  + 
Sbjct: 199 MYGKFSSDSDIWSFGVVLWEIFSFGL-QPYYGFSNQEVIEMVRKRQ-------LLPCSED 250

Query: 83  TKD-ILDLMNECWKRSPTERPSFTEIHLFLQ 112
               +  LM ECW+  P+ RP F +IH  L+
Sbjct: 251 CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281


>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine
           Kinase, Tie2.  Protein Tyrosine Kinase (PTK) family;
           Tie2; catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tie2 is a receptor tyr
           kinase (RTK) containing an extracellular region, a
           transmembrane segment, and an intracellular catalytic
           domain. The extracellular region contains an
           immunoglobulin (Ig)-like domain, three epidermal growth
           factor (EGF)-like domains, a second Ig-like domain, and
           three fibronectin type III repeats. Tie2 is expressed
           mainly in endothelial cells and hematopoietic stem
           cells. It is also found in a subset of tumor-associated
           monocytes and eosinophils. The angiopoietins (Ang-1 to
           Ang-4) serve as ligands for Tie2. The binding of Ang-1
           to Tie2 leads to receptor autophosphorylation and
           activation, promoting cell migration and survival. In
           contrast, Ang-2 binding to Tie2 does not result in the
           same response, suggesting that Ang-2 may function as an
           antagonist. Tie2 signaling plays key regulatory roles in
           vascular integrity and quiescence, and in inflammation.
          Length = 303

 Score = 68.9 bits (168), Expect = 5e-15
 Identities = 37/88 (42%), Positives = 50/88 (56%), Gaps = 9/88 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD- 85
           +TT SDVWS+GV LWEI++L    PY G+T  E+ E +        +   L  P    D 
Sbjct: 200 YTTNSDVWSYGVLLWEIVSLG-GTPYCGMTCAELYEKLP-------QGYRLEKPLNCDDE 251

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFLQR 113
           + DLM +CW+  P ERPSF +I + L R
Sbjct: 252 VYDLMRQCWREKPYERPSFAQILVSLNR 279


>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase,
           Abelson kinase.  Protein Tyrosine Kinase (PTK) family;
           Abelson (Abl) kinase; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Abl (or
           c-Abl) is a ubiquitously-expressed cytoplasmic (or
           nonreceptor) tyr kinase that contains SH3, SH2, and tyr
           kinase domains in its N-terminal region, as well as
           nuclear localization motifs, a putative DNA-binding
           domain, and F- and G-actin binding domains in its
           C-terminal tail. It also contains a short autoinhibitory
           cap region in its N-terminus. Abl is normally inactive
           and requires phosphorylation and myristoylation for
           activation. Abl function depends on its subcellular
           localization. In the cytoplasm, Abl plays a role in cell
           proliferation and survival. In response to DNA damage or
           oxidative stress, Abl is transported to the nucleus
           where it induces apoptosis. In chronic myelogenous
           leukemia (CML) patients, an aberrant translocation
           results in the replacement of the first exon of Abl with
           the BCR (breakpoint cluster region) gene. The resulting
           BCR-Abl fusion protein is constitutively active and
           associates into tetramers, resulting in a hyperactive
           kinase sending a continuous signal. This leads to
           uncontrolled proliferation, morphological transformation
           and anti-apoptotic effects. BCR-Abl is the target of
           selective inhibitors, such as imatinib (Gleevec), used
           in the treatment of CML. Abl2, also known as ARG
           (Abelson-related gene), is thought to play a cooperative
           role with Abl in the proper development of the nervous
           system. The Tel-ARG fusion protein, resulting from
           reciprocal translocation between chromosomes 1 and 12,
           is associated with acute myeloid leukemia (AML). The TEL
           gene is a frequent fusion partner of other tyr kinase
           oncogenes, including Tel/Abl, Tel/PDGFRbeta, and
           Tel/Jak2, found in patients with leukemia and
           myeloproliferative disorders.
          Length = 263

 Score = 68.0 bits (166), Expect = 7e-15
 Identities = 33/83 (39%), Positives = 45/83 (54%), Gaps = 7/83 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KF+ KSDVW+FGV LWEI       PY G+     L  +  L  + G  +  P       
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGM-SPYPGID----LSQVYEL-LEKGYRMERP-EGCPPK 233

Query: 86  ILDLMNECWKRSPTERPSFTEIH 108
           + +LM  CW+ +P++RPSF EIH
Sbjct: 234 VYELMRACWQWNPSDRPSFAEIH 256


>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine
           Kinase, HER2.  Protein Tyrosine Kinase (PTK) family;
           HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER2 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. HER2 does not bind to any known EGFR
           subfamily ligands, but contributes to the kinase
           activity of all possible heterodimers. It acts as the
           preferred partner with other ligand-bound EGFR proteins
           and functions as a signal amplifier, with the HER2-HER3
           heterodimer being the most potent pair in mitogenic
           signaling. HER2 plays an important role in cell
           development, proliferation, survival and motility.
           Overexpression of HER2 results in its activation and
           downstream signaling, even in the absence of ligand.
           HER2 overexpression, mainly due to gene amplification,
           has been shown in a variety of human cancers. Its role
           in breast cancer is especially well-documented. HER2 is
           up-regulated in about 25% of breast tumors and is
           associated with increases in tumor aggressiveness,
           recurrence and mortality. HER2 is a target for
           monoclonal antibodies and small molecule inhibitors,
           which are being developed as treatments for cancer. The
           first humanized antibody approved for clinical use is
           Trastuzumab (Herceptin), which is being used in
           combination with other therapies to improve the survival
           rates of patients with HER2-overexpressing breast
           cancer.
          Length = 279

 Score = 68.1 bits (166), Expect = 8e-15
 Identities = 32/85 (37%), Positives = 50/85 (58%), Gaps = 7/85 (8%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           LHR+FT +SDVWS+GVT+WE++     +PY+G+   E+ + +     + GE +  P P  
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGA-KPYDGIPAREIPDLL-----EKGERLPQP-PIC 236

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
           T D+  +M +CW      RP F E+
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFREL 261


>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine
           Kinases, Class EphA Ephrin Receptors.  Protein Tyrosine
           Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
           most class EphA receptors including EphA3, EphA4, EphA5,
           and EphA7, but excluding EphA1, EphA2 and EphA10;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. EphRs comprise the
           largest subfamily of receptor tyr kinases (RTKs). In
           general, class EphA receptors bind GPI-anchored ephrin-A
           ligands. There are ten vertebrate EphA receptors
           (EphA1-10), which display promiscuous interactions with
           six ephrin-A ligands. One exception is EphA4, which also
           binds ephrins-B2/B3. EphRs contain an ephrin-binding
           domain and two fibronectin repeats extracellularly, a
           transmembrane segment, and a cytoplasmic tyr kinase
           domain. Binding of the ephrin ligand to EphR requires
           cell-cell contact since both are anchored to the plasma
           membrane. The resulting downstream signals occur
           bidirectionally in both EphR-expressing cells (forward
           signaling) and ephrin-expressing cells (reverse
           signaling). Ephrin/EphR interaction mainly results in
           cell-cell repulsion or adhesion, making it important in
           neural development and plasticity, cell morphogenesis,
           cell-fate determination, embryonic development, tissue
           patterning, and angiogenesis. EphARs and ephrin-A
           ligands are expressed in multiple areas of the
           developing brain, especially in the retina and tectum.
           They are part of a system controlling retinotectal
           mapping.
          Length = 267

 Score = 67.6 bits (165), Expect = 1e-14
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           +RKFT+ SDVWS+G+ +WE+++    RPY  +++ +V++ I        E   LP P   
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGE-RPYWEMSNQDVIKAIE-------EGYRLPAPMDC 234

Query: 84  KDIL-DLMNECWKRSPTERPSFTEIHLFLQR 113
              L  LM +CW++   ERP F +I   L +
Sbjct: 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDK 265


>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine
           Kinases, Lymphocyte-specific kinase and Blk.  Protein
           Tyrosine Kinase (PTK) family; Lck and Blk kinases;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Lck (lymphocyte-specific
           kinase) and Blk are members of the Src subfamily of
           proteins, which are cytoplasmic (or non-receptor) tyr
           kinases. Src kinases contain an N-terminal SH4 domain
           with a myristoylation site, followed by SH3 and SH2
           domains, a tyr kinase domain, and a regulatory
           C-terminal region containing a conserved tyr. They are
           activated by autophosphorylation at the tyr kinase
           domain, but are negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           Src proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Lck is expressed in T-cells and natural
           killer (NK) cells. It plays a critical role in T-cell
           maturation, activation, and T-cell receptor (TCR)
           signaling. Lck phosphorylates ITAM (immunoreceptor tyr
           activation motif) sequences on several subunits of TCRs,
           leading to the activation of different second messenger
           cascades. Phosphorylated ITAMs serve as binding sites
           for other signaling factor such as Syk and ZAP-70,
           leading to their activation and propagation of
           downstream events. In addition, Lck regulates
           drug-induced apoptosis by interfering with the
           mitochondrial death pathway. The apototic role of Lck is
           independent of its primary function in T-cell signaling.
           Blk is expressed specifically in B-cells. It is involved
           in pre-BCR (B-cell receptor) signaling.
          Length = 260

 Score = 67.6 bits (165), Expect = 1e-14
 Identities = 33/79 (41%), Positives = 47/79 (59%), Gaps = 9/79 (11%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT-KD 85
           FT KSDVWSFG+ L EI+   R  PY G+T+ EV++N+   +        +P P    ++
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR-IPYPGMTNPEVIQNLERGYR-------MPRPDNCPEE 231

Query: 86  ILDLMNECWKRSPTERPSF 104
           + +LM  CWK  P ERP+F
Sbjct: 232 LYELMRLCWKEKPEERPTF 250


>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine
           Kinase, Tropomyosin Related Kinase B.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase B
           (TrkB); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. TrkB is a member of the
           Trk subfamily of proteins, which are receptor tyr
           kinases (RTKs) containing an extracellular region with
           arrays of leucine-rich motifs flanked by two
           cysteine-rich clusters followed by two
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. Binding of TrkB
           to its ligands, brain-derived neurotrophic factor (BDNF)
           or neurotrophin 4 (NT4), results in receptor
           oligomerization and activation of the catalytic domain.
           TrkB is broadly expressed in the nervous system and in
           some non-neural tissues. It plays important roles in
           cell proliferation, differentiation, and survival.
           BDNF/Trk signaling plays a key role in regulating
           activity-dependent synaptic plasticity. TrkB also
           contributes to protection against gp120-induced neuronal
           cell death. TrkB overexpression is associated with poor
           prognosis in neuroblastoma (NB) and other human cancers.
           It acts as a suppressor of anoikis (detachment-induced
           apoptosis) and contributes to tumor metastasis.
          Length = 288

 Score = 67.4 bits (164), Expect = 2e-14
 Identities = 42/101 (41%), Positives = 58/101 (57%), Gaps = 11/101 (10%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           ++RKFTT+SDVWS GV LWEI    + +P+  L++ EV+E I+           L  P+T
Sbjct: 195 MYRKFTTESDVWSLGVVLWEIFTYGK-QPWYQLSNNEVIECITQGRV-------LQRPRT 246

Query: 83  T-KDILDLMNECWKRSPTERPSFTEIHLFLQRKNLGYVPPM 122
             K++ DLM  CW+R P  R +  EIH  LQ  NL    P+
Sbjct: 247 CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ--NLAKASPV 285


>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase,
           Spleen tyrosine kinase.  Protein Tyrosine Kinase (PTK)
           family; Spleen tyrosine kinase (Syk); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Syk,
           together with Zap-70, form the Syk subfamily of kinases
           which are cytoplasmic (or nonreceptor) tyr kinases
           containing two Src homology 2 (SH2) domains N-terminal
           to the catalytic tyr kinase domain. Syk was first cloned
           from the spleen, and its function in hematopoietic cells
           is well-established. Syk is involved in the signaling
           downstream of activated receptors (including B-cell and
           Fc receptors) that contain ITAMs (immunoreceptor tyr
           activation motifs), leading to processes such as cell
           proliferation, differentiation, survival, adhesion,
           migration, and phagocytosis. More recently, Syk
           expression has been detected in other cell types
           (including epithelial cells, vascular endothelial cells,
           neurons, hepatocytes, and melanocytes), suggesting a
           variety of biological functions in non-immune cells. Syk
           plays a critical role in maintaining vascular integrity
           and in wound healing during embryogenesis. It also
           regulates Vav3, which is important in osteoclast
           function including bone development. In breast
           epithelial cells, where Syk acts as a negative regulator
           for epidermal growth factor receptor (EGFR) signaling,
           loss of Syk expression is associated with abnormal
           proliferation during cancer development suggesting a
           potential role as a tumor suppressor. In mice, Syk has
           been shown to inhibit malignant transformation of
           mammary epithelial cells induced with murine mammary
           tumor virus (MMTV).
          Length = 257

 Score = 66.5 bits (162), Expect = 2e-14
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 7/87 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KF++KSDVWSFGV +WE  +  + +PY+G+   EV + I     + GE +  P  +   +
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQ-KPYKGMKGNEVTQMI-----ESGERMECP-QRCPPE 226

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFLQ 112
           + DLM  CW     ERP F  + L L+
Sbjct: 227 MYDLMKLCWTYGVDERPGFAVVELRLR 253


>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine
           Kinase, Tyro3.  Protein Tyrosine Kinase (PTK) family;
           Tyro3; catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tyro3 (or Sky) is a
           member of the Axl subfamily, which is composed of
           receptor tyr kinases (RTKs) containing an extracellular
           ligand-binding region with two immunoglobulin-like
           domains followed by two fibronectin type III repeats, a
           transmembrane segment, and an intracellular catalytic
           domain. Binding to their ligands, Gas6 and protein S,
           leads to receptor dimerization, autophosphorylation,
           activation, and intracellular signaling. Tyro3 is
           predominantly expressed in the central nervous system
           and the brain, and functions as a neurotrophic factor.
           It is also expressed in osteoclasts and has a role in
           bone resorption.
          Length = 273

 Score = 66.9 bits (163), Expect = 2e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +TT SDVW+FGVT+WEI+   +  PY G+ + E+       +   G  +  P P   +D+
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQ-TPYAGVENSEIYN-----YLIKGNRLKQP-PDCLEDV 244

Query: 87  LDLMNECWKRSPTERPSFTEIHLFLQRKNL 116
            +LM +CW   P  RPSF   HL  Q + +
Sbjct: 245 YELMCQCWSPEPKCRPSFQ--HLRDQLELI 272


>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase,
           Src.  Protein Tyrosine Kinase (PTK) family; Src kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Src (or c-Src) is a
           cytoplasmic (or non-receptor) tyr kinase, containing an
           N-terminal SH4 domain with a myristoylation site,
           followed by SH3 and SH2 domains, a tyr kinase domain,
           and a regulatory C-terminal region with a conserved tyr.
           It is activated by autophosphorylation at the tyr kinase
           domain, and is negatively regulated by phosphorylation
           at the C-terminal tyr by Csk (C-terminal Src Kinase).
           c-Src is the vertebrate homolog of the oncogenic protein
           (v-Src) from Rous sarcoma virus. Together with other Src
           subfamily proteins, it is involved in signaling pathways
           that regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Src also play a role in regulating cell
           adhesion, invasion, and motility in cancer cells and
           tumor vasculature, contributing to cancer progression
           and metastasis. Elevated levels of Src kinase activity
           have been reported in a variety of human cancers.
           Several inhibitors of Src have been developed as
           anti-cancer drugs. Src is also implicated in acute
           inflammatory responses and osteoclast function.
          Length = 262

 Score = 66.6 bits (162), Expect = 3e-14
 Identities = 35/91 (38%), Positives = 55/91 (60%), Gaps = 7/91 (7%)

Query: 22  SLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ 81
           +L+ +FT KSDVWSFG+ L E+    R  PY G+ + EVL+ +     + G  +  P P+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGR-VPYPGMVNREVLDQV-----ERGYRMPCP-PE 227

Query: 82  TTKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
             + + DLM +CW++ P ERP+F  +  FL+
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258


>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine
           Kinase, Ephrin Receptor A2.  Protein Tyrosine Kinase
           (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2
           receptor; catalytic (c) domain. The PTKc family is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). In general, class EphA receptors bind
           GPI-anchored ephrin-A ligands. There are ten vertebrate
           EphA receptors (EphA1-10), which display promiscuous
           interactions with six ephrin-A ligands. EphRs contain an
           ephrin binding domain and two fibronectin repeats
           extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). Ephrin/EphR
           interaction mainly results in cell-cell repulsion or
           adhesion, making it important in neural development and
           plasticity, cell morphogenesis, cell-fate determination,
           embryonic development, tissue patterning, and
           angiogenesis. The EphA2 receptor is overexpressed in
           tumor cells and tumor blood vessels in a variety of
           cancers including breast, prostate, lung, and colon. As
           a result, it is an attractive target for drug design
           since its inhibition could affect several aspects of
           tumor progression.
          Length = 268

 Score = 66.5 bits (162), Expect = 3e-14
 Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 9/85 (10%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           +RKFT+ SDVWSFG+ +WE+++    RPY  +++ EV++ I+       +   LP P   
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGE-RPYWDMSNHEVMKAIN-------DGFRLPAPMDC 235

Query: 84  KD-ILDLMNECWKRSPTERPSFTEI 107
              +  LM +CW++    RP F +I
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDI 260


>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase,
           Axl.  Protein Tyrosine Kinase (PTK) family; Axl;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Axl is a member of the
           Axl subfamily, which is composed of receptor tyr kinases
           (RTKs) containing an extracellular ligand-binding region
           with two immunoglobulin-like domains followed by two
           fibronectin type III repeats, a transmembrane segment,
           and an intracellular catalytic domain. Binding to their
           ligands, Gas6 and protein S, leads to receptor
           dimerization, autophosphorylation, activation, and
           intracellular signaling. Axl is widely expressed in a
           variety of organs and cells including epithelial,
           mesenchymal, hematopoietic, as well as non-transformed
           cells. Axl signaling is important in many cellular
           functions such as survival, anti-apoptosis,
           proliferation, migration, and adhesion. Axl was
           originally isolated from patients with chronic
           myelogenous leukemia and a chronic myeloproliferative
           disorder. Axl is overexpressed in many human cancers
           including colon, squamous cell, thyroid, breast, and
           lung carcinomas.
          Length = 272

 Score = 66.6 bits (162), Expect = 3e-14
 Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 7/89 (7%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           R +TTKSDVWSFGVT+WEI    +  PY G+ + E+ + +       G  +  P P    
Sbjct: 189 RVYTTKSDVWSFGVTMWEIATRGQ-TPYPGVENSEIYDYLRQ-----GNRLKQP-PDCLD 241

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQR 113
            +  LM+ CW  +P +RPSF  +   L++
Sbjct: 242 GLYSLMSSCWLLNPKDRPSFETLRCELEK 270


>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine
           Kinases, Tyrosine kinase expressed in hepatocellular
           carcinoma and Resting lymphocyte kinase.  Protein
           Tyrosine Kinase (PTK) family; Tyrosine kinase expressed
           in hepatocellular carcinoma (Tec) and Resting lymphocyte
           kinase (Rlk); catalytic (c) domain. The PTKc family is
           part of a larger superfamily, that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Tec and
           Rlk (also named Txk) are members of the Tec subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases with similarity to Src kinases in that they
           contain Src homology protein interaction domains (SH3,
           SH2) N-terminal to the catalytic tyr kinase domain.
           Unlike Src kinases, most Tec subfamily members (except
           Rlk) also contain an N-terminal pleckstrin homology (PH)
           domain, which binds the products of PI3K and allows
           membrane recruitment and activation. Instead of PH, Rlk
           contains an N-terminal cysteine-rich region. In addition
           to PH, Tec also contains the Tec homology (TH) domain
           with proline-rich and zinc-binding regions. Tec kinases
           are expressed mainly by haematopoietic cells. Tec is
           more widely-expressed than other Tec subfamily kinases.
           It is found in endothelial cells, both B- and T-cells,
           and a variety of myeloid cells including mast cells,
           erythroid cells, platelets, macrophages and neutrophils.
           Rlk is expressed in T-cells and mast cell lines. Tec and
           Rlk are both key components of T-cell receptor (TCR)
           signaling. They are important in TCR-stimulated
           proliferation, IL-2 production and phopholipase C-gamma1
           activation.
          Length = 256

 Score = 66.0 bits (161), Expect = 4e-14
 Identities = 30/82 (36%), Positives = 47/82 (57%), Gaps = 7/82 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           K+++KSDVWSFGV +WE+    +  P+E  ++ EV+E IS      G  +Y P    +  
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISR-----GFRLYRPK-LASMT 229

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           + ++M  CW   P  RP+F E+
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAEL 251


>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine
           Kinase, Tropomyosin Related Kinase C.  Protein Tyrosine
           Kinase (PTK) family; Tropomyosin Related Kinase C
           (TrkC); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. TrkC is a member of the
           Trk subfamily of proteins, which are receptor tyr
           kinases (RTKs) containing an extracellular region with
           arrays of leucine-rich motifs flanked by two
           cysteine-rich clusters followed by two
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. Binding of TrkC
           to its ligand, neurotrophin 3 (NT3), results in receptor
           oligomerization and activation of the catalytic domain.
           TrkC is broadly expressed in the nervous system and in
           some non-neural tissues including the developing heart.
           NT3/TrkC signaling plays an important role in the
           innervation of the cardiac conducting system and the
           development of smooth muscle cells. Mice deficient with
           NT3 and TrkC have multiple heart defects. NT3/TrkC
           signaling is also critical for the development and
           maintenance of enteric neurons that are important for
           the control of gut peristalsis.
          Length = 291

 Score = 66.2 bits (161), Expect = 5e-14
 Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 7/89 (7%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           ++RKFTT+SDVWSFGV LWEI    + +P+  L++ EV+E I+      G  +  P    
Sbjct: 198 MYRKFTTESDVWSFGVILWEIFTYGK-QPWFQLSNTEVIECITQ-----GRVLERPR-VC 250

Query: 83  TKDILDLMNECWKRSPTERPSFTEIHLFL 111
            K++ D+M  CW+R P +R +  EI+  L
Sbjct: 251 PKEVYDIMLGCWQREPQQRLNIKEIYKIL 279


>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to
           tyrosine kinase).  Protein Tyrosine Kinase (PTK) family;
           Receptor related to tyrosine kinase (Ryk); pseudokinase
           domain. The PTKc (catalytic domain) family to which this
           subfamily belongs, is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ryk is a
           receptor tyr kinase (RTK) containing an extracellular
           region with two leucine-rich motifs, a transmembrane
           segment, and an intracellular inactive pseudokinase
           domain. The extracellular region of Ryk shows homology
           to the N-terminal domain of Wnt inhibitory factor-1
           (WIF) and serves as the ligand (Wnt) binding domain of
           Ryk. Ryk is expressed in many different tissues both
           during development and in adults, suggesting a
           widespread function. It acts as a chemorepulsive axon
           guidance receptor of Wnt glycoproteins and is
           responsible for the establishment of axon tracts during
           the development of the central nervous system. In
           addition, studies in mice reveal that Ryk is essential
           in skeletal, craniofacial, and cardiac development.
           Thus, it appears Ryk is involved in signal transduction
           despite its lack of kinase activity. Ryk may function as
           an accessory protein that modulates the signals coming
           from catalytically active partner RTKs such as the Eph
           receptors.
          Length = 280

 Score = 65.5 bits (160), Expect = 7e-14
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           +++++++ SDVWSFGV LWE++ L +  PY    +++  E  ++L   DG    L  P  
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQ-TPYV---EIDPFEMAAYLK--DG--YRLAQPIN 243

Query: 83  TKDIL-DLMNECWKRSPTERPSFTEIHLFLQ 112
             D L  +M  CW   P ERPSF+++   L 
Sbjct: 244 CPDELFAVMACCWALDPEERPSFSQLVQCLT 274


>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Vascular Endothelial Growth Factor Receptors.
           Protein Tyrosine Kinase (PTK) family; Vascular
           Endothelial Growth Factor Receptor (VEGFR) subfamily;
           catalytic (c) domain. The VEGFR subfamily consists of
           VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           VEGFR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           seven immunoglobulin (Ig)-like domains, a transmembrane
           segment, and an intracellular catalytic domain. In
           VEGFR3, the fifth Ig-like domain is replaced by a
           disulfide bridge. The binding of VEGFRs to their
           ligands, the VEGFs, leads to receptor dimerization,
           activation, and intracellular signaling. There are five
           VEGF ligands in mammals, which bind, in an overlapping
           pattern to the three VEGFRs, which can form homo or
           heterodimers. VEGFRs regulate the cardiovascular system.
           They are critical for vascular development during
           embryogenesis and blood vessel formation in adults. They
           induce cellular functions common to other growth factor
           receptors such as cell migration, survival, and
           proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta
           growth factor (PLGF). It regulates monocyte and
           macrophage migration, vascular permeability,
           haematopoiesis, and the recruitment of haematopietic
           progenitor cells from the bone marrow.
          Length = 337

 Score = 66.0 bits (161), Expect = 7e-14
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 8/84 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLT-DLEVLENISHLHADDGEFIYLPTPQTT 83
           + +TT+SDVWSFGV LWEI +L    PY G+  D E    +       G  +  P    T
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGA-SPYPGVQIDEEFCRRLKE-----GTRMRAPE-YAT 302

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
            +I  +M +CW  +P +RP+F+E+
Sbjct: 303 PEIYSIMLDCWHNNPEDRPTFSEL 326


>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase,
           Fes.  Protein Tyrosine Kinase (PTK) family; Fes (or Fps)
           kinase subfamily; catalytic (c) domain. The PTKc family
           is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Fes
           subfamily proteins are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal region with FCH
           (Fes/Fer/CIP4 homology) and coiled-coil domains,
           followed by a SH2 domain, and a C-terminal catalytic
           domain. The genes for Fes (feline sarcoma) and Fps
           (Fujinami poultry sarcoma) were first isolated from
           tumor-causing retroviruses. The viral oncogenes encode
           chimeric Fes proteins consisting of Gag sequences at the
           N-termini, resulting in unregulated tyr kinase activity.
           Fes kinase is expressed in myeloid, vascular
           endothelial, epithelial, and neuronal cells. It plays
           important roles in cell growth and differentiation,
           angiogenesis, inflammation and immunity, and
           cytoskeletal regulation. A recent study implicates Fes
           kinase as a tumor suppressor in colorectal cancer.
          Length = 252

 Score = 63.9 bits (155), Expect = 2e-13
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 9/88 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTP-QTTK 84
           +++++SDVWSFG+ LWE  +L    PY  L++ +  E I        + + LP P     
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGA-VPYANLSNQQTREAIE-------QGVRLPCPELCPD 223

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQ 112
            +  LM  CW+  P +RPSF+ +H  LQ
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251


>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinases, Janus kinases.  Protein Tyrosine
           Kinase (PTK) family; Janus kinase (Jak) subfamily;
           catalytic (c) domain (repeat 2). The Jak subfamily is
           composed of Jak1, Jak2, Jak3, TYK2, and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Jak subfamily proteins are cytoplasmic (or nonreceptor)
           tyr kinases containing an N-terminal FERM domain,
           followed by a Src homology 2 (SH2) domain, a
           pseudokinase domain, and a C-terminal tyr kinase
           catalytic domain. Most Jaks are expressed in a wide
           variety of tissues, except for Jak3, which is expressed
           only in hematopoietic cells. Jaks are crucial for
           cytokine receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Jaks are also involved in regulating the surface
           expression of some cytokine receptors. The Jak-STAT
           pathway is involved in many biological processes
           including hematopoiesis, immunoregulation, host defense,
           fertility, lactation, growth, and embryogenesis.
          Length = 284

 Score = 64.0 bits (156), Expect = 3e-13
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 9/97 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYL------- 77
            KF++ SDVWSFGVTL+E+             +   +  I+         + L       
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS-QSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 78  -PTPQTTKDILDLMNECWKRSPTERPSFTEIHLFLQR 113
              P    ++ DLM  CW+  P +RPSF ++ L + R
Sbjct: 246 PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282


>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase,
           Lyn.  Protein Tyrosine Kinase (PTK) family; Lyn kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Lyn is a member of the
           Src subfamily of proteins, which are cytoplasmic (or
           non-receptor) tyr kinases. Src kinases contain an
           N-terminal SH4 domain with a myristoylation site,
           followed by SH3 and SH2 domains, a tyr kinase domain,
           and a regulatory C-terminal region containing a
           conserved tyr. They are activated by autophosphorylation
           at the tyr kinase domain, but are negatively regulated
           by phosphorylation at the C-terminal tyr by Csk
           (C-terminal Src Kinase). Src proteins are involved in
           signaling pathways that regulate cytokine and growth
           factor responses, cytoskeleton dynamics, cell
           proliferation, survival, and differentiation. Lyn is
           expressed in B lymphocytes and myeloid cells. It
           exhibits both positive and negative regulatory roles in
           B cell receptor (BCR) signaling. Lyn, as well as Fyn and
           Blk, promotes B cell activation by phosphorylating ITAMs
           (immunoreceptor tyr activation motifs) in CD19 and in Ig
           components of BCR. It negatively regulates signaling by
           its unique ability to phosphorylate ITIMs
           (immunoreceptor tyr inhibition motifs) in cell surface
           receptors like CD22 and CD5. Lyn also plays an important
           role in G-CSF receptor signaling by phosphorylating a
           variety of adaptor molecules.
          Length = 261

 Score = 63.1 bits (153), Expect = 4e-13
 Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 9/86 (10%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           FT KSDVWSFG+ L+EI+   +  PY G+++ +V+  +   +        +P  +   D 
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGK-IPYPGMSNSDVMSALQRGYR-------MPRMENCPDE 232

Query: 87  L-DLMNECWKRSPTERPSFTEIHLFL 111
           L D+M  CWK    ERP+F  +   L
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVL 258


>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase,
           Hematopoietic cell kinase.  Protein Tyrosine Kinase
           (PTK) family; Hematopoietic cell kinase (Hck); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Hck is a member of the Src subfamily of proteins, which
           are cytoplasmic (or non-receptor) tyr kinases. Src
           kinases contain an N-terminal SH4 domain with a
           myristoylation site, followed by SH3 and SH2 domains, a
           tyr kinase domain, and a regulatory C-terminal region
           containing a conserved tyr. They are activated by
           autophosphorylation at the tyr kinase domain, but are
           negatively regulated by phosphorylation at the
           C-terminal tyr by Csk (C-terminal Src Kinase). Src
           proteins are involved in signaling pathways that
           regulate cytokine and growth factor responses,
           cytoskeleton dynamics, cell proliferation, survival, and
           differentiation. Hck is present in myeloid and lymphoid
           cells that play a role in the development of cancer. It
           may be important in the oncogenic signaling of the
           protein Tel-Abl, which induces a chronic myelogenous
           leukemia (CML)-like disease. Hck also acts as a negative
           regulator of granulocyte colony-stimulating factor
           (G-CSF)-induced proliferation of granulocytic
           precursors, suggesting a possible role in the
           development of acute myeloid leukemia (AML). In
           addition, Hck is essential in regulating the
           degranulation of polymorphonuclear leukocytes (PMNs).
           Genetic polymorphisms affect the expression level of
           Hck, which affects PMN mediator release and influences
           the development of chronic obstructive pulmonary disease
           (COPD).
          Length = 260

 Score = 63.1 bits (153), Expect = 4e-13
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 7/86 (8%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           FT KSDVWSFG+ L EI+   R  PY G+++ EV+  +         +         +++
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALER------GYRMPRPENCPEEL 232

Query: 87  LDLMNECWKRSPTERPSFTEIHLFLQ 112
            ++M  CWK  P ERP+F  I   L 
Sbjct: 233 YNIMMRCWKNRPEERPTFEYIQSVLD 258


>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase,
           C-terminal Src kinase.  Protein Tyrosine Kinase (PTK)
           family; C-terminal Src kinase (Csk); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. The Csk
           subfamily kinases are cytoplasmic (or nonreceptor) tyr
           kinases containing the Src homology domains, SH3 and
           SH2, N-terminal to the catalytic tyr kinase domain. They
           negatively regulate the activity of Src kinases that are
           anchored to the plasma membrane. To inhibit Src kinases,
           Csk is translocated to the membrane via binding to
           specific transmembrane proteins, G-proteins, or adaptor
           proteins near the membrane. Csk catalyzes the tyr
           phosphorylation of the regulatory C-terminal tail of Src
           kinases, resulting in their inactivation. Csk is
           expressed in a wide variety of tissues. As a negative
           regulator of Src, Csk plays a role in cell
           proliferation, survival, and differentiation, and
           consequently, in cancer development and progression. In
           addition, Csk also shows Src-independent functions. It
           is a critical component in G-protein signaling, and
           plays a role in cytoskeletal reorganization and cell
           migration.
          Length = 256

 Score = 62.7 bits (152), Expect = 6e-13
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 13/91 (14%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEV---LENISHLHADDGEFIYLPTPQ 81
           +KF+TKSDVWSFG+ LWEI +  R  PY  +   +V   +E    + A DG       P 
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVVPRVEKGYKMDAPDG------CPP 226

Query: 82  TTKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
               + D+M +CW      RPSF ++   L+
Sbjct: 227 V---VYDVMKQCWHLDAATRPSFLQLREQLE 254


>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine
           Kinase, Zeta-chain-associated protein of 70kDa.  Protein
           Tyrosine Kinase (PTK) family; Zeta-chain-associated
           protein of 70kDa (Zap-70); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Zap-70 is
           a member of the Syk subfamily of kinases, which are
           cytoplasmic (or nonreceptor) tyr kinases containing two
           Src homology 2 (SH2) domains N-terminal to the catalytic
           tyr kinase domain. Zap-70 is primarily expressed in
           T-cells and NK cells, and is a crucial component in
           T-cell receptor (TCR) signaling. Zap-70 binds the
           phosphorylated ITAM (immunoreceptor tyr activation
           motif) sequences of the activated TCR zeta-chain through
           its SH2 domains, leading to its phosphorylation and
           activation. It then phosphorylates target proteins,
           which propagate the signals to downstream pathways.
           Zap-70 is hardly detected in normal peripheral B-cells,
           but is present in some B-cell malignancies. It is used
           as a diagnostic marker for chronic lymphocytic leukemia
           (CLL) as it is associated with the more aggressive
           subtype of the disease.
          Length = 257

 Score = 62.7 bits (152), Expect = 7e-13
 Identities = 26/85 (30%), Positives = 49/85 (57%), Gaps = 7/85 (8%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
             RKF+++SDVWS+G+T+WE  +  + +PY+ +   EV+  I     + G+ +  P  + 
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQ-KPYKKMKGPEVMSFI-----EQGKRLDCP-AEC 223

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
             ++  LM +CW     +RP+F ++
Sbjct: 224 PPEMYALMKDCWIYKWEDRPNFAKV 248


>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine
           Kinases, Class EphB Ephrin Receptors.  Protein Tyrosine
           Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
           class EphB receptors; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EphRs
           comprise the largest subfamily of receptor tyr kinases
           (RTKs). Class EphB receptors bind to transmembrane
           ephrin-B ligands. There are six vertebrate EhpB
           receptors (EphB1-6), which display promiscuous
           interactions with three ephrin-B ligands. One exception
           is EphB2, which also interacts with ephrin A5. EphRs
           contain an ephrin-binding domain and two fibronectin
           repeats extracellularly, a transmembrane segment, and a
           cytoplasmic tyr kinase domain. Binding of the ephrin
           ligand to EphR requires cell-cell contact since both are
           anchored to the plasma membrane. The resulting
           downstream signals occur bidirectionally in both
           EphR-expressing cells (forward signaling) and
           ephrin-expressing cells (reverse signaling). Ephrin/EphR
           interaction mainly results in cell-cell repulsion or
           adhesion. EphBRs play important roles in synapse
           formation and plasticity, spine morphogenesis, axon
           guidance, and angiogenesis. In the intestinal
           epithelium, EphBRs are Wnt signaling target genes that
           control cell compartmentalization. They function as
           suppressors of color cancer progression.
          Length = 269

 Score = 61.8 bits (150), Expect = 1e-12
 Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 9/85 (10%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           +RKFT+ SDVWS+G+ +WE+++    RPY  +++ +V+  I   +        LP P   
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYG-ERPYWDMSNQDVINAIEQDYR-------LPPPMDC 236

Query: 84  KDIL-DLMNECWKRSPTERPSFTEI 107
              L  LM +CW++    RP F +I
Sbjct: 237 PTALHQLMLDCWQKDRNARPKFGQI 261


>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine
           Kinase, Epidermal Growth Factor Receptor.  Protein
           Tyrosine Kinase (PTK) family; Epidermal Growth Factor
           Receptor (EGFR); catalytic (c) domain. The PTKc family
           is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. EGFR
           (HER1, ErbB1) is a member of the EGFR (HER, ErbB)
           subfamily of proteins, which are receptor tyr kinases
           (RTKs) containing an extracellular EGF-related
           ligand-binding region, a transmembrane helix, and a
           cytoplasmic region with a tyr kinase domain and a
           regulatory C-terminal tail. Unlike other tyr kinases,
           phosphorylation of the activation loop of EGFR proteins
           is not critical to their activation. Instead, they are
           activated by ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Ligands for EGFR include EGF, heparin binding
           EGF-like growth factor (HBEGF), epiregulin,
           amphiregulin, TGFalpha, and betacellulin. Upon ligand
           binding, EGFR can form homo- or heterodimers with other
           EGFR subfamily members. The EGFR signaling pathway is
           one of the most important pathways regulating cell
           proliferation, differentiation, survival, and growth.
           Overexpression and mutation in the kinase domain of EGFR
           have been implicated in the development and progression
           of a variety of cancers. A number of monoclonal
           antibodies and small molecule inhibitors have been
           developed that target EGFR, including the antibodies
           Cetuximab and Panitumumab, which are used in combination
           with other therapies for the treatment of colorectal
           cancer and non-small cell lung carcinoma (NSCLC). The
           small molecule inhibitors Gefitinib (Iressa) and
           Erlotinib (Tarceva), already used for NSCLC, are
           undergoing clinical trials for other types of cancer
           including gastrointestinal, breast, head and neck, and
           bladder.
          Length = 316

 Score = 62.3 bits (151), Expect = 1e-12
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 13/88 (14%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLE---VLENISHLHADDGEFIYLPT 79
           LHR +T +SDVWS+GVT+WE++     +PY+G+   E   +LE         GE +  P 
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGS-KPYDGIPASEISSILEK--------GERLPQP- 233

Query: 80  PQTTKDILDLMNECWKRSPTERPSFTEI 107
           P  T D+  +M +CW      RP F E+
Sbjct: 234 PICTIDVYMIMVKCWMIDADSRPKFREL 261


>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine
           Kinases, Platelet Derived Growth Factor Receptors.
           Protein Tyrosine Kinase (PTK) family; Platelet Derived
           Growth Factor Receptor (PDGFR) subfamily; catalytic (c)
           domain. The PDGFR subfamily consists of PDGFR alpha,
           PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar
           proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           PDGFR subfamily members are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           five immunoglobulin-like domains, a transmembrane
           segment, and an intracellular catalytic domain. PDGFR
           kinase domains are autoinhibited by their juxtamembrane
           regions containing tyr residues. The binding to their
           ligands leads to receptor dimerization, trans
           phosphorylation and activation, and intracellular
           signaling. PDGFR subfamily receptors are important in
           the development of a variety of cells. PDGFRs are
           expressed in a many cells including fibroblasts,
           neurons, endometrial cells, mammary epithelial cells,
           and vascular smooth muscle cells. PDGFR signaling is
           critical in normal embryonic development, angiogenesis,
           and wound healing. PDGFRs transduce mitogenic signals
           for connective tissue cells and are important for cell
           shape and motility. Kit is important in the development
           of melanocytes, germ cells, mast cells, hematopoietic
           stem cells, the interstitial cells of Cajal, and the
           pacemaker cells of the GI tract. CSF-1R signaling is
           critical in the regulation of macrophages and
           osteoclasts. Mammalian FLT3 plays an important role in
           the survival, proliferation, and differentiation of stem
           cells.
          Length = 302

 Score = 61.3 bits (149), Expect = 3e-12
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 6/90 (6%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
            +  +T +SDVWS+G+ LWEI +L  + PY G+     +++  +    +G  +  P    
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSN-PYPGM----PVDSKFYKLIKEGYRMAQPE-HA 269

Query: 83  TKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
             +I D+M  CW   P +RP+F +I   + 
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299


>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain. 
          Length = 260

 Score = 60.7 bits (148), Expect = 4e-12
 Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 6/91 (6%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISH-LHADDGEFIYLPTPQT 82
              +  K DVWS GV L+E+L      P+ G   L+ L+ I   L     EF        
Sbjct: 173 GNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQLQLIRRILGPPL-EFDEPKWSSG 229

Query: 83  TKDILDLMNECWKRSPTERPSFTEI--HLFL 111
           +++  DL+ +C  + P++RP+  EI  H + 
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260


>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 4.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 4 (FGFR4); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR4 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Unlike other FGFRs,
           there is only one splice form of FGFR4. It binds FGF1,
           FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective
           ligand for FGFR4. Although disruption of FGFR4 in mice
           causes no obvious phenotype, in vivo inhibition of FGFR4
           in cultured skeletal muscle cells resulted in an arrest
           of muscle progenitor differentiation. FGF6 and FGFR4 are
           uniquely expressed in myofibers and satellite cells.
           FGF6/FGFR4 signaling appears to play a key role in the
           regulation of muscle regeneration. A polymorphism in
           FGFR4 is found in head and neck squamous cell carcinoma.
          Length = 314

 Score = 60.7 bits (147), Expect = 4e-12
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 11/106 (10%)

Query: 6   DLMRDLTNGRI----FKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVL 61
           D  +  +NGR+       +    R +T +SDVWSFG+ +WEI  L    PY G+   E+ 
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-GSPYPGIPVEELF 246

Query: 62  ENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           + +   H  D           T ++  LM ECW   PT+RP+F ++
Sbjct: 247 KLLREGHRMD------KPSNCTHELYMLMRECWHAVPTQRPTFKQL 286


>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 3.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 3 (FGFR3); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR3 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Many FGFR3 splice
           variants have been reported with the IIIb and IIIc
           isoforms being the predominant forms. FGFR3 IIIc is the
           isoform expressed in chondrocytes, the cells affected in
           dwarfism, while IIIb is expressed in epithelial cells.
           FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and
           FGF23. It is a negative regulator of long bone growth.
           In the cochlear duct and in the lens, FGFR3 is involved
           in differentiation while it appears to have a role in
           cell proliferation in epithelial cells. Germline
           mutations in FGFR3 are associated with skeletal
           disorders including several forms of dwarfism. Some
           missense mutations are associated with multiple myeloma
           and carcinomas of the bladder and cervix. Overexpression
           of FGFR3 is found in thyroid carcinoma.
          Length = 334

 Score = 60.4 bits (146), Expect = 7e-12
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)

Query: 6   DLMRDLTNGRI----FKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVL 61
           D  +  TNGR+       +    R +T +SDVWSFGV LWEI  L    PY G+   E+ 
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-GSPYPGIPVEELF 246

Query: 62  ENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           + +   H  D           T ++  +M ECW   P++RP+F ++
Sbjct: 247 KLLKEGHRMD------KPANCTHELYMIMRECWHAVPSQRPTFKQL 286


>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine
           Kinase, Vascular Endothelial Growth Factor Receptor 2.
           Protein Tyrosine Kinase (PTK) family; Vascular
           Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           VEGFR2 (or Flk1) is a member of the VEGFR subfamily of
           proteins, which are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           seven immunoglobulin (Ig)-like domains, a transmembrane
           segment, and an intracellular catalytic domain. The
           binding of VEGFRs to their ligands, the VEGFs, leads to
           receptor dimerization, activation, and intracellular
           signaling. The carboxyl terminus of VEGFR2 plays an
           important role in its autophosphorylation and
           activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD
           and VEGFE. VEGFR2 signaling is implicated in all aspects
           of normal and pathological vascular endothelial cell
           biology. It induces a variety of cellular effects
           including migration, survival, and proliferation. It is
           critical in regulating embryonic vascular development
           and angiogenesis. VEGFR2 is the major signal transducer
           in pathological angiogenesis including cancer and
           diabetic retinopathy, and is a target for inhibition in
           cancer therapy.
          Length = 343

 Score = 60.0 bits (145), Expect = 8e-12
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 8/84 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGL-TDLEVLENISHLHADDGEFIYLPTPQTT 83
           R +T +SDVWSFGV LWEI +L    PY G+  D E    +      +G  +  P   TT
Sbjct: 256 RVYTIQSDVWSFGVLLWEIFSLGA-SPYPGVKIDEEFCRRLK-----EGTRMRAPD-YTT 308

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
            ++   M +CW   P++RP+F+E+
Sbjct: 309 PEMYQTMLDCWHGEPSQRPTFSEL 332


>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine
           Kinases, Met and Ron.  Protein Tyrosine Kinase (PTK)
           family; Met and Ron; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Met and
           Ron are receptor tyr kinases (RTKs) composed of an
           alpha-beta heterodimer. The extracellular alpha chain is
           disulfide linked to the beta chain, which contains an
           extracellular ligand-binding region with a sema domain,
           a PSI domain and four IPT repeats, a transmembrane
           segment, and an intracellular catalytic domain. Binding
           to their ligands leads to receptor dimerization,
           autophosphorylation, activation, and intracellular
           signaling. Met binds to the ligand, hepatocyte growth
           factor/scatter factor (HGF/SF), and is also called the
           HGF receptor. HGF/Met signaling plays a role in growth,
           transformation, cell motility, invasion, metastasis,
           angiogenesis, wound healing, and tissue regeneration.
           Aberrant expression of Met through mutations or gene
           amplification is associated with many human cancers
           including hereditary papillary renal and gastric
           carcinomas. The ligand for Ron is macrophage stimulating
           protein (MSP). Ron signaling is important in regulating
           cell motility, adhesion, proliferation, and apoptosis.
           Aberrant Ron expression is implicated in tumorigenesis
           and metastasis.
          Length = 262

 Score = 59.4 bits (144), Expect = 1e-11
 Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 9/83 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KFTTKSDVWSFGV LWE++      PY  +   ++   +       G    L  P+   D
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGA-PPYPDVDSFDITVYLL-----QGR--RLLQPEYCPD 229

Query: 86  IL-DLMNECWKRSPTERPSFTEI 107
            L ++M  CW   P  RP+F+E+
Sbjct: 230 PLYEVMLSCWHPKPEMRPTFSEL 252


>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase,
           Fer.  Protein Tyrosine Kinase (PTK) family; Fer kinase;
           catalytic (c) domain. The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Fer kinase is a member
           of the Fes subfamily of proteins which are cytoplasmic
           (or nonreceptor) tyr kinases containing an N-terminal
           region with FCH (Fes/Fer/CIP4 homology) and coiled-coil
           domains, followed by a SH2 domain, and a C-terminal
           catalytic domain. Fer kinase is expressed in a wide
           variety of tissues, and is found to reside in both the
           cytoplasm and the nucleus. It plays important roles in
           neuronal polarization and neurite development,
           cytoskeletal reorganization, cell migration, growth
           factor signaling, and the regulation of cell-cell
           interactions mediated by adherens junctions and focal
           adhesions. Fer kinase also regulates cell cycle
           progression in malignant cells.
          Length = 250

 Score = 59.2 bits (143), Expect = 1e-11
 Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 9/84 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT-K 84
           +++++SDVWS+G+ LWE  +L    PY G+T+ +  E +   +        +  PQ    
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVC-PYPGMTNQQAREQVEKGYR-------MSCPQKCPD 221

Query: 85  DILDLMNECWKRSPTERPSFTEIH 108
           D+  +M  CW   P  RP F+E+ 
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSELQ 245


>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine
           Kinase, Vascular Endothelial Growth Factor Receptor 3.
           Protein Tyrosine Kinase (PTK) family; Vascular
           Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic
           (c) domain. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           VEGFR3 (or Flt4) is a member of the VEGFR subfamily of
           proteins, which are receptor tyr kinases (RTKs)
           containing an extracellular ligand-binding region with
           seven immunoglobulin (Ig)-like domains, a transmembrane
           segment, and an intracellular catalytic domain. In
           VEGFR3, the fifth Ig-like domain is replaced by a
           disulfide bridge. The binding of VEGFRs to their
           ligands, the VEGFs, leads to receptor dimerization,
           activation, and intracellular signaling. VEGFR3
           preferentially binds the ligands VEGFC and VEGFD. VEGFR3
           is essential for lymphatic endothelial cell (EC)
           development and function. It has been shown to regulate
           adaptive immunity during corneal transplantation. VEGFR3
           is upregulated on blood vascular ECs in pathological
           conditions such as vascular tumors and the periphery of
           solid tumors. It plays a role in cancer progression and
           lymph node metastasis. Missense mutations in the VEGFR3
           gene are associated with primary human lymphedema.
          Length = 338

 Score = 59.6 bits (144), Expect = 1e-11
 Identities = 32/82 (39%), Positives = 46/82 (56%), Gaps = 8/82 (9%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLT-DLEVLENISHLHADDGEFIYLPTPQTTKD 85
           +TT+SDVWSFGV LWEI +L    PY G+  + E  + +      DG  +  P    T +
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGA-SPYPGVQINEEFCQRLK-----DGTRMRAPE-NATPE 305

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           I  +M  CW+  P ERP+F+ +
Sbjct: 306 IYRIMLACWQGDPKERPTFSAL 327


>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 1.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 1 (FGFR1); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR1 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. Alternative splicing of
           FGFR1 transcripts produces a variety of isoforms, which
           are differentially expressed in cells. FGFR1 binds the
           ligands, FGF1 and FGF2, with high affinity and has also
           been reported to bind FGF4, FGF6, and FGF9. FGFR1
           signaling is critical in the control of cell migration
           during embryo development. It promotes cell
           proliferation in fibroblasts. Nuclear FGFR1 plays a role
           in the regulation of transcription. Mutations,
           insertions or deletions of FGFR1 have been identified in
           patients with Kallman's syndrome (KS), an inherited
           disorder characterized by hypogonadotropic hypogonadism
           and loss of olfaction. Aberrant FGFR1 expression has
           been found in some human cancers including 8P11
           myeloproliferative syndrome (EMS), breast cancer, and
           pancreatic adenocarcinoma.
          Length = 307

 Score = 59.3 bits (143), Expect = 1e-11
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 11/106 (10%)

Query: 6   DLMRDLTNGRI----FKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVL 61
           D  +  TNGR+       +    R +T +SDVWSFGV LWEI  L    PY G+   E+ 
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-GSPYPGVPVEELF 252

Query: 62  ENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           + +   H  D      P+   T ++  +M +CW   P++RP+F ++
Sbjct: 253 KLLKEGHRMDK-----PS-NCTNELYMMMRDCWHAVPSQRPTFKQL 292


>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine
           Kinase, Receptor tyrosine kinase-like Orphan Receptor 2.
            Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
           kinase-like Orphan Receptor 2 (Ror2); catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Ror
           proteins are orphan receptor tyr kinases (RTKs)
           containing an extracellular region with
           immunoglobulin-like, cysteine-rich, and kringle domains,
           a transmembrane segment, and an intracellular catalytic
           domain. Ror RTKs are unrelated to the nuclear receptor
           subfamily called retinoid-related orphan receptors
           (RORs). RTKs are usually activated through ligand
           binding, which causes dimerization and
           autophosphorylation of the intracellular tyr kinase
           catalytic domain. Ror2 plays important roles in skeletal
           and heart formation. Ror2-deficient mice show widespread
           bone abnormalities, ventricular defects in the heart,
           and respiratory dysfunction. Mutations in human Ror2
           result in two different bone development genetic
           disorders, recessive Robinow syndrome and brachydactyly
           type B. Ror2 is also implicated in neural development.
          Length = 283

 Score = 59.3 bits (143), Expect = 1e-11
 Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 9/84 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           KF+  SD+WS+GV LWE+ +    +PY G ++ +V+E I +          LP P     
Sbjct: 202 KFSIDSDIWSYGVVLWEVFSYGL-QPYCGYSNQDVIEMIRNRQV-------LPCPDDCPA 253

Query: 86  -ILDLMNECWKRSPTERPSFTEIH 108
            +  LM ECW   P+ RP F +IH
Sbjct: 254 WVYTLMLECWNEFPSRRPRFKDIH 277


>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase,
           REarranged during Transfection protein.  Protein
           Tyrosine Kinase (PTK) family; RET (REarranged during
           Transfection) protein; catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. RET is a
           receptor tyr kinase (RTK) containing an extracellular
           region with four cadherin-like repeats, a
           calcium-binding site, and a cysteine-rich domain, a
           transmembrane segment, and an intracellular catalytic
           domain. It is part of a multisubunit complex that binds
           glial-derived neurotropic factor (GDNF) family ligands
           (GFLs) including GDNF, neurturin, artemin, and
           persephin. GFLs bind RET along with four GPI-anchored
           coreceptors, bringing two RET molecules together,
           leading to autophosphorylation, activation, and
           intracellular signaling. RET is essential for the
           development of the sympathetic, parasympathetic and
           enteric nervous systems, and the kidney. RET disruption
           by germline mutations causes diseases in humans
           including congenital aganglionosis of the
           gastrointestinal tract (Hirschsprung's disease) and
           three related inherited cancers: multiple endocrine
           neoplasia type 2A (MEN2A), MEN2B, and familial medullary
           thyroid carcinoma (FMTC).
          Length = 290

 Score = 59.2 bits (143), Expect = 2e-11
 Identities = 32/81 (39%), Positives = 49/81 (60%), Gaps = 7/81 (8%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +TT+SDVWSFGV LWEI+ L  + PY G+      E + +L    G  +  P    ++++
Sbjct: 206 YTTQSDVWSFGVLLWEIVTLGGN-PYPGIAP----ERLFNL-LKTGYRMERPE-NCSEEM 258

Query: 87  LDLMNECWKRSPTERPSFTEI 107
            +LM  CWK+ P +RP+F +I
Sbjct: 259 YNLMLTCWKQEPDKRPTFADI 279


>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine
           Kinase, HER4.  Protein Tyrosine Kinase (PTK) family;
           HER4 (ErbB4); catalytic (c) domain. The PTKc family is
           part of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER4 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. Ligands that bind HER4 fall into two groups,
           the neuregulins (or heregulins) and some EGFR (HER1)
           ligands including betacellulin, HBEGF, and epiregulin.
           All four neuregulins (NRG1-4) interact with HER4. Upon
           ligand binding, HER4 forms homo- or heterodimers with
           other HER proteins. HER4 is essential in embryonic
           development. It is implicated in mammary gland, cardiac,
           and neural development. As a postsynaptic receptor of
           NRG1, HER4 plays an important role in synaptic
           plasticity and maturation. The impairment of NRG1/HER4
           signaling may contribute to schizophrenia.
          Length = 303

 Score = 59.3 bits (143), Expect = 2e-11
 Identities = 31/84 (36%), Positives = 49/84 (58%), Gaps = 7/84 (8%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           +RKFT +SDVWS+GVT+WE++     +PY+G+   E+ + +     + GE +  P P  T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFG-GKPYDGIPTREIPDLL-----EKGERLPQP-PICT 237

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
            D+  +M +CW      RP F E+
Sbjct: 238 IDVYMVMVKCWMIDADSRPKFKEL 261


>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine
           Kinases, Apoptosis-associated tyrosine kinases.  Protein
           Tyrosine Kinase (PTK) family; Apoptosis-associated
           tyrosine kinase (Aatyk) subfamily; catalytic (c) domain.
           The Aatyk subfamily is also referred to as the lemur
           tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1
           (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and
           similar proteins. The PTKc family is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Aatyk proteins are mostly receptor tyr kinases (RTKs)
           containing a transmembrane segment and a long C-terminal
           cytoplasmic tail with a catalytic domain. Aatyk1 does
           not contain a transmembrane segment and is a cytoplasmic
           (or nonreceptor) kinase. Aatyk proteins are classified
           as tyr kinases based on overall sequence similarity and
           the phylogenetic tree. However, analysis of catalytic
           residues suggests that Aatyk proteins may be
           multispecific kinases, functioning also as
           serine/threonine kinases. They are involved in neural
           differentiation, nerve growth factor (NGF) signaling,
           apoptosis, and spermatogenesis.
          Length = 269

 Score = 58.7 bits (142), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 11/95 (11%)

Query: 21  NSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTP 80
           + L +  T KS++WS GVT+WE+   A  +PY  L+D +VL+ +  +   D   I LP P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAAD-QPYPDLSDEQVLKQV--VREQD---IKLPKP 233

Query: 81  QTTKDILD----LMNECWKRSPTERPSFTEIHLFL 111
           Q      D    +M  CW   P  RP+  E+H  L
Sbjct: 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267


>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine
           Kinase, Colony-Stimulating Factor-1 Receptor.  Protein
           Tyrosine Kinase (PTK) family; Colony-Stimulating
           Factor-1 Receptor (CSF-1R); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. CSF-1R,
           also called c-Fms, is a member of the Platelet Derived
           Growth Factor Receptor (PDGFR) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular ligand-binding region with five
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding of
           CSF-1R to its ligand, CSF-1, leads to receptor
           dimerization, trans phosphorylation and activation, and
           intracellular signaling. CSF-1R signaling is critical in
           the regulation of macrophages and osteoclasts. It leads
           to increases in gene transcription and protein
           translation, and induces cytoskeletal remodeling. CSF-1R
           signaling leads to a variety of cellular responses
           including survival, proliferation, and differentiation
           of target cells. It plays an important role in innate
           immunity, tissue development and function, and the
           pathogenesis of some diseases including atherosclerosis
           and cancer. CSF-1R signaling is also implicated in
           mammary gland development during pregnancy and
           lactation. Aberrant CSF-1/CSF-1R expression correlates
           with tumor cell invasiveness, poor clinical prognosis,
           and bone metastasis in breast cancer. Although the
           structure of the human CSF-1R catalytic domain is known,
           it is excluded from this specific alignment model
           because it contains a deletion in its sequence.
          Length = 374

 Score = 58.3 bits (141), Expect = 4e-11
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +T +SDVWS+G+ LWEI +L +  PY G+    ++ +  +     G  +  P      +I
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKS-PYPGI----LVNSKFYKMVKRGYQMSRPD-FAPPEI 344

Query: 87  LDLMNECWKRSPTERPSFTEIHLFLQR 113
             +M  CW   PTERP+F++I   +QR
Sbjct: 345 YSIMKMCWNLEPTERPTFSQISQLIQR 371


>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic
           domain.  Phosphotransferases. Serine or
           threonine-specific kinase subfamily.
          Length = 254

 Score = 57.5 bits (140), Expect = 5e-11
 Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 5/85 (5%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L + +    D+WS GV L+E+  L    P+ G   L     +             P    
Sbjct: 169 LGKGYGKAVDIWSLGVILYEL--LTGKPPFPGDDQLLE---LFKKIGKPKPPFPPPEWDI 223

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
           + +  DL+ +   + P +R +  E 
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEA 248


>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine
           Kinase, Fibroblast Growth Factor Receptor 2.  Protein
           Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
           Receptor 2 (FGFR2); catalytic (c) domain. The PTKc
           family is part of a larger superfamily that includes the
           catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. FGFR2 is
           part of the FGFR subfamily, which are receptor tyr
           kinases (RTKs) containing an extracellular
           ligand-binding region with three immunoglobulin-like
           domains, a transmembrane segment, and an intracellular
           catalytic domain. The binding of FGFRs to their ligands,
           the FGFs, results in receptor dimerization and
           activation, and intracellular signaling. The binding of
           FGFs to FGFRs is promiscuous, in that a receptor may be
           activated by several ligands and a ligand may bind to
           more that one type of receptor. There are many splice
           variants of FGFR2 which show differential expression and
           binding to FGF ligands. Disruption of either FGFR2 or
           FGFR2b is lethal in mice, due to defects in the placenta
           or severe impairment of tissue development including
           lung, limb, and thyroid, respectively. Disruption of
           FGFR2c in mice results in defective bone and skull
           development. Genetic alterations of FGFR2 are associated
           with many human skeletal disorders including Apert
           syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and
           Pfeiffer syndrome.
          Length = 304

 Score = 56.6 bits (136), Expect = 1e-10
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 11/106 (10%)

Query: 6   DLMRDLTNGRI----FKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVL 61
           D  +  TNGR+       +    R +T +SDVWSFGV +WEI  L    PY G+   E+ 
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-GSPYPGIPVEELF 249

Query: 62  ENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           + +   H  D           T ++  +M +CW   P+ RP+F ++
Sbjct: 250 KLLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPTFKQL 289


>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine
           Kinase, HER3.  Protein Tyrosine Kinase (PTK) family;
           HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic
           domain) family to which this subfamily belongs, is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. HER3 is a
           member of the EGFR (HER, ErbB) subfamily of proteins,
           which are receptor tyr kinases (RTKs) containing an
           extracellular EGF-related ligand-binding region, a
           transmembrane helix, and a cytoplasmic region with a tyr
           kinase domain and a regulatory C-terminal tail. Unlike
           other tyr kinases, phosphorylation of the activation
           loop of EGFR proteins is not critical to their
           activation. Instead, they are activated by
           ligand-induced dimerization, leading to the
           phosphorylation of tyr residues in the C-terminal tail,
           which serve as binding sites for downstream signaling
           molecules. HER3 binds the neuregulin ligands, NRG1 and
           NRG2. HER3 contains an impaired tyr kinase domain and
           relies on its heterodimerization partners for activity
           following ligand binding. The HER2-HER3 heterodimer
           constitutes a high affinity co-receptor capable of
           potent mitogenic signaling. HER3 participates in a
           signaling pathway involved in the proliferation,
           survival, adhesion, and motility of tumor cells.
          Length = 279

 Score = 55.3 bits (133), Expect = 4e-10
 Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 9/86 (10%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
           L  ++T +SDVWS+GVT+WE+++     PY G+   EV + +     + GE   L  PQ 
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGA-EPYAGMRPHEVPDLL-----EKGE--RLAQPQI 235

Query: 83  -TKDILDLMNECWKRSPTERPSFTEI 107
            T D+  +M +CW      RP+F E+
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261


>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine
           Kinase, Platelet Derived Growth Factor Receptor alpha.
           Protein Tyrosine Kinase (PTK) family; Platelet Derived
           Growth Factor Receptor (PDGFR) alpha; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. PDGFR
           alpha is a receptor tyr kinase (RTK) containing an
           extracellular ligand-binding region with five
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding to
           its ligands, the PDGFs, leads to receptor dimerization,
           trans phosphorylation and activation, and intracellular
           signaling. PDGFR alpha forms homodimers or heterodimers
           with PDGFR beta, depending on the nature of the PDGF
           ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha
           homodimerization. PDGFR signaling plays many roles in
           normal embryonic development and adult physiology. PDGFR
           alpha signaling is important in the formation of lung
           alveoli, intestinal villi, mesenchymal dermis, and hair
           follicles, as well as in the development of
           oligodendrocytes, retinal astrocytes, neural crest
           cells, and testicular cells. Aberrant PDGFR alpha
           expression is associated with some human cancers.
           Mutations in PDGFR alpha have been found within a subset
           of gastrointestinal stromal tumors (GISTs). An active
           fusion protein FIP1L1-PDGFR alpha, derived from
           interstitial deletion, is associated with idiopathic
           hypereosinophilic syndrome (HES) and chronic
           eosinophilic leukemia (CEL).
          Length = 400

 Score = 55.0 bits (132), Expect = 6e-10
 Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 6/78 (7%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +TT SDVWS+G+ LWEI +L    PY G+    ++++  +     G  +  P    T+++
Sbjct: 316 YTTLSDVWSYGILLWEIFSLG-GTPYPGM----IVDSTFYNKIKSGYRMAKPD-HATQEV 369

Query: 87  LDLMNECWKRSPTERPSF 104
            D+M +CW   P +RPSF
Sbjct: 370 YDIMVKCWNSEPEKRPSF 387


>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine
           Kinase, Platelet Derived Growth Factor Receptor beta.
           Protein Tyrosine Kinase (PTK) family; Platelet Derived
           Growth Factor Receptor (PDGFR) beta; catalytic (c)
           domain. The PTKc family is part of a larger superfamily
           that includes the catalytic domains of other kinases
           such as protein serine/threonine kinases, RIO kinases,
           and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. PDGFR
           beta is a receptor tyr kinase (RTK) containing an
           extracellular ligand-binding region with five
           immunoglobulin-like domains, a transmembrane segment,
           and an intracellular catalytic domain. The binding to
           its ligands, the PDGFs, leads to receptor dimerization,
           trans phosphorylation and activation, and intracellular
           signaling. PDGFR beta forms homodimers or heterodimers
           with PDGFR alpha, depending on the nature of the PDGF
           ligand. PDGF-BB and PDGF-DD induce PDGFR beta
           homodimerization. PDGFR signaling plays many roles in
           normal embryonic development and adult physiology. PDGFR
           beta signaling leads to a variety of cellular effects
           including the stimulation of cell growth and chemotaxis,
           as well as the inhibition of apoptosis and GAP
           junctional communication. It is critical in normal
           angiogenesis as it is involved in the recruitment of
           pericytes and smooth muscle cells essential for vessel
           stability. Aberrant PDGFR beta expression is associated
           with some human cancers. The continuously-active fusion
           proteins of PDGFR beta with COL1A1 and TEL are
           associated with dermatofibrosarcoma protuberans (DFSP)
           and a subset of chronic myelomonocytic leukemia (CMML),
           respectively.
          Length = 401

 Score = 52.7 bits (126), Expect = 3e-09
 Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 15/117 (12%)

Query: 6   DLMRD---LTNGRIF------KNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLT 56
           D+MRD   ++ G  F        ++  +  +TT SDVWSFG+ LWEI  L    PY  L 
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG-GTPYPELP 346

Query: 57  DLEVLENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIHLFLQR 113
             E   N        G  +  P    + +I ++M +CW+     RP F+++   +  
Sbjct: 347 MNEQFYNA----IKRGYRMAKPA-HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398


>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the
           Protein Tyrosine Kinases, Janus kinases 2 and 3.
           Protein Tyrosine Kinase (PTK) family; Janus kinase 2
           (Jak2) and Jak3; catalytic (c) domain (repeat 2). The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Jak2 and
           Jak3 are members of the Janus kinase (Jak) subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal FERM domain, followed
           by a Src homology 2 (SH2) domain, a pseudokinase domain,
           and a C-terminal catalytic tyr kinase domain. Jaks are
           crucial for cytokine receptor signaling. They are
           activated by autophosphorylation upon cytokine-induced
           receptor aggregation, and subsequently trigger
           downstream signaling events such as the phosphorylation
           of signal transducers and activators of transcription
           (STATs). Jak2 is widely expressed in many tissues while
           Jak3 is expressed only in hematopoietic cells. Jak2 is
           essential for the signaling of hormone-like cytokines
           such as growth hormone, erythropoietin, thrombopoietin,
           and prolactin, as well as some IFNs and cytokines that
           signal through the IL-3 and gp130 receptors. Jak3 binds
           the shared receptor subunit common gamma chain and thus,
           is essential in the signaling of cytokines that use it
           such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
           Disruption of Jak2 in mice results in an embryonic
           lethal phenotype with multiple defects including
           erythropoietic and cardiac abnormalities. It is the only
           Jak gene that results in a lethal phenotype when
           disrupted in mice. A mutation in the pseudokinase domain
           of Jak2, V617F, is present in many myeloproliferative
           diseases, including almost all patients with
           polycythemia vera, and 50% of patients with essential
           thrombocytosis and myelofibrosis. Jak3 is important in
           lymphoid development and myeloid cell differentiation.
           Inactivating mutations in Jak3 have been reported in
           humans with severe combined immunodeficiency (SCID).
          Length = 284

 Score = 51.7 bits (124), Expect = 6e-09
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 8/90 (8%)

Query: 26  KFTTKSDVWSFGVTLWEIL---NLARHRPYEGLT----DLEVLENISHLHADDGEFIYLP 78
           KF+  SDVWSFGV L+E+    + +   P E +     D +    + HL         LP
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246

Query: 79  TPQTTKD-ILDLMNECWKRSPTERPSFTEI 107
            P      I  +M ECW   P++RPSF+E+
Sbjct: 247 APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276


>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine
           Kinase, Never In Mitosis gene A-related kinase.
           Serine/Threonine Kinases (STKs), Never In Mitosis gene A
           (NIMA)-related kinase (Nek) family, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. The Nek family is
           composed of 11 different mammalian members (Nek1-11)
           with similarity to the catalytic domain of Aspergillus
           nidulans NIMA kinase, the founding member of the Nek
           family which was identified in a screen for cell cycle
           mutants that were prevented from entering mitosis. Neks
           contain a conserved N-terminal catalytic domain and a
           more divergent C-terminal regulatory region of various
           sizes and structures. They are involved in the
           regulation of downstream processes following the
           activation of Cdc2, and many of their functions are cell
           cycle-related. They play critical roles in microtubule
           dynamics during ciliogenesis and mitosis.
          Length = 258

 Score = 51.7 bits (125), Expect = 6e-09
 Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 8/84 (9%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           ++ +  KSD+WS G  L+E+  L    P+EG   LE+   I       G++  +P  Q +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTL--KHPFEGENLLELALKILK-----GQYPPIP-SQYS 228

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
            ++ +L++   ++ P ERPS  +I
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQI 252


>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase,
           Kit.  Protein Tyrosine Kinase (PTK) family; Kit (or
           c-Kit); catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Kit is a member of the
           Platelet Derived Growth Factor Receptor (PDGFR)
           subfamily of proteins, which are receptor tyr kinases
           (RTKs) containing an extracellular ligand-binding region
           with five immunoglobulin-like domains, a transmembrane
           segment, and an intracellular catalytic domain. The
           binding of Kit to its ligand, the stem-cell factor
           (SCF), leads to receptor dimerization, trans
           phosphorylation and activation, and intracellular
           signaling. Kit is important in the development of
           melanocytes, germ cells, mast cells, hematopoietic stem
           cells, the interstitial cells of Cajal, and the
           pacemaker cells of the GI tract. Kit signaling is
           involved in major cellular functions including cell
           survival, proliferation, differentiation, adhesion, and
           chemotaxis. Mutations in Kit, which result in
           constitutive ligand-independent activation, are found in
           human cancers such as gastrointestinal stromal tumor
           (GIST) and testicular germ cell tumor (TGCT). The
           aberrant expression of Kit and/or SCF is associated with
           other tumor types such as systemic mastocytosis and
           cancers of the breast, neurons, lung, prostate, colon,
           and rectum.  Although the structure of the human Kit
           catalytic domain is known, it is excluded from this
           specific alignment model because it contains a deletion
           in its sequence.
          Length = 375

 Score = 51.0 bits (122), Expect = 1e-08
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 10/83 (12%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGL-TDLEVLENISHLHADDGEFIYLPTPQ-TTK 84
           +T +SDVWS+G+ LWEI +L    PY G+  D +  + I        E   + +P+    
Sbjct: 293 YTFESDVWSYGILLWEIFSLG-SSPYPGMPVDSKFYKMIK-------EGYRMLSPECAPS 344

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
           ++ D+M  CW   P +RP+F +I
Sbjct: 345 EMYDIMKSCWDADPLKRPTFKQI 367


>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional.
          Length = 478

 Score = 50.8 bits (121), Expect = 2e-08
 Identities = 26/95 (27%), Positives = 54/95 (56%), Gaps = 11/95 (11%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           ++++ K+D+WS GV L+E+L L  HRP++G +  E+++ + +     G++   P P  + 
Sbjct: 246 KRYSKKADMWSLGVILYELLTL--HRPFKGPSQREIMQQVLY-----GKYDPFPCP-VSS 297

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQRKNLGYV 119
            +  L++    ++P  RP+  ++   L  + L YV
Sbjct: 298 GMKALLDPLLSKNPALRPTTQQL---LHTEFLKYV 329


>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine
           Kinase, Apoptosis-associated tyrosine kinase 2.  Protein
           Tyrosine Kinase (PTK) family; Apoptosis-associated
           tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The
           PTKc family is part of a larger superfamily that
           includes the catalytic domains of other kinases such as
           protein serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Aatyk2 is
           a member of the Aatyk subfamily of proteins, which are
           receptor kinases containing a transmembrane segment and
           a long C-terminal cytoplasmic tail with a catalytic
           domain. Aatyk2 is also called lemur tyrosine kinase 2
           (Lmtk2) or brain-enriched kinase (Brek). It is expressed
           at high levels in early postnatal brain, and has been
           shown to play a role in nerve growth factor (NGF)
           signaling. Studies with knockout mice reveal that Aatyk2
           is essential for late stage spermatogenesis. Although it
           is classified as a tyr kinase based on sequence
           similarity and the phylogenetic tree, Aatyk2 has been
           characterized as a serine/threonine kinase.
          Length = 268

 Score = 49.9 bits (119), Expect = 2e-08
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 28  TTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDIL 87
           T  S+VW+ GVTLWE+   A  +PY  L+D EVL      H    + + L  PQ      
Sbjct: 186 TKPSNVWALGVTLWELFENAA-QPYSHLSDREVLN-----HVIKDQQVKLFKPQLELPYS 239

Query: 88  DLMNE----CWKRSPTERPSFTEIHLFL 111
           +   E    CW  SP +R +  E+H  L
Sbjct: 240 ERWYEVLQFCW-LSPEKRATAEEVHRLL 266


>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein
           Tyrosine Kinases, Apoptosis-associated tyrosine kinases
           1 and 3.  Protein Tyrosine Kinase (PTK) family;
           Apoptosis-associated tyrosine kinase 1 (Aatyk1) and
           Aatyk3; catalytic (c) domain. The PTKc family is part of
           a larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Aatyk1 and Aatyk3 are
           members of the Aatyk subfamily of proteins. Aatyk3 is a
           receptor kinase containing a transmembrane segment and a
           long C-terminal cytoplasmic tail with a catalytic
           domain. Aatyk1 has a similar domain arrangement but
           without the transmembrane segment and is thus, a
           cytoplasmic (or nonreceptor) kinase. The expression of
           Aatyk1 (also referred simply as Aatyk) is upregulated
           during growth arrest and apoptosis in myeloid cells.
           Aatyk1 has been implicated in neural differentiation,
           and is a regulator of the Na-K-2Cl cotransporter, a
           membrane protein involved in cell proliferation and
           survival, epithelial transport, and blood pressure
           control. The function of Aatyk3 is still unknown.
          Length = 269

 Score = 49.9 bits (119), Expect = 3e-08
 Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 11/88 (12%)

Query: 28  TTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDIL 87
           T +S+VWS GVT+WE+  L   +PY  L+D +VL      +    + + LP P+    + 
Sbjct: 187 TKESNVWSLGVTIWELFELG-SQPYRHLSDEQVLT-----YTVREQQLKLPKPRLKLPLS 240

Query: 88  D----LMNECWKRSPTERPSFTEIHLFL 111
           D    +M  CW + P +RPS  E+HL L
Sbjct: 241 DRWYEVMQFCWLQ-PEQRPSAEEVHLLL 267


>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional.
          Length = 283

 Score = 49.7 bits (119), Expect = 4e-08
 Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 7/86 (8%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           ++T K D++S GV LWEI       P+E LT  E+ + I  ++ ++   + L  P   K 
Sbjct: 198 EYTIKDDIYSLGVVLWEI--FTGKIPFENLTTKEIYDLI--INKNNSLKLPLDCPLEIKC 253

Query: 86  ILDLMNECWKRSPTERPSFTEIHLFL 111
           I++    C      +RP+  EI   L
Sbjct: 254 IVE---ACTSHDSIKRPNIKEILYNL 276


>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinase, Janus kinase 1.  Protein Tyrosine
           Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic
           (c) domain (repeat 2). The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Jak1 is a member of the
           Janus kinase (Jak) subfamily of proteins, which are
           cytoplasmic (or nonreceptor) tyr kinases containing an
           N-terminal FERM domain, followed by a Src homology 2
           (SH2) domain, a pseudokinase domain, and a C-terminal
           tyr kinase domain. Jaks are crucial for cytokine
           receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Jak1 is widely expressed in many tissues. Many cytokines
           are dependent on Jak1 for signaling, including those
           that use the shared receptor subunits common gamma chain
           (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6,
           IL-11, oncostatin M, G-CSF, and IFNs, among others). The
           many varied interactions of Jak1 and its ubiquitous
           expression suggest many biological roles. Jak1 is
           important in neurological development, as well as in
           lymphoid development and function. It also plays a role
           in the pathophysiology of cardiac hypertrophy and heart
           failure. A mutation in the ATP-binding site of Jak1 was
           identified in a human uterine leiomyosarcoma cell line,
           resulting in defective cytokine induction and antigen
           presentation, thus allowing the tumor to evade the
           immune system.
          Length = 284

 Score = 47.2 bits (112), Expect = 3e-07
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 17/97 (17%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILN------------LARHRPYEGLTDLEVLENISHLHAD 70
           +  KF   SDVWSFGVTL+E+L             L    P  G   +  L  +     +
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV----LE 240

Query: 71  DGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           +G+ +  P P   +++  LM +CW+  P++R +F  +
Sbjct: 241 EGKRLPRP-PNCPEEVYQLMRKCWEFQPSKRTTFQNL 276


>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein
           Tyrosine Kinase, Tyrosine kinase 2.  Protein Tyrosine
           Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic
           (c) domain (repeat 2). The PTKc family is part of a
           larger superfamily that includes the catalytic domains
           of other kinases such as protein serine/threonine
           kinases, RIO kinases, and phosphoinositide 3-kinase
           (PI3K). PTKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to tyrosine (tyr)
           residues in protein substrates. Tyk2 is a member of the
           Janus kinase (Jak) subfamily of proteins, which are
           cytoplasmic (or nonreceptor) tyr kinases containing an
           N-terminal FERM domain, followed by a Src homology 2
           (SH2) domain, a pseudokinase domain, and a C-terminal
           tyr kinase catalytic domain. Jaks are crucial for
           cytokine receptor signaling. They are activated by
           autophosphorylation upon cytokine-induced receptor
           aggregation, and subsequently trigger downstream
           signaling events such as the phosphorylation of signal
           transducers and activators of transcription (STATs).
           Tyk2 is widely expressed in many tissues. It is involved
           in signaling via the cytokine receptors IFN-alphabeta,
           IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell
           surface urokinase receptor (uPAR) signaling and plays a
           role in modulating vascular smooth muscle cell (VSMC)
           functional behavior in response to injury. Tyk2 is also
           important in dendritic cell function and T helper (Th)1
           cell differentiation. A homozygous mutation of Tyk2 was
           found in a patient with hyper-IgE syndrome (HIES), a
           primary immunodeficiency characterized by recurrent skin
           abscesses, pneumonia, and elevated serum IgE. This
           suggests that Tyk2 may play important roles in multiple
           cytokine signaling involved in innate and adaptive
           immunity.
          Length = 283

 Score = 46.0 bits (109), Expect = 7e-07
 Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 11/88 (12%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHA--------DDGEFIYL 77
           KF+  SDVWSFGVTL+E+L     +        E++                + G    L
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM--RL 243

Query: 78  PTPQTT-KDILDLMNECWKRSPTERPSF 104
           P P+   +++  LM  CW+     RP+F
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTF 271


>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity
           Protein Kinase, Mitogen-Activated Protein Kinase Kinase.
            Protein kinases (PKs), MAP kinase kinase (MAPKK)
           subfamily, catalytic (c) domain. PKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK or MAP2K), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK or
           MAP3K). MAPKKs are dual-specificity PKs that
           phosphorylate their downstream targets, MAPKs, at
           specific threonine and tyrosine residues. There are
           three MAPK subfamilies: extracellular signal-regulated
           kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In
           mammalian cells, there are seven MAPKKs (named MKK1-7)
           and 20 MAPKKKs. Each MAPK subfamily can be activated by
           at least two cognate MAPKKs and by multiple MAPKKKs.
          Length = 265

 Score = 45.4 bits (108), Expect = 9e-07
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 16/96 (16%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHR-PYEG-----LTDLEVLENISHLHADDGEFIYLPT 79
            ++ KSD+WS G++L E   LA  R PY           E+L+ I      +     LP+
Sbjct: 175 DYSVKSDIWSLGLSLIE---LATGRFPYPPENDPPDGIFELLQYIV-----NEPPPRLPS 226

Query: 80  PQTTKDILDLMNECWKRSPTERPSFTEI--HLFLQR 113
            + + D  D +N C  + P ERPS+ E+  H F+++
Sbjct: 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262


>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases.  Protein Kinases
           (PKs), catalytic (c) domain. PKs catalyze the transfer
           of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The PK family is part of a larger
           superfamily that includes the catalytic domains of RIO
           kinases, aminoglycoside phosphotransferase, choline
           kinase, phosphoinositide 3-kinase (PI3K), and
           actin-fragmin kinase. PKs make up a large family of
           serine/threonine kinases, protein tyrosine kinases
           (PTKs), and dual-specificity PKs that phosphorylate both
           serine/threonine and tyrosine residues of target
           proteins. Majority of protein phosphorylation, about
           95%, occurs on serine residues while only 1% occurs on
           tyrosine residues. Protein phosphorylation is a
           mechanism by which a wide variety of cellular proteins,
           such as enzymes and membrane channels, are reversibly
           regulated in response to certain stimuli. PKs often
           function as components of signal transduction pathways
           in which one kinase activates a second kinase, which in
           turn, may act on other kinases; this sequential action
           transmits a signal from the cell surface to target
           proteins, which results in cellular responses. The PK
           family is one of the largest known protein families with
           more than 100 homologous yeast enzymes and 550 human
           proteins. A fraction of PK family members are
           pseudokinases that lack crucial residues for catalytic
           activity. The mutiplicity of kinases allows for specific
           regulation according to substrate, tissue distribution,
           and cellular localization. PKs regulate many cellular
           processes including proliferation, division,
           differentiation, motility, survival, metabolism,
           cell-cycle progression, cytoskeletal rearrangement,
           immunity, and neuronal functions. Many kinases are
           implicated in the development of various human diseases
           including different types of cancer.
          Length = 215

 Score = 44.5 bits (106), Expect = 2e-06
 Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 40/82 (48%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
            ++ KSD+WS GV L+E+                                         +
Sbjct: 170 YYSEKSDIWSLGVILYEL----------------------------------------PE 189

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           + DL+ +  ++ P +RPS  EI
Sbjct: 190 LKDLIRKMLQKDPEKRPSAKEI 211


>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the
           Protein Tyrosine Kinases, Janus kinases.  Protein
           Tyrosine Kinase (PTK) family; Janus kinase (Jak)
           subfamily; pseudokinase domain (repeat1). The Jak
           subfamily is composed of Jak1, Jak2, Jak3, TYK2, and
           similar proteins. The PTKc (catalytic domain) family to
           which this subfamily belongs, is part of a larger
           superfamily that includes the catalytic domains of other
           kinases such as protein serine/threonine kinases, RIO
           kinases, and phosphoinositide 3-kinase (PI3K). PTKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to tyrosine (tyr) residues in protein substrates.
           Jak subfamily proteins are cytoplasmic (or nonreceptor)
           tyr kinases containing an N-terminal FERM domain,
           followed by a Src homology 2 (SH2) domain, a
           pseudokinase domain, and a C-terminal catalytic tyr
           kinase domain. The pseudokinase domain shows similarity
           to tyr kinases but lacks crucial residues for catalytic
           activity and ATP binding. It modulates the kinase
           activity of the C-terminal catalytic domain. Most Jaks
           are expressed in a wide variety of tissues, except for
           Jak3, which is expressed only in hematopoietic cells.
           Jaks are crucial for cytokine receptor signaling. They
           are activated by autophosphorylation upon
           cytokine-induced receptor aggregation, and subsequently
           trigger downstream signaling events such as the
           phosphorylation of signal transducers and activators of
           transcription (STATs). Jaks are also involved in
           regulating the surface expression of some cytokine
           receptors. The Jak-STAT pathway is involved in many
           biological processes including hematopoiesis,
           immunoregulation, host defense, fertility, lactation,
           growth, and embryogenesis.
          Length = 259

 Score = 44.8 bits (106), Expect = 2e-06
 Identities = 29/82 (35%), Positives = 38/82 (46%), Gaps = 9/82 (10%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
             T  +D WSFG TL EI         E L+ L   E     + D      LP P    +
Sbjct: 182 SLTIAADKWSFGTTLLEIC----SNGEEPLSTLSSSEKE-RFYQDQHR---LPMPDC-AE 232

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           + +L+N+CW   PT+RPSF  I
Sbjct: 233 LANLINQCWTYDPTKRPSFRAI 254


>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity
           Protein Kinases, MAP kinase kinases 3 and 6.  Protein
           kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6
           subfamily, catalytic (c) domain. PKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MKK3 and MKK6 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MKK3 and MKK6 are dual-specificity PKs that
           phosphorylate and activate their downstream target, p38
           MAPK, on specific threonine and tyrosine residues.
           MKK3/6 plays roles in the regulation of cell cycle
           progression, cytokine- and stress-induced apoptosis,
           oncogenic transformation, and adult tissue regeneration.
           In addition, MKK6 plays a critical role in osteoclast
           survival in inflammatory disease while MKK3 is
           associated with tumor invasion, progression, and poor
           patient survival in glioma.
          Length = 283

 Score = 44.0 bits (104), Expect = 4e-06
 Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 18/93 (19%)

Query: 27  FTTKSDVWSFGVTLWEILNLAR-----HRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ 81
           +  KSDVWS G+T+ E+            P++ L   +V+E  S           LP  +
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK--QVVEEPSP---------QLPAEK 232

Query: 82  TTKDILDLMNECWKRSPTERPSFTEI--HLFLQ 112
            + +  D +N+C K++  ERP++ E+  H F +
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265


>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 2.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek2 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. The Nek2
           subfamily includes Aspergillus nidulans NIMA kinase, the
           founding member of the Nek family, which was identified
           in a screen for cell cycle mutants prevented from
           entering mitosis. NIMA is essential for mitotic entry
           and progression through mitosis, and its degradation is
           essential for mitotic exit. NIMA is involved in nuclear
           membrane fission. Vertebrate Nek2 is a cell
           cycle-regulated STK, localized in centrosomes and
           kinetochores, that regulates centrosome splitting at the
           G2/M phase. It also interacts with other mitotic kinases
           such as Polo-like kinase 1 and may play a role in
           spindle checkpoint. An increase in the expression of the
           human NEK2 gene is strongly associated with the
           progression of non-Hodgkin lymphoma.
          Length = 265

 Score = 43.0 bits (102), Expect = 6e-06
 Identities = 20/85 (23%), Positives = 40/85 (47%), Gaps = 8/85 (9%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT 82
            H  +  KSD+WS G  ++E+   A   P+     L++   I      +G+F  +P  + 
Sbjct: 183 NHMSYDEKSDIWSLGCLIYEL--CALSPPFTARNQLQLASKIK-----EGKFRRIP-YRY 234

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
           + ++ +++       P +RPS  E+
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEEL 259


>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control
           protein 7-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs),  (Cdc7)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Cdc7-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this subfamily include
           Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae
           Cdc15, Arabidopsis thaliana mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK) epsilon, and
           related proteins. MAPKKKs phosphorylate and activate
           MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals. Fission yeast Cdc7
           is essential for cell division by playing a key role in
           the initiation of septum formation and cytokinesis.
           Budding yeast Cdc15 functions to coordinate mitotic exit
           with cytokinesis. Arabidopsis MAPKKK epsilon is required
           for pollen development in the plasma membrane.
          Length = 254

 Score = 42.6 bits (101), Expect = 9e-06
 Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 10/77 (12%)

Query: 28  TTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT-TKDI 86
           +T SD+WS G T+ E+  L  + PY  L  +  L  I     DD    + P P+  + ++
Sbjct: 177 STASDIWSLGCTVIEL--LTGNPPYYDLNPMAALFRIVQ---DD----HPPLPEGISPEL 227

Query: 87  LDLMNECWKRSPTERPS 103
            D + +C+++ P  RP+
Sbjct: 228 KDFLMQCFQKDPNLRPT 244


>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 5.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek5 subfamily is
           one of a family of 11 different Neks (Nek1-11). The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Neks are involved in the regulation of
           downstream processes following the activation of Cdc2,
           and many of their functions are cell cycle-related. They
           play critical roles in microtubule dynamics during
           ciliogenesis and mitosis. The specific function of Nek5
           is unknown.
          Length = 257

 Score = 42.6 bits (100), Expect = 9e-06
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 10/85 (11%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLP-TPQT 82
           +R +  K+D+WS G  L+E+  L +H P+EG        N+  L     +  + P +P  
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTL-KH-PFEG-------NNLHQLVLKICQGYFAPISPNF 226

Query: 83  TKDILDLMNECWKRSPTERPSFTEI 107
           ++D+  L+++ +K SP +RPS T I
Sbjct: 227 SRDLRSLISQLFKVSPRDRPSITSI 251


>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase (MAPKK) subfamily, fungal
           Byr1-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Byr1 from
           Schizosaccharomyces pombe, FUZ7 from Ustilago maydis,
           and related proteins. Byr1 phosphorylates its downstream
           target, the MAPK Spk1, and is regulated by the MAPKKK
           Byr2. The Spk1 cascade is pheromone-responsive and is
           essential for sporulation and sexual differentiation in
           fission yeast. FUZ7 phosphorylates and activates its
           target, the MAPK Crk1, which is required in mating and
           virulence in U. maydis.
          Length = 284

 Score = 42.5 bits (100), Expect = 1e-05
 Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 14/92 (15%)

Query: 26  KFTTKSDVWSFGVTLWEIL---------NLARHRPYEGLTDLEVLENISHLHADDGEFIY 76
           K+T KSDVWS G+++ E+          N+      + +  L++L+ I            
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR----- 232

Query: 77  LPTPQTTKDILDLMNECWKRSPTERPSFTEIH 108
           LP+    +D+ D ++ C  + PTERP+  ++ 
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264


>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the
           Protein Tyrosine Kinase, Janus kinase 1.  Protein
           Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1);
           pseudokinase domain (repeat 1). The PTKc (catalytic
           domain) family to which this subfamily belongs, is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Jak1 is a
           member of the Janus kinase (Jak) subfamily of proteins,
           which are cytoplasmic (or nonreceptor) tyr kinases
           containing an N-terminal FERM domain, followed by a Src
           homology 2 (SH2) domain, a pseudokinase domain, and a
           C-terminal tyr kinase domain. The pseudokinase domain
           shows similarity to tyr kinases but lacks crucial
           residues for catalytic activity and ATP binding. It
           modulates the kinase activity of the C-terminal
           catalytic domain. Jaks are crucial for cytokine receptor
           signaling. They are activated by autophosphorylation
           upon cytokine-induced receptor aggregation, and
           subsequently trigger downstream signaling events such as
           the phosphorylation of signal transducers and activators
           of transcription (STATs). Jak1 is widely expressed in
           many tissues. Many cytokines are dependent on Jak1 for
           signaling, including those that use the shared receptor
           subunits common gamma chain (IL-2, IL-4, IL-7, IL-9,
           IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M,
           G-CSF, and IFNs, among others). The many varied
           interactions of Jak1 and its ubiquitous expression
           suggest many biological roles. Jak1 is important in
           neurological development, as well as in lymphoid
           development and function. It also plays a role in the
           pathophysiology of cardiac hypertrophy and heart
           failure. A mutation in the ATP-binding site of Jak1 was
           identified in a human uterine leiomyosarcoma cell line,
           resulting in defective cytokine induction and antigen
           presentation, thus allowing the tumor to evade the
           immune system.
          Length = 262

 Score = 42.6 bits (100), Expect = 1e-05
 Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 9/83 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           +  +  +D WSFG TLWEI        Y G   L+           +G+ + L TP + K
Sbjct: 184 KNLSIAADKWSFGTTLWEIC-------YNGEIPLKDKTLAEKERFYEGQCM-LVTP-SCK 234

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
           ++ DLM  C    P +RP F  I
Sbjct: 235 ELADLMTHCMNYDPNQRPFFRAI 257


>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 1.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek1 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek1 is
           associated with centrosomes throughout the cell cycle.
           It is involved in the formation of primary cilium and in
           the maintenance of centrosomes. It cycles through the
           nucleus and may be capable of relaying signals between
           the cilium and the nucleus. Nek1 is implicated in the
           development of polycystic kidney disease, which is
           characterized by benign polycystic tumors formed by
           abnormal overgrowth of renal epithelial cells. It
           appears also to be involved in DNA damage response, and
           may be important for both correct DNA damage checkpoint
           activation and DNA repair.
          Length = 256

 Score = 42.1 bits (99), Expect = 2e-05
 Identities = 24/84 (28%), Positives = 43/84 (51%), Gaps = 8/84 (9%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT 83
           +R +  KSD+W+ G  L+E+  L +H    G     VL+ I       G +  +     +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTL-KHAFEAGNMKNLVLKIIR------GSYPPVS-SHYS 226

Query: 84  KDILDLMNECWKRSPTERPSFTEI 107
            D+ +L+++ +KR+P +RPS   I
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSI 250


>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein
           Serine/Threonine Kinases, Never In Mitosis gene
           A-related kinase 6 and 7.  Serine/Threonine Kinases
           (STKs), Never In Mitosis gene A (NIMA)-related kinase 6
           (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The Nek6/7 subfamily is part of a family of 11 different
           Neks (Nek1-11) that are involved in cell cycle control.
           The Nek family is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Nek6 and Nek7 are the shortest Neks,
           consisting only of the catalytic domain and a very short
           N-terminal extension. They show distinct expression
           patterns and both appear to be downstream substrates of
           Nek9. They are required for mitotic spindle formation
           and cytokinesis. They may also be regulators of the p70
           ribosomal S6 kinase.
          Length = 267

 Score = 41.3 bits (97), Expect = 3e-05
 Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 30/120 (25%)

Query: 10  DLTNGRIFKNKNS-LHRKFTT----------------KSDVWSFGVTLWEILNLARHRPY 52
           DL  GR F +K +  H    T                KSD+WS G  L+E+  L    P+
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL--QSPF 206

Query: 53  EG----LTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIH 108
            G    L  L   + I        ++  LP    ++++ DL++ C    P +RP  + + 
Sbjct: 207 YGDKMNLYSL--CKKIEK-----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259


>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase(MAPKK) subfamily, fungal
           Pek1-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Pek1/Skh1 from
           Schizosaccharomyces pombe and MKK2 from Saccharomyces
           cerevisiae, and related proteins. Both fission yeast
           Pek1 and baker's yeast MKK2 are components of the cell
           integrity MAPK pathway. In fission yeast, Pek1
           phosphorylates and activates the MAPK Pmk1/Spm1 and is
           regulated by the MAPKKK Mkh1. In baker's yeast, the
           pathway involves the MAPK Slt2, the MAPKKs MKK1 and
           MKK2, and the MAPKKK Bck1. The cell integrity MAPK
           cascade is activated by multiple stress conditions, and
           is essential  in cell wall construction, morphogenesis,
           cytokinesis, and ion homeostasis.
          Length = 287

 Score = 40.9 bits (96), Expect = 4e-05
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 19/88 (21%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHR---PYEGLTDL---EVLENISH-----LHADDGEFI 75
           ++  SDVWS G+TL E+   A++R   P EG   L   E+L  I +     L  + G  I
Sbjct: 180 YSITSDVWSLGLTLLEV---AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236

Query: 76  YLPTPQTTKDILDLMNECWKRSPTERPS 103
                  +++  D + +C ++ PT RP+
Sbjct: 237 KW-----SEEFKDFIKQCLEKDPTRRPT 259


>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 7.  Protein kinases (PKs), MAP
           kinase kinase 7 (MKK7) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK7 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MKK7 is a dual-specificity PK that phosphorylates and
           activates its downstream target, c-Jun N-terminal kinase
           (JNK), on specific threonine and tyrosine residues.
           Although MKK7 is capable of dual phosphorylation, it
           prefers to phosphorylate the threonine residue of JNK.
           Thus, optimal activation of JNK requires both MKK4 (not
           included in this subfamily) and MKK7. MKK7 is primarily
           activated by cytokines. MKK7 is essential for liver
           formation during embryogenesis. It plays roles in G2/M
           cell cycle arrest and cell growth. In addition, it is
           involved in the control of programmed cell death, which
           is crucial in oncogenesis, cancer chemoresistance, and
           antagonism to TNFalpha-induced killing, through its
           inhibition by Gadd45beta and the subsequent suppression
           of the JNK cascade.
          Length = 296

 Score = 40.8 bits (96), Expect = 4e-05
 Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 11/94 (11%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLARHR-PYEGL-TDLEVLENISHLHADDGEFIYLPTPQ 81
           + K+  ++DVWS G++L E   LA  + PY+   T+ EVL  I      +      P   
Sbjct: 192 NPKYDIRADVWSLGISLVE---LATGQFPYKNCKTEFEVLTKI----LQEEPPSLPPNEG 244

Query: 82  TTKDILDLMNECWKRSPTERPSFTEI--HLFLQR 113
            + D    ++ C  +   +RP + E+  H F++R
Sbjct: 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278


>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant
           dual-specificity MAP kinase kinases and similar
           proteins.  Protein kinases (PKs), MAP kinase kinase
           (MAPKK) subfamily, Plant MAPKKs and similar proteins,
           catalytic (c) domain. PKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine or
           tyrosine residues on protein substrates. The MAPKK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein serine/threonine
           kinases, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. The mitogen-activated protein
           (MAP) kinase signaling pathways are important mediators
           of cellular responses to extracellular signals. The
           pathways involve a triple kinase core cascade comprising
           of the MAP kinase (MAPK), which is phosphorylated and
           activated by a MAPK kinase (MAPKK or MKK), which itself
           is phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). Members of this group include MAPKKs
           from plants, kinetoplastids, alveolates, and mycetozoa.
           The MAPKK, LmxPK4, from Leishmania mexicana, is
           important in differentiation and virulence.
           Dictyostelium discoideum MEK1 is required for proper
           chemotaxis. MEK1 null mutants display severe defects in
           cell polarization and directional movement. Plants
           contain multiple MAPKKs like other eukaryotes. The
           Arabidopsis genome encodes for 10 MAPKKs while poplar
           and rice contain 13 MAPKKs each. The functions of these
           proteins have not been fully elucidated. There is
           evidence to suggest that MAPK cascades are involved in
           plant stress responses. In Arabidopsis, MKK3 plays a
           role in pathogen signaling, MKK2 is involved in cold and
           salt stress signaling, MKK4/MKK5 participates in innate
           immunity, and MKK7 regulates basal and systemic acquired
           resistance.
          Length = 264

 Score = 41.0 bits (97), Expect = 4e-05
 Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 12/93 (12%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPY---EGLTDLEVLENISHLHADDGEFIYLPTPQ 81
             ++  +D+WS G+TL E   L +  P+      +  E+++ I      DG    LP  +
Sbjct: 175 ESYSYAADIWSLGLTLLECA-LGKF-PFLPPGQPSFFELMQAIC-----DGPPPSLPAEE 227

Query: 82  TTKDILDLMNECWKRSPTERPSFTEI--HLFLQ 112
            + +  D ++ C ++ P +RPS  E+  H F++
Sbjct: 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260


>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases.
           Protein Kinases (PKs), STE family, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The STE family is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases (STKs), protein
           tyrosine kinases (PTKs), RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase (PI3K). This family is composed of STKs, and
           some dual-specificity PKs that phosphorylate both
           threonine and tyrosine residues of target proteins. Most
           members are kinases involved in mitogen-activated
           protein kinase (MAPK) signaling cascades, acting as MAPK
           kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK
           kinase kinase kinases (MAP4Ks). The MAPK signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAPK, which is
           phosphorylated and activated by a MAPKK, which itself is
           phosphorylated and activated by a MAPKKK. Each MAPK
           cascade is activated either by a small GTP-binding
           protein or by an adaptor protein, which transmits the
           signal either directly to a MAPKKK to start the triple
           kinase core cascade or indirectly through a mediator
           kinase, a MAP4K. Other STE family members include
           p21-activated kinases (PAKs) and class III myosins,
           among others. PAKs are Rho family GTPase-regulated
           kinases that serve as important mediators in the
           function of Cdc42 (cell division cycle 42) and Rac.
           Class III myosins are motor proteins containing an
           N-terminal kinase catalytic domain and a C-terminal
           actin-binding domain, which can phosphorylate several
           cytoskeletal proteins, conventional myosin regulatory
           light chains, as well as autophosphorylate the
           C-terminal motor domain. They play an important role in
           maintaining the structural integrity of photoreceptor
           cell microvilli.
          Length = 253

 Score = 39.9 bits (94), Expect = 8e-05
 Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 8/81 (9%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +  K+D+WS G+T  E+       PY  L  ++ L  I+           L  P+   D 
Sbjct: 174 YDYKADIWSLGITAIELAE--GKPPYSELPPMKALFKIATNG-----PPGLRNPEKWSDE 226

Query: 87  L-DLMNECWKRSPTERPSFTE 106
             D + +C +++P +RP+  +
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQ 247


>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the
           Protein Tyrosine Kinases, Janus kinases 2 and 3.
           Protein Tyrosine Kinase (PTK) family; Janus kinase 2
           (Jak2) and Jak3; pseudokinase domain (repeat 1). The
           PTKc (catalytic domain) family to which this subfamily
           belongs, is part of a larger superfamily that includes
           the catalytic domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Jak2 and
           Jak3 are members of the Janus kinase (Jak) subfamily of
           proteins, which are cytoplasmic (or nonreceptor) tyr
           kinases containing an N-terminal FERM domain, followed
           by a Src homology 2 (SH2) domain, a pseudokinase domain,
           and a C-terminal tyr kinase domain. The pseudokinase
           domain shows similarity to tyr kinases but lacks crucial
           residues for catalytic activity and ATP binding. It
           modulates the kinase activity of the C-terminal
           catalytic domain. Jaks are crucial for cytokine receptor
           signaling. They are activated by autophosphorylation
           upon cytokine-induced receptor aggregation, and
           subsequently trigger downstream signaling events such as
           the phosphorylation of signal transducers and activators
           of transcription (STATs). Jak2 is widely expressed in
           many tissues while Jak3 is expressed only in
           hematopoietic cells. Jak2 is essential for the signaling
           of hormone-like cytokines such as growth hormone,
           erythropoietin, thrombopoietin, and prolactin, as well
           as some IFNs and cytokines that signal through the IL-3
           and gp130 receptors. Jak3 binds the shared receptor
           subunit common gamma chain and thus, is essential in the
           signaling of cytokines that use it such as IL-2, IL-4,
           IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice
           results in an embryonic lethal phenotype with multiple
           defects including erythropoietic and cardiac
           abnormalities. It is the only Jak gene that results in a
           lethal phenotype when disrupted in mice. A mutation in
           the pseudokinase domain of Jak2, V617F, is present in
           many myeloproliferative diseases, including almost all
           patients with polycythemia vera, and 50% of patients
           with essential thrombocytosis and myelofibrosis. Jak3 is
           important in lymphoid development and myeloid cell
           differentiation. Inactivating mutations in Jak3 have
           been reported in humans with severe combined
           immunodeficiency (SCID).
          Length = 258

 Score = 39.8 bits (93), Expect = 9e-05
 Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           +  +  +D WSFG TLWEI +    +P   L   + L+     H        LP P+ T 
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS-GGDKPLSALDSQKKLQFYEDRHQ-------LPAPKWT- 230

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
           ++ +L+N+C    P  RPSF  I
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAI 253


>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 5.  Protein kinases (PKs), MAP
           kinase kinase 5 (MKK5) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK5 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising of the MAP
           kinase (MAPK), which is phosphorylated and activated by
           a MAPK kinase (MAPKK or MKK), which itself is
           phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a
           dual-specificity PK that phosphorylates its downstream
           target, extracellular signal-regulated kinase 5 (ERK5),
           on specific threonine and tyrosine residues. MKK5 is
           activated by MEKK2 and MEKK3 in response to mitogenic
           and stress stimuli. The ERK5 cascade promotes cell
           proliferation, differentiation, neuronal survival, and
           neuroprotection. This cascade plays an essential role in
           heart development. Mice deficient in either ERK5 or MKK5
           die around embryonic day 10 due to cardiovascular
           defects including underdevelopment of the myocardium. In
           addition, MKK5 is associated with metastasis and
           unfavorable prognosis in prostate cancer.
          Length = 279

 Score = 39.9 bits (93), Expect = 1e-04
 Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 22/112 (19%)

Query: 15  RIFKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYE-------GLTDLEVLENISHL 67
           RI   +  +H      SDVWS G++  E L L R  PY         L  L++L+ I   
Sbjct: 164 RISGEQYGIH------SDVWSLGISFME-LALGRF-PYPQIQKNQGSLMPLQLLQCIV-- 213

Query: 68  HADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI--HLFLQRKNLG 117
              D +   LP  Q ++  +  + +C ++ P ERP+   +  H F+ + N G
Sbjct: 214 ---DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262


>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like
           dual-specificity MAP kinase kinases.  Protein kinases
           (PKs), MAP kinase kinase (MAPKK) subfamily, fungal
           PBS2-like proteins, catalytic (c) domain. PKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine or tyrosine residues on protein
           substrates. The MAPKK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising of the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK).
           Members of this group include the MAPKKs Polymyxin B
           resistance protein 2 (PBS2) from Saccharomyces
           cerevisiae, Wis1 from Schizosaccharomyces pombe, and
           related proteins. PBS2 and Wis1 are components of
           stress-activated MAPK cascades in budding and fission
           yeast, respectively. PBS2 is the specific activator of
           the MAPK Hog1, which plays a central role in the
           response of budding yeast to stress including exposure
           to arsenite and hyperosmotic environments. Wis1
           phosphorylates and activates the MAPK Sty1 (also called
           Spc1 or Phh1), which stimulates a transcriptional
           response to a wide range of cellular insults through the
           bZip transcription factors Atf1, Pcr1, and Pap1.
          Length = 286

 Score = 39.1 bits (91), Expect = 2e-04
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 13/90 (14%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHR-PYEGLTDLEVLENI-SHLHAD-DGEFIYLPTPQTT 83
           +T +SDVWS G++   IL +A  R PY      E   NI + L A  DG+   LP    +
Sbjct: 184 YTVQSDVWSLGLS---ILEMALGRYPYPP----ETYANIFAQLSAIVDGDPPTLP-SGYS 235

Query: 84  KDILDLMNECWKRSPTERPSFTEI--HLFL 111
            D  D + +C  + P  RP++ ++  H +L
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265


>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the
           Protein Tyrosine Kinase, Tyrosine kinase 2.  Protein
           Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2);
           pseudokinase domain (repeat 1). The PTKc (catalytic
           domain) family to which this subfamily belongs, is part
           of a larger superfamily that includes the catalytic
           domains of other kinases such as protein
           serine/threonine kinases, RIO kinases, and
           phosphoinositide 3-kinase (PI3K). PTKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           tyrosine (tyr) residues in protein substrates. Tyk2 is a
           member of the Janus kinase (Jak) subfamily of proteins,
           which are cytoplasmic (or nonreceptor) tyr kinases
           containing an N-terminal FERM domain, followed by a Src
           homology 2 (SH2) domain, a pseudokinase domain, and a
           C-terminal tyr kinase domain. The pseudokinase domain
           shows similarity to tyr kinases but lacks crucial
           residues for catalytic activity and ATP binding. It
           modulates the kinase activity of the C-terminal
           catalytic domain. Jaks are crucial for cytokine receptor
           signaling. They are activated by autophosphorylation
           upon cytokine-induced receptor aggregation, and
           subsequently trigger downstream signaling events such as
           the phosphorylation of signal transducers and activators
           of transcription (STATs). Tyk2 is widely expressed in
           many tissues. It is involved in signaling via the
           cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12,
           IL-13, and IL-23. It mediates cell surface urokinase
           receptor (uPAR) signaling and plays a role in modulating
           vascular smooth muscle cell (VSMC) functional behavior
           in response to injury. Tyk2 is also important in
           dendritic cell function and T helper (Th)1 cell
           differentiation. A homozygous mutation of Tyk2 was found
           in a patient with hyper-IgE syndrome (HIES), a primary
           immunodeficiency characterized by recurrent skin
           abscesses, pneumonia, and elevated serum IgE. This
           suggests that Tyk2 may play important roles in multiple
           cytokine signaling involved in innate and adaptive
           immunity.
          Length = 274

 Score = 39.1 bits (91), Expect = 2e-04
 Identities = 30/90 (33%), Positives = 39/90 (43%), Gaps = 13/90 (14%)

Query: 18  KNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYL 77
              NSL     T +D WSFG TL EI       P +  T  E        H        L
Sbjct: 193 PGGNSLS----TAADKWSFGTTLLEIC-FDGEVPLKERTPSEKERFYEKKHR-------L 240

Query: 78  PTPQTTKDILDLMNECWKRSPTERPSFTEI 107
           P P + K++  L+++C    PT+RPSF  I
Sbjct: 241 PEP-SCKELATLISQCLTYEPTQRPSFRTI 269


>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine
           Kinase, Thousand-and-one amino acids proteins.
           Serine/threonine kinases (STKs), thousand-and-one amino
           acids (TAO) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. They activate the MAPKs, p38 and c-Jun
           N-terminal kinase (JNK), by phosphorylating and
           activating the respective MAP/ERK kinases (MEKs, also
           known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK
           signaling cascades are important in mediating cellular
           responses to extracellular signals. Vertebrates contain
           three TAO subfamily members, named TAO1, TAO2, and TAO3.
          Length = 307

 Score = 38.2 bits (89), Expect = 4e-04
 Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 9/91 (9%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           ++  K DVWS G+T  E   LA  +P   L ++  +  + H+  +D     L +   +  
Sbjct: 190 QYDGKVDVWSLGITCIE---LAERKP--PLFNMNAMSALYHIAQNDSP--TLSSNDWSDY 242

Query: 86  ILDLMNECWKRSPTERPSFTEI--HLFLQRK 114
             + ++ C ++ P +RPS  E+  H F+ R+
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273


>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein
           Serine/Threonine Kinases, Oxidative stress response
           kinase and Ste20-related proline alanine-rich kinase.
           Serine/threonine kinases (STKs), oxidative stress
           response kinase (OSR1) and Ste20-related proline
           alanine-rich kinase (SPAK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The OSR1 and SPAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. SPAK is also referred to as STK39 or PASK
           (proline-alanine-rich STE20-related kinase). OSR1 and
           SPAK regulate the activity of cation-chloride
           cotransporters through direct interaction and
           phosphorylation. They are also implicated in
           cytoskeletal rearrangement, cell differentiation,
           transformation and proliferation. OSR1 and SPAK contain
           a conserved C-terminal (CCT) domain, which recognizes a
           unique motif ([RK]FX[VI]) present in their activating
           kinases (WNK1/WNK4) and their substrates.
          Length = 267

 Score = 38.1 bits (89), Expect = 4e-04
 Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 19/92 (20%)

Query: 24  HRKFTTKSDVWSFGVTLWEILNLAR-HRPYEGLTDLEVLENI-----SHLH--ADDGEFI 75
              +  K+D+WSFG+T  E   LA    PY     ++VL          L   AD  ++ 
Sbjct: 181 VHGYDFKADIWSFGITAIE---LATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY- 236

Query: 76  YLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
                  +K    +++ C ++ P++RP+  E+
Sbjct: 237 -------SKSFRKMISLCLQKDPSKRPTAEEL 261


>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine
           Kinase, p21-activated kinase.  Serine/threonine kinases
           (STKs), p21-activated kinase (PAK) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PAK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PAKs are Rho
           family GTPase-regulated kinases that serve as important
           mediators in the function of Cdc42 (cell division cycle
           42) and Rac. PAKs are implicated in the regulation of
           many cellular processes including growth factor
           receptor-mediated proliferation, cell polarity, cell
           motility, cell death and survival, and actin
           cytoskeleton organization. PAK deregulation is
           associated with tumor development. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           Group I PAKs contain a PBD (p21-binding domain)
           overlapping with an AID (autoinhibitory domain), a
           C-terminal catalytic domain, SH3 binding sites and a
           non-classical SH3 binding site for PIX (PAK-interacting
           exchange factor). Group II PAKs contain a PBD and a
           catalytic domain, but lack other motifs found in group I
           PAKs. Since group II PAKs do not contain an obvious AID,
           they may be regulated differently from group I PAKs.
           Group I PAKs interact with the SH3 containing proteins
           Nck, Grb2 and PIX; no such binding has been demonstrated
           for group II PAKs.
          Length = 286

 Score = 38.0 bits (89), Expect = 5e-04
 Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 16/94 (17%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT--- 82
            +  K D+WS G+   E+       PY     L  L  I       G    +P  +    
Sbjct: 192 DYGPKVDIWSLGIMCIEMAE--GEPPYLREPPLRALFLI----TTKG----IPPLKNPEK 241

Query: 83  -TKDILDLMNECWKRSPTERPSFTEI--HLFLQR 113
            + +  D +N+C  + P +RPS  E+  H FL++
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275


>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 9.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek9 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek9, also called
           Nercc1, is primarily a cytoplasmic protein but can also
           localize in the nucleus. It is involved in modulating
           chromosome alignment and splitting during mitosis. It
           interacts with the gamma-tubulin ring complex and the
           Ran GTPase, and is implicated in microtubule
           organization. Nek9 associates with FACT (FAcilitates
           Chromatin Transcription) and modulates interphase
           progression. It also interacts with Nek6, and Nek7,
           during mitosis, resulting in their activation.
          Length = 256

 Score = 37.8 bits (88), Expect = 5e-04
 Identities = 19/82 (23%), Positives = 42/82 (51%), Gaps = 8/82 (9%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           K+  KSD+W+ G  L+E+L L   R ++    L ++  I       G +  + +   + +
Sbjct: 177 KYNFKSDIWALGCVLYELLTL--KRTFDATNPLNLVVKIVQ-----GNYTPVVSVY-SSE 228

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           ++ L++   ++ P +RP+  E+
Sbjct: 229 LISLVHSLLQQDPEKRPTADEV 250


>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional.
          Length = 496

 Score = 37.9 bits (88), Expect = 6e-04
 Identities = 23/79 (29%), Positives = 42/79 (53%), Gaps = 8/79 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + ++ K+D++S GV L+E+L L   RP++G    E +E + H     G +  LP P  + 
Sbjct: 220 KPYSKKADMFSLGVLLYELLTL--KRPFDG----ENMEEVMH-KTLAGRYDPLP-PSISP 271

Query: 85  DILDLMNECWKRSPTERPS 103
           ++ +++       P  RPS
Sbjct: 272 EMQEIVTALLSSDPKRRPS 290


>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 6.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek6 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek6 is required
           for the transition from metaphase to anaphase. It also
           plays important roles in mitotic spindle formation and
           cytokinesis.  Activated by Nek9 during mitosis, Nek6
           phosphorylates Eg5, a kinesin that is important for
           spindle bipolarity. Nek6 localizes to spindle
           microtubules during metaphase and anaphase, and to the
           midbody during cytokinesis.
          Length = 267

 Score = 37.3 bits (86), Expect = 8e-04
 Identities = 22/90 (24%), Positives = 44/90 (48%), Gaps = 5/90 (5%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +  KSD+WS G  L+E+  L    P+ G  D   L ++     +  ++  LPT   ++ +
Sbjct: 183 YNFKSDIWSLGCLLYEMAAL--QSPFYG--DKMNLFSLCQ-KIEQCDYPPLPTEHYSEKL 237

Query: 87  LDLMNECWKRSPTERPSFTEIHLFLQRKNL 116
            +L++ C    P +RP    +H   ++ ++
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267


>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 11.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 11 (Nek11)
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           Nek11 subfamily is one of a family of 11 different Neks
           (Nek1-11) that are involved in cell cycle control. The
           Nek family is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Nek11 is involved, through direct
           phosphorylation, in regulating the degradation of Cdc25A
           (Cell Division Cycle 25 homolog A), which plays a role
           in cell cycle progression and in activating cyclin
           dependent kinases. Nek11 is activated by CHK1
           (CHeckpoint Kinase 1) and may be involved in the G2/M
           checkpoint. Nek11 may also play a role in the S-phase
           checkpoint as well as in DNA replication and genotoxic
           stress responses.
          Length = 260

 Score = 37.2 bits (86), Expect = 8e-04
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 9/103 (8%)

Query: 6   DLMRDLTNGRIFKNKNSL-HRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           DL    T    + +  +L H+ + +KSD+WS G  L+E+  LA    +EG   L V+  I
Sbjct: 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA--HAFEGQNFLSVVLRI 217

Query: 65  SHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
                 +G    LP    ++ +  +M     + P+ RPS  EI
Sbjct: 218 V-----EGPTPSLPE-TYSRQLNSIMQSMLNKDPSLRPSAAEI 254


>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mitogen-Activated Protein
           Kinase Kinase Kinase.  Serine/threonine kinases (STKs),
           mitogen-activated protein kinase (MAPK) kinase kinase
           (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called
           MAP/ERK kinase kinases (MEKKs) in some cases. They
           phosphorylate and activate MAPK kinases (MAPKKs or MKKs
           or MAP2Ks), which in turn phosphorylate and activate
           MAPKs during signaling cascades that are important in
           mediating cellular responses to extracellular signals.
           This subfamily is composed of the Apoptosis
           Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or
           MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant
           and fungal MAPKKKs. Also included in this subfamily are
           the cell division control proteins Schizosaccharomyces
           pombe Cdc7 and Saccharomyces cerevisiae Cdc15.
          Length = 260

 Score = 36.8 bits (86), Expect = 0.001
 Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 12/90 (13%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPT--PQTT 83
           ++   +D+WS G T+ E+    +  P+  L +   +  +  +    GE   +P    +  
Sbjct: 179 EYGRAADIWSLGCTVIEMAT-GKP-PWSELGN--PMAALYKI-GSSGEPPEIPEHLSEEA 233

Query: 84  KDILDLMNECWKRSPTERPSFTEI--HLFL 111
           KD L     C +R P +RP+  E+  H FL
Sbjct: 234 KDFLRK---CLRRDPKKRPTADELLQHPFL 260


>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like
           Protein Serine/Threonine Kinases.  Serine/threonine
           kinases (STKs), Nak1 subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The Nak1 subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. This subfamily is composed of
           Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae
           Kic1p (kinase that interacts with Cdc31p) and related
           proteins. Nak1 (also known as N-rich kinase 1), is
           required by fission yeast for polarizing the tips of
           actin cytoskeleton and is involved in cell growth, cell
           separation, cell morphology and cell-cycle progression.
           Kic1p is required by budding yeast for cell integrity
           and morphogenesis. Kic1p interacts with Cdc31p, the
           yeast homologue of centrin, and phosphorylates
           substrates in a Cdc31p-dependent manner.
          Length = 277

 Score = 36.3 bits (84), Expect = 0.002
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 7/83 (8%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + + TK+D+WS G+T++E+     + PY  +     +  I            L     +K
Sbjct: 177 KYYDTKADIWSLGITIYEMAT--GNPPYSDVDAFRAMMLIPKSKPPR-----LEDNGYSK 229

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
            + + +  C    P ER S  E+
Sbjct: 230 LLREFVAACLDEEPKERLSAEEL 252


>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein
           Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2,
            and similar domains.  Serine/Threonine Kinases (STKs),
           Chlamydomonas reinhardtii Never In Mitosis gene A
           (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Chlamydomonas
           reinhardtii CNK2-like subfamily belongs to the
           (NIMA)-related kinase (Nek) family. The Nek family
           includes seven different Chlamydomonas Neks (CNKs 1-6
           and Fa2). This subfamily includes CNK1, and -2.  The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase.  Chlamydomonas reinhardtii CNK2 has both
           cilliary and cell cycle functions. It influences
           flagellar length through promoting flagellar
           disassembly, and it regulates cell size, through
           influencing the size threshold at which cells commit to
           mitosis.
          Length = 256

 Score = 35.9 bits (83), Expect = 0.002
 Identities = 20/83 (24%), Positives = 41/83 (49%), Gaps = 8/83 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           R ++ KSD+WS G  L+E+   A   P+E  +  ++   +       G++  +P P  ++
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFA--PPFEARSMQDLRYKVQR-----GKYPPIP-PIYSQ 227

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
           D+ + +    +  P  RP+  +I
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKI 250


>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 3.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 3 (TAO3) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           TAO3 is also known as JIK (JNK inhibitory kinase) or KFC
           (kinase from chicken). It specifically activates c-Jun
           N-terminal kinase (JNK), presumably by phosphorylating
           and activating MKK4/MKK7. In Saccharomyces cerevisiae,
           TAO3 is a component of the RAM (regulation of Ace2p
           activity and cellular morphogenesis) signaling pathway.
           TAO3 is upregulated in retinal ganglion cells after
           axotomy, and may play a role in apoptosis.
          Length = 313

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 15/93 (16%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT--- 82
           ++  K DVWS G+T  E   LA  +P   L ++  +  + H+  +D      PT Q+   
Sbjct: 196 QYDGKVDVWSLGITCIE---LAERKP--PLFNMNAMSALYHIAQNDS-----PTLQSNEW 245

Query: 83  TKDILDLMNECWKRSPTERPSFTEI--HLFLQR 113
           T      ++ C ++ P ERP+  E+  H F++R
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278


>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Novel Protein Kinase C delta.
           Serine/Threonine Kinases (STKs), Novel Protein Kinase C
           (nPKC), delta isoform, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The nPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. nPKCs are calcium-independent,
           but require DAG (1,2-diacylglycerol) and
           phosphatidylserine (PS) for activity. There are four
           nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta
           plays a role in cell cycle regulation and programmed
           cell death in many cell types. It slows down cell
           proliferation, inducing cell cycle arrest and enhancing
           cell differentiation. PKC-delta is also involved in the
           regulation of transcription as well as immune and
           inflammatory responses. It plays a central role in the
           genotoxic stress response that leads to DNA
           damaged-induced apoptosis.
          Length = 316

 Score = 35.7 bits (82), Expect = 0.003
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 20/97 (20%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ---- 81
           K+T   D WSFGV L+E+  L    P+ G  + E+ E+I            + TP     
Sbjct: 172 KYTFSVDWWSFGVLLYEM--LIGQSPFHGDDEDELFESIR-----------VDTPHYPRW 218

Query: 82  TTKDILDLMNECWKRSPTERPSFT---EIHLFLQRKN 115
            TK+  D++ + ++R PT R         H F +  N
Sbjct: 219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255


>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 3.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek3 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek3 is primarily
           localized in the cytoplasm and shows no cell
           cycle-dependent changes in its activity. It is present
           in the axons of neurons and affects morphogenesis and
           polarity through its regulation of microtubule
           acetylation. Nek3 modulates the signaling of the
           prolactin receptor through its activation of Vav2 and
           contributes to prolactin-mediated motility of breast
           cancer cells.
          Length = 255

 Score = 35.3 bits (81), Expect = 0.003
 Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 10/82 (12%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTP-QTTKD 85
           +  KSD+WS G  L+E+  L +H P++         +  +L     +  Y P P   + +
Sbjct: 177 YNNKSDIWSLGCILYELCTL-KH-PFQA-------NSWKNLILKVCQGSYKPLPSHYSYE 227

Query: 86  ILDLMNECWKRSPTERPSFTEI 107
           +  L+ + +KR+P  RPS T I
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTI 249


>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like
           protein kinase 3-like Protein Serine/Threonine Kinases. 
           Serine/threonine kinases (STKs), mammalian Ste20-like
           protein kinase 3 (MST3)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST3-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily is composed of MST3, MST4,
           STK25, Schizosaccharomyces pombe Nak1 and Sid1,
           Saccharomyces cerevisiae sporulation-specific protein 1
           (SPS1), and related proteins. Nak1 is required by
           fission yeast for polarizing the tips of actin
           cytoskeleton and is involved in cell growth, cell
           separation, cell morphology and cell-cycle progression.
           Sid1 is a component in the septation initiation network
           (SIN) signaling pathway, and plays a role in
           cytokinesis. SPS1 plays a role in regulating proteins
           required for spore wall formation. MST4 plays a role in
           mitogen-activated protein kinase (MAPK) signaling during
           cytoskeletal rearrangement, morphogenesis, and
           apoptosis. MST3 phosphorylates the STK NDR and may play
           a role in cell cycle progression and cell morphology.
           STK25 may play a role in the regulation of cell
           migration and polarization.
          Length = 274

 Score = 34.5 bits (80), Expect = 0.006
 Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 9/87 (10%)

Query: 29  TKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILD 88
            K+D+WS G+T  E+       P   L  + VL  I   +        L   + +K   D
Sbjct: 177 EKADIWSLGITAIELAK--GEPPLSDLHPMRVLFLIPKNNPPS-----LEGNKFSKPFKD 229

Query: 89  LMNECWKRSPTERPSFTEI--HLFLQR 113
            ++ C  + P ERPS  E+  H F+++
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFIKK 256


>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 1.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 1 (TAO1) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           TAO1 is sometimes referred to as prostate-derived
           sterile 20-like kinase 2 (PSK2). TAO1 activates the p38
           MAPK through direct interaction with and activation of
           MEK3. TAO1 is highly expressed in the brain and may play
           a role in neuronal apoptosis. TAO1 interacts with the
           checkpoint proteins BubR1 and Mad2, and plays an
           important role in regulating mitotic progression, which
           is required for both chromosome congression and
           checkpoint-induced anaphase delay. TAO1 may play a role
           in protecting genomic stability.
          Length = 317

 Score = 34.7 bits (79), Expect = 0.006
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 15/94 (15%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK- 84
           ++  K DVWS G+T  E   LA  +P   L ++  +  + H+  ++      PT Q+ + 
Sbjct: 200 QYDGKVDVWSLGITCIE---LAERKP--PLFNMNAMSALYHIAQNES-----PTLQSNEW 249

Query: 85  --DILDLMNECWKRSPTERPSFTEI--HLFLQRK 114
                + ++ C ++ P +RP+  E+  H+F+ R+
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283


>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein
           Kinase, MAP/ERK Kinase.  Protein kinases (PKs), MAP/ERK
           kinase (MEK) subfamily, catalytic (c) domain. PKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine or tyrosine residues on protein
           substrates. The MEK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein serine/threonine kinases, protein tyrosine
           kinases, RIO kinases, aminoglycoside phosphotransferase,
           choline kinase, and phosphoinositide 3-kinase. The
           mitogen-activated protein (MAP) kinase signaling
           pathways are important mediators of cellular responses
           to extracellular signals. The pathways involve a triple
           kinase core cascade comprising the MAP kinase (MAPK),
           which is phosphorylated and activated by a MAPK kinase
           (MAPKK or MKK), which itself is phosphorylated and
           activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1
           and MEK2 are dual-specificity PKs that phosphorylate and
           activate the downstream targets, ERK(extracellular
           signal-regulated kinase) 1 and ERK2, on specific
           threonine and tyrosine residues. The ERK cascade starts
           with extracellular signals including growth factors,
           hormones, and neurotransmitters, which act through
           receptors and ion channels to initiate intracellular
           signaling that leads to the activation at the MAPKKK
           (Raf-1 or MOS) level, which leads to the transmission of
           signals to MEK1/2, and finally to ERK1/2. The ERK
           cascade plays an important role in cell proliferation,
           differentiation, oncogenic transformation, and cell
           cycle control, as well as in apoptosis and cell survival
           under certain conditions. This cascade has also been
           implicated in synaptic plasticity, migration,
           morphological determination, and stress response
           immunological reactions. Gain-of-function mutations in
           genes encoding ERK cascade proteins, including MEK1/2,
           cause cardiofaciocutaneous (CFC) syndrome, a condition
           leading to multiple congenital anomalies and mental
           retardation in patients.
          Length = 308

 Score = 34.3 bits (79), Expect = 0.008
 Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 33/120 (27%)

Query: 26  KFTTKSDVWSFGVTLWEI--------------LNLARHRPYEGLTDLEVLENISHLHADD 71
            +T +SD+WS G++L E+              L     RP       E    +S  H  D
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG-HPPD 232

Query: 72  G----------EFIY------LPTPQTTKDILDLMNECWKRSPTERPSFTEI--HLFLQR 113
                      ++I       LP+   + +  D +++C K++P ER    E+  H F++R
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292


>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like
           Protein Serine/Threonine Kinases.  Serine/threonine
           kinases (STKs), Ste20-like kinase (SLK)-like subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The SLK-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of the subfamily include SLK, STK10
           (also called LOK for lymphocyte-oriented kinase), SmSLK
           (Schistosoma mansoni SLK), and related proteins. SLK
           promotes apoptosis through apoptosis signal-regulating
           kinase 1 (ASK1) and the mitogen-activated protein kinase
           (MAPK) p38. It also plays a role in mediating actin
           reorganization. STK10 is responsible in regulating the
           CD28 responsive element in T cells, as well as leukocyte
           function associated antigen (LFA-1)-mediated lymphocyte
           adhesion. SmSLK is capable of activating the MAPK Jun
           N-terminal kinase (JNK) pathway in human embryonic
           kidney (HEK) cells as well as in Xenopus oocytes. It may
           participate in regulating MAPK cascades during
           host-parasite interactions.
          Length = 280

 Score = 33.9 bits (78), Expect = 0.009
 Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 12/88 (13%)

Query: 30  KSDVWSFGVTLWEILNLARHR-PYEGLTDLEVLENISHLHADDGEFIYLPTPQT-TKDIL 87
           K+D+WS G+TL E   LA+   P+  L  + VL  I        E   L  P   +    
Sbjct: 188 KADIWSLGITLIE---LAQMEPPHHELNPMRVLLKIL-----KSEPPTLDQPSKWSSSFN 239

Query: 88  DLMNECWKRSPTERPSFTEI--HLFLQR 113
           D +  C  + P +RP+  E+  H F+  
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSD 267


>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal
           Bck1-like MAP Kinase Kinase Kinases.  Serine/threonine
           kinases (STKs), mitogen-activated protein kinase (MAPK)
           kinase kinase (MAPKKK) subfamily, fungal Bck1-like
           proteins, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include the MAPKKKs
           Saccharomyces cerevisiae Bck1 and Schizosaccharomyces
           pombe Mkh1, and related proteins. MAPKKKs phosphorylate
           and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks),
           which in turn phosphorylate and activate MAPKs during
           signaling cascades that are important in mediating
           cellular responses to extracellular signals. Budding
           yeast Bck1 is part of the cell integrity MAPK pathway,
           which is activated by stresses and aggressions to the
           cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and
           the MAPK Slt2 make up the cascade that is important in
           the maintenance of cell wall homeostasis. Fission yeast
           Mkh1 is involved in MAPK cascades regulating cell
           morphology, cell wall integrity, salt resistance, and
           filamentous growth in response to stress.
          Length = 272

 Score = 34.0 bits (78), Expect = 0.010
 Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 9/93 (9%)

Query: 22  SLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLP--T 79
           S  + ++ K D+WS G  + E+   A  RP+   +D E +  +  L          P  +
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEM--FAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 80  PQTTKDILDLMNECWKRSPTERPSFTEI--HLF 110
              +   LD +N C+  +P  RP+  E+  H F
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271


>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein
           Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2
           and similar domains.  Serine/Threonine Kinases (STKs),
           Chlamydomonas reinhardtii FA2-like subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Chlamydomonas
           reinhardtii FA2-like subfamily belongs to the
           (NIMA)-related kinase (Nek) family. The Nek family
           includes seven different Chlamydomonas Neks (CNKs 1-6
           and Fa2). This subfamily includes FA2 and CNK4.  The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase.  Chlamydomonas reinhardtii FA2 was discovered
           in a genetic screen for deflagellation-defective
           mutants. It is essential for
           basal-body/centriole-associated microtubule severing,
           and plays a role in cell cycle progression. No cellular
           function has yet been ascribed to CNK4.
          Length = 256

 Score = 33.6 bits (77), Expect = 0.013
 Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 8/78 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + +  KSDVW+ GV L+E        P++      ++  I       G F  +     ++
Sbjct: 176 KPYNEKSDVWALGVVLYEC--CTGKHPFDANNQGALILKIIR-----GVFPPVSQM-YSQ 227

Query: 85  DILDLMNECWKRSPTERP 102
            +  L+++C  +   +RP
Sbjct: 228 QLAQLIDQCLTKDYRQRP 245


>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 7.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek7 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek7 is required
           for mitotic spindle formation and cytokinesis. It is
           enriched in the centrosome and is critical for
           microtubule nucleation. Nek7 is activated by Nek9 during
           mitosis, and may regulate the p70 ribosomal S6 kinase.
          Length = 267

 Score = 33.5 bits (76), Expect = 0.016
 Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 22/121 (18%)

Query: 10  DLTNGRIFKNKNS----------------LHRK-FTTKSDVWSFGVTLWEILNLARHRPY 52
           DL  GR F +K +                +H   +  KSD+WS G  L+E+  L    P+
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL--QSPF 206

Query: 53  EGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMNECWKRSPTERPSFTEIHLFLQ 112
            G  D   L ++     +  ++  LP+   ++++  L+N C    P +RP  T ++   +
Sbjct: 207 YG--DKMNLYSLCK-KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263

Query: 113 R 113
           R
Sbjct: 264 R 264


>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 8.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek8 subfamily is
           one of a family of 11 different Neks (Nek1-11) that are
           involved in cell cycle control. The Nek family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. Nek8 contains an
           N-terminal kinase catalytic domain and a C-terminal RCC1
           (regulator of chromosome condensation) domain. A double
           point mutation in Nek8 causes cystic kidney disease in
           mice that genetically resembles human autosomal
           recessive polycystic kidney disease (ARPKD). Nek8 is
           also associated with a rare form of juvenile renal
           cystic disease, nephronophthisis type 9. It has been
           suggested that a defect in the ciliary localization of
           Nek8 contributes to the development of cysts manifested
           by these diseases.
          Length = 256

 Score = 33.3 bits (76), Expect = 0.020
 Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 8/83 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + +  KSD+W+ G  L+E+ +L R      L  L VL+ +S   A   +     +P   +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-VLKIMSGTFAPISDRY---SPDLRQ 231

Query: 85  DILDLMNECWKRSPTERPSFTEI 107
            IL ++N      P++RP  ++I
Sbjct: 232 LILSMLN----LDPSKRPQLSQI 250


>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein
           Serine/Threonine Kinase, Thousand-and-one amino acids 2.
            Serine/threonine kinases (STKs), thousand-and-one amino
           acids 2 (TAO2) subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The TAO subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. TAO proteins possess mitogen-activated protein
           kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
           activity. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
           Human TAO2 is also known as prostate-derived Ste20-like
           kinase (PSK) and was identified in a screen for
           overexpressed RNAs in prostate cancer. TAO2 activates
           both p38 and c-Jun N-terminal kinase (JNK), by
           phosphorylating and activating the respective MAP/ERK
           kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6
           and MKK4/MKK7. TAO2 contains a long C-terminal extension
           with autoinhibitory segments. It is activated by the
           release of this inhibition and the phosphorylation of
           its activation loop serine. TAO2 functions as a
           regulator of actin cytoskeletal and microtubule
           organization. In addition, it regulates the transforming
           growth factor-activated kinase 1 (TAK1), which is a
           MAPKKK that plays an essential role in the signaling
           pathways of tumor necrosis factor (TNF), interleukin 1
           (IL-1), and Toll-like receptor (TLR).
          Length = 308

 Score = 33.1 bits (75), Expect = 0.024
 Identities = 21/91 (23%), Positives = 45/91 (49%), Gaps = 9/91 (9%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           ++  K DVWS G+T  E   LA  +P   L ++  +  + H+  ++     L +   ++ 
Sbjct: 190 QYDGKVDVWSLGITCIE---LAERKP--PLFNMNAMSALYHIAQNESPA--LQSGHWSEY 242

Query: 86  ILDLMNECWKRSPTERPSFTEI--HLFLQRK 114
             + ++ C ++ P +RP+   +  H F+ R+
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273


>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase
           4.  Serine/threonine kinases (STKs), yeast
           Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The YSK4 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. YSK4 is a
           putative MAPKKK, whose mammalian gene has been isolated.
           MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate
           MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals.
          Length = 265

 Score = 32.6 bits (74), Expect = 0.036
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 8/84 (9%)

Query: 30  KSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDL 89
           KSD+WS G T++E   +A  +P   L  ++ L  + ++ A  G    LP    +   +D 
Sbjct: 188 KSDIWSIGCTVFE---MATGKP--PLASMDRLAAMFYIGAHRGLMPRLPD-SFSAAAIDF 241

Query: 90  MNECWKRSPTERPSFTEI--HLFL 111
           +  C  R   ERPS  ++  H FL
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265


>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein
           Serine/Threonine Kinases, Novel Protein Kinase C theta
           and delta.  Serine/Threonine Kinases (STKs), Novel
           Protein Kinase C (nPKC), theta and delta-like isoforms,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The nPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           nPKCs are calcium-independent, but require DAG
           (1,2-diacylglycerol) and phosphatidylserine (PS) for
           activity. There are four nPKC isoforms, delta, epsilon,
           eta, and theta. PKC-theta is selectively expressed in
           T-cells and plays an important and non-redundant role in
           several aspects of T-cell biology. PKC-delta plays a
           role in cell cycle regulation and programmed cell death
           in many cell types.
          Length = 316

 Score = 32.5 bits (74), Expect = 0.042
 Identities = 21/76 (27%), Positives = 40/76 (52%), Gaps = 9/76 (11%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           K+    D WSFGV L+E+  L    P+ G  + E+ ++I +      +  + P    +K+
Sbjct: 172 KYNESVDWWSFGVLLYEM--LIGQSPFHGEDEDELFDSILN------DRPHFPR-WISKE 222

Query: 86  ILDLMNECWKRSPTER 101
             D +++ ++R PT+R
Sbjct: 223 AKDCLSKLFERDPTKR 238


>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein
           Kinase, MAP kinase kinase 4.  Protein kinases (PKs), MAP
           kinase kinase 4 (MKK4) subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MKK4 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising of the MAP
           kinase (MAPK), which is phosphorylated and activated by
           a MAPK kinase (MAPKK or MKK), which itself is
           phosphorylated and activated by a MAPK kinase kinase
           (MAPKKK or MKKK). MKK4 is a dual-specificity PK that
           phosphorylates and activates the downstream targets,
           c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific
           threonine and tyrosine residues. JNK and p38 are
           collectively known as stress-activated MAPKs, as they
           are activated in response to a variety of environmental
           stresses and pro-inflammatory cytokines. Their
           activation is associated with the induction of cell
           death. Mice deficient in MKK4 die during embryogenesis
           and display anemia, severe liver hemorrhage, and
           abnormal hepatogenesis. MKK4 may also play roles in the
           immune system and in cardiac hypertrophy. It plays a
           major role in cancer as a tumor and metastasis
           suppressor. Under certain conditions, MKK4 is
           pro-oncogenic.
          Length = 288

 Score = 32.0 bits (73), Expect = 0.058
 Identities = 20/81 (24%), Positives = 40/81 (49%), Gaps = 9/81 (11%)

Query: 30  KSDVWSFGVTLWEILNLARHR-PYEGLTDLEVLENISHLHADDGEFIYLPTP--QTTKDI 86
           +SDVWS G+TL+E   +A  + PY       V + ++ +   D   I   +   + +   
Sbjct: 190 RSDVWSLGITLYE---VATGKFPYPKWN--SVFDQLTQVVKGDPP-ILSNSEEREFSPSF 243

Query: 87  LDLMNECWKRSPTERPSFTEI 107
           ++ +N C  +  ++RP + E+
Sbjct: 244 VNFINLCLIKDESKRPKYKEL 264


>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, Phosphoinositide-dependent
           kinase 1.  Serine/Threonine Kinases (STKs),
           Phosphoinositide-dependent kinase 1 (PDK1) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PDK1 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase (PI3K). PDK1
           carries an N-terminal catalytic domain and a C-terminal
           pleckstrin homology (PH) domain that binds
           phosphoinositides. It phosphorylates the activation loop
           of AGC kinases that are regulated by PI3K such as PKB,
           SGK, and PKC, among others, and is crucial for their
           activation. Thus, it contributes in regulating many
           processes including metabolism, growth, proliferation,
           and survival. PDK1 also has the ability to
           autophosphorylate and is constitutively active in
           mammalian cells. PDK1 is essential for normal embryo
           development and is important in regulating cell volume.
          Length = 280

 Score = 31.4 bits (72), Expect = 0.084
 Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 9/81 (11%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
                SD+W+ G  ++++  L    P+ G  +    + I  L     E+ + P      D
Sbjct: 198 PAGKSSDLWALGCIIYQM--LTGKPPFRGSNEYLTFQKILKL-----EYSFPPNF--PPD 248

Query: 86  ILDLMNECWKRSPTERPSFTE 106
             DL+ +     P +R    E
Sbjct: 249 AKDLIEKLLVLDPQDRLGVNE 269


>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 10.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 10 (Nek10)
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           Nek10 subfamily is one of a family of 11 different Neks
           (Nek1-11) that are involved in cell cycle control. The
           Nek family is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. No function has yet been ascribed to Nek10.
           The gene encoding Nek10 is a putative causative gene for
           breast cancer; it is located within a breast cancer
           susceptibility loci on chromosome 3p24.
          Length = 269

 Score = 30.9 bits (70), Expect = 0.11
 Identities = 18/81 (22%), Positives = 35/81 (43%), Gaps = 7/81 (8%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           +  K+DVW+FG  L+++  L    P+     L +   I      +  +  LP    ++D+
Sbjct: 190 YGEKADVWAFGCILYQMCTL--QPPFYSTNMLSLATKIV-----EAVYEPLPEGMYSEDV 242

Query: 87  LDLMNECWKRSPTERPSFTEI 107
            D++  C       RP   ++
Sbjct: 243 TDVITSCLTPDAEARPDIIQV 263


>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine
           Kinase, Protein Kinase C.  Serine/Threonine Kinases
           (STKs), Protein Kinase C (PKC) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The PKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, classical PKCs depend on
           calcium, DAG (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. Novel PKCs are
           calcium-independent, but require DAG and PS for
           activity, while atypical PKCs only require PS. PKCs
           phosphorylate and modify the activities of a wide
           variety of cellular proteins including receptors,
           enzymes, cytoskeletal proteins, transcription factors,
           and other kinases. They play a central role in signal
           transduction pathways that regulate cell migration and
           polarity, proliferation, differentiation, and apoptosis.
           Also included in this subfamily are the PKC-like
           proteins, called PKNs.
          Length = 318

 Score = 31.2 bits (71), Expect = 0.11
 Identities = 13/35 (37%), Positives = 21/35 (60%), Gaps = 2/35 (5%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENISH 66
           D W+ GV L+E+  LA   P+EG  + E+ ++I  
Sbjct: 178 DWWALGVLLYEM--LAGQSPFEGDDEDELFQSILE 210


>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein
           Serine/Threonine Kinases.  Serine/Threonine Kinases
           (STKs), AGC (Protein Kinases A, G and C) family,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The AGC family is part
           of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and Phosphoinositide 3-Kinase (PI3K). Members of
           this family include cAMP-dependent Protein Kinase (PKA),
           cGMP-dependent Protein Kinase (PKG), Protein Kinase C
           (PKC), Protein Kinase B (PKB), G protein-coupled
           Receptor Kinase (GRK), Serum- and Glucocorticoid-induced
           Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase
           (p70S6K or S6K), among others. AGC kinases share an
           activation mechanism based on the phosphorylation of up
           to three sites: the activation loop (A-loop), the
           hydrophobic motif (HM) and the turn motif.
           Phosphorylation at the A-loop is required of most AGC
           kinases, which results in a disorder-to-order transition
           of the A-loop. The ordered conformation results in the
           access of substrates and ATP to the active site. A
           subset of AGC kinases with C-terminal extensions
           containing the HM also requires phosphorylation at this
           site. Phosphorylation at the HM allows the C-terminal
           extension to form an ordered structure that packs into
           the hydrophobic pocket of the catalytic domain, which
           then reconfigures the kinase into an active bi-lobed
           state. In addition, growth factor-activated AGC kinases
           such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require
           phosphorylation at the turn motif (also called tail or
           zipper site), located N-terminal to the HM at the
           C-terminal extension. AGC kinases regulate many cellular
           processes including division, growth, survival,
           metabolism, motility, and differentiation. Many are
           implicated in the development of various human diseases.
          Length = 250

 Score = 31.0 bits (71), Expect = 0.12
 Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 9/75 (12%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMN 91
           D WS GV L+E+  L    P+      E+ E I  L       +  P    + +  DL++
Sbjct: 175 DWWSLGVLLYEM--LTGKPPFYAEDRKEIYEKI--LKDP----LRFP-EFLSPEARDLIS 225

Query: 92  ECWKRSPTERPSFTE 106
              ++ PT+R     
Sbjct: 226 GLLQKDPTKRLGSGG 240


>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mammalian Ste20-like protein
           kinase 3.  Serine/threonine kinases (STKs), mammalian
           Ste20-like protein kinase 3 (MST3) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST3 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. MST3
           phosphorylates the STK NDR and may play a role in cell
           cycle progression and cell morphology. It may also
           regulate paxillin and consequently, cell migration. MST3
           is present in human placenta, where it plays an
           essential role in the oxidative stress-induced apoptosis
           of trophoblasts in normal spontaneous delivery.
           Dysregulation of trophoblast apoptosis may result in
           pregnancy complications such as preeclampsia and
           intrauterine growth retardation.
          Length = 277

 Score = 30.8 bits (69), Expect = 0.13
 Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 12/90 (13%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHR-PYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           + +K+D+WS G+T  E   LA+   P+  L  ++VL  I   +    E  Y      +K 
Sbjct: 178 YDSKADIWSLGITAIE---LAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY------SKP 228

Query: 86  ILDLMNECWKRSPTERPSFTEI--HLFLQR 113
           + + +  C  + P+ RP+  E+  H F+ R
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVR 258


>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein
           Serine/Threonine Kinase, STK10 or Lymphocyte-oriented
           kinase.  Serine/threonine kinases (STKs), STK10
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           STK10 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Other names for STK10 include
           lymphocyte-oriented kinase (LOK) and Xenopus polo-like
           kinase kinase 1 (xPlkk1). STK10 is highly expressed in
           lymphocytes and is responsible in regulating leukocyte
           function associated antigen (LFA-1)-mediated lymphocyte
           adhesion. It plays a role in regulating the CD28
           responsive element in T cells, and may also function as
           a regulator of polo-like kinase 1 (Plk1), a protein
           which is overexpressed in multiple tumor types.
          Length = 292

 Score = 30.8 bits (69), Expect = 0.14
 Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 10/89 (11%)

Query: 30  KSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQT-TKDILD 88
           K+D+WS G+TL E+  +    P+  L  + VL  I+       E   L  P   + +  D
Sbjct: 195 KADIWSLGITLIEMAQI--EPPHHELNPMRVLLKIA-----KSEPPTLSQPSKWSMEFRD 247

Query: 89  LMNECWKRSPTERPSFTEI--HLFLQRKN 115
            +     + P  RPS  ++  H F+    
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSSVT 276


>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C
           beta.  Serine/Threonine Kinases (STKs), Classical
           Protein Kinase C (cPKC) subfamily, beta isoforms,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. There are four
           cPKC isoforms, named alpha, betaI, betaII, and gamma.
           The PKC beta isoforms (I and II), generated by
           alternative splicing of a single gene, are
           preferentially activated by hyperglycemia-induced DAG in
           retinal tissues. This is implicated in diabetic
           microangiopathy such as ischemia, neovascularization,
           and abnormal vasodilator function. PKC-beta also plays
           an important role in VEGF signaling. In addition,
           glucose regulates proliferation in retinal endothelial
           cells via PKC-betaI. PKC-beta is also being explored as
           a therapeutic target in cancer. It contributes to tumor
           formation and is involved in the tumor host mechanisms
           of inflammation and angiogenesis.
          Length = 323

 Score = 30.7 bits (69), Expect = 0.15
 Identities = 14/33 (42%), Positives = 22/33 (66%), Gaps = 2/33 (6%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           D W+FGV L+E+  LA   P+EG  + E+ ++I
Sbjct: 183 DWWAFGVLLYEM--LAGQAPFEGEDEDELFQSI 213


>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Novel Protein Kinase C theta.
           Serine/Threonine Kinases (STKs), Novel Protein Kinase C
           (nPKC), theta isoform, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The nPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. nPKCs are calcium-independent,
           but require DAG (1,2-diacylglycerol) and
           phosphatidylserine (PS) for activity. There are four
           nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta
           is selectively expressed in T-cells and plays an
           important and non-redundant role in several aspects of
           T-cell biology. Although T-cells also express other PKC
           isoforms, PKC-theta is unique in that upon antigen
           stimulation, it is translocated to the plasma membrane
           at the immunological synapse, where it mediates signals
           essential for T-cell activation. It is essential for
           TCR-induced proliferation, cytokine production, T-cell
           survival, and the differentiation and effector function
           of T-helper (Th) cells, particularly Th2 and Th17.
           PKC-theta is being developed as a therapeutic target for
           Th2-mediated allergic inflammation and Th17-mediated
           autoimmune diseases.
          Length = 316

 Score = 30.7 bits (69), Expect = 0.15
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 2/42 (4%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           L +K+ T  D WSFGV L+E+  L    P+ G  + E+ ++I
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEM--LIGQSPFHGHDEEELFQSI 208


>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional.
          Length = 1021

 Score = 30.5 bits (68), Expect = 0.18
 Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 10/100 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + +  KSD+W+ G  ++E+ +        G T      N S L ++      LP    +K
Sbjct: 218 KSYDDKSDMWALGCIIYELCS--------GKTPFHKANNFSQLISELKRGPDLPIKGKSK 269

Query: 85  DILDLMNECWKRSPTERPSFTEIHLFLQRKNLGYVPPMNS 124
           ++  L+      S  ERPS  +   +   KN+G  PP+ +
Sbjct: 270 ELNILIKNLLNLSAKERPSALQCLGYQIIKNVG--PPVGA 307


>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine
           Kinase, Ste20-like kinase.  Serine/threonine kinases
           (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The SLK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. SLK promotes
           apoptosis through apoptosis signal-regulating kinase 1
           (ASK1) and the mitogen-activated protein kinase (MAPK)
           p38. It acts as a MAPK kinase kinase (MAPKKK) by
           phosphorylating ASK1, resulting in the phosphorylation
           of p38. SLK also plays a role in mediating actin
           reorganization. It is part of a microtubule-associated
           complex that is targeted at adhesion sites, and is
           required in focal adhesion turnover and in regulating
           cell migration.
          Length = 282

 Score = 30.0 bits (67), Expect = 0.23
 Identities = 21/88 (23%), Positives = 44/88 (50%), Gaps = 6/88 (6%)

Query: 20  KNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPT 79
           + S  R +  K+DVWS G+TL E+  +    P+  L  + VL  I+     +   +  P+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQI--EPPHHELNPMRVLLKIAK---SEPPTLAQPS 232

Query: 80  PQTTKDILDLMNECWKRSPTERPSFTEI 107
            + + +  D + +C +++   R + T++
Sbjct: 233 -RWSSEFKDFLKKCLEKNVDARWTTTQL 259


>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function
           prediction only / Signal transduction mechanisms /
           Transcription / DNA replication, recombination, and
           repair].
          Length = 384

 Score = 30.1 bits (66), Expect = 0.28
 Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 4/88 (4%)

Query: 20  KNSLHRKFTTKSDVWSFGVTLWEILN--LARHRPYEGLTDLEVLENISHLHADDGEFIYL 77
                   ++ SD+WS G+TL+E+L                + L+ I  L          
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240

Query: 78  P--TPQTTKDILDLMNECWKRSPTERPS 103
           P      +K   DL+ +   + P  R S
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLS 268


>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Mammalian Ste20-like protein
           kinase 4.  Serine/threonine kinases (STKs), mammalian
           Ste20-like protein kinase 4 (MST4) subfamily, catalytic
           (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MST4 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. MST4 is sometimes
           referred to as MASK (MST3 and SOK1-related kinase). It
           plays a role in mitogen-activated protein kinase (MAPK)
           signaling during cytoskeletal rearrangement,
           morphogenesis, and apoptosis. It influences cell growth
           and transformation by modulating the extracellular
           signal-regulated kinase (ERK) pathway. MST4 may also
           play a role in tumor formation and progression. It
           localizes in the Golgi apparatus by interacting with the
           Golgi matrix protein GM130 and may play a role in cell
           migration.
          Length = 277

 Score = 29.6 bits (66), Expect = 0.30
 Identities = 20/87 (22%), Positives = 44/87 (50%), Gaps = 10/87 (11%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDI 86
           + +K+D+WS G+T  E   LA+  P    +D+  +  +  +  ++   +   T + +K  
Sbjct: 178 YDSKADIWSLGITAIE---LAKGEPPN--SDMHPMRVLFLIPKNNPPTL---TGEFSKPF 229

Query: 87  LDLMNECWKRSPTERPSFTEI--HLFL 111
            + ++ C  + P+ RP+  E+  H F+
Sbjct: 230 KEFIDACLNKDPSFRPTAKELLKHKFI 256


>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like
           Protein Serine/Threonine Kinases.  Serine/Threonine
           Kinases (STKs), Microtubule-associated serine/threonine
           (MAST) kinase subfamily, fungal Rim15-like kinases,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The MAST kinase
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include Saccharomyces
           cerevisiae Rim15, Schizosaccharomyces pombe cek1, and
           similar fungal proteins. They contain a central
           catalytic domain, which contains an insert relative to
           MAST kinases. In addition, Rim15 contains a C-terminal
           signal receiver (REC) domain while cek1 contains an
           N-terminal PAS domain. Rim15 (or Rim15p) functions as a
           regulator of meiosis. It acts as a downstream effector
           of PKA and regulates entry into stationary phase (G0).
           Thus, it plays a crucial role in regulating yeast
           proliferation, differentiation, and aging. Cek1 may
           facilitate progression of mitotic anaphase.
          Length = 260

 Score = 29.0 bits (65), Expect = 0.54
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 13/78 (16%)

Query: 28  TTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISH----LHADDGEFIYLPTPQTT 83
              SD WS G  ++E   L  + P+   T   V +NI         +  EF        +
Sbjct: 171 DKMSDWWSLGCVIFEF--LFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC-------S 221

Query: 84  KDILDLMNECWKRSPTER 101
            + +DL+N      P +R
Sbjct: 222 PEAVDLINRLLCMDPAKR 239


>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, STK25 or Yeast
           Sps1/Ste20-related kinase 1.  Serine/threonine kinases
           (STKs), STK25 subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The STK25 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. STK25 is also called Ste20/oxidant stress
           response kinase 1 (SOK1) or yeast Sps1/Ste20-related
           kinase 1 (YSK1). STK25 is localized in the Golgi
           apparatus through its interaction with the Golgi matrix
           protein GM130. It may play a role in the regulation of
           cell migration and polarization. STK25 binds and
           phosphorylates CCM3 (cerebral cavernous malformation 3),
           also called PCD10 (programmed cell death 10), and may
           play a role in apoptosis. Human STK25 is a candidate
           gene responsible for pseudopseudohypoparathyroidism
           (PPHP), a disease that shares features with the Albright
           hereditary osteodystrophy (AHO) phenotype.
          Length = 277

 Score = 28.9 bits (64), Expect = 0.69
 Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 12/87 (13%)

Query: 30  KSDVWSFGVTLWEILNLARHR-PYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILD 88
           K+D+WS G+T  E   LA+   P   L  + VL  I        E       Q +K   +
Sbjct: 181 KADIWSLGITAIE---LAKGEPPNSDLHPMRVLFLIPKNSPPTLE------GQYSKPFKE 231

Query: 89  LMNECWKRSPTERPSFTEI--HLFLQR 113
            +  C  + P  RP+  E+  H F+ R
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFITR 258


>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein
           Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. 
           Serine/threonine kinases (STKs), plant MAP/ERK kinase
           kinase 1 (MEKK1)-like subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The plant MEKK1 subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein STKs, protein tyrosine kinases, RIO
           kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. This subfamily is
           composed of plant mitogen-activated protein kinase
           (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks)
           including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1
           is a MAPKKK that phosphorylates and activates MAPK
           kinases (MAPKKs or MKKs or MAP2Ks), which in turn
           phosphorylate and activate MAPKs during signaling
           cascades that are important in mediating cellular
           responses to extracellular signals. Arabidopsis thaliana
           MEKK1 activates MPK4, a MAPK that regulates systemic
           acquired resistance. MEKK1 also participates in the
           regulation of temperature-sensitive and tissue-specific
           cell death.
          Length = 258

 Score = 28.5 bits (64), Expect = 0.75
 Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 31/93 (33%)

Query: 32  DVWSFGVTLWEILNLARHR-PYEGLTDLEVLENIS----------HLHADDGEFIYLPTP 80
           D+WS G T   +L +A  + P+  L  +  +  I           HL  +  +FI     
Sbjct: 184 DIWSLGCT---VLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK--- 237

Query: 81  QTTKDILDLMNECWKRSPTERPSFTEI--HLFL 111
                       C +R P+ RP+  E+  H F+
Sbjct: 238 ------------CLQRDPSLRPTAAELLEHPFV 258


>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein
           Serine/Threonine Kinases, Mammalian Ste20-like protein
           kinase 1 and 2.  Serine/threonine kinases (STKs),
           mammalian Ste20-like protein kinase 1 (MST1) and MST2
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MST1/2 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. This subfamily is composed of MST1, MST2, and
           related proteins including Drosophila Hippo and
           Dictyostelium discoideum Krs1 (kinase responsive to
           stress 1). MST1/2 and Hippo are involved in a conserved
           pathway that governs cell contact inhibition, organ size
           control, and tumor development. MST1 activates the
           mitogen-activated protein kinases (MAPKs) p38 and c-Jun
           N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and
           MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase
           kinase kinase (MAPKKKK). Activation of JNK by MST1 leads
           to caspase activation and apoptosis. MST1 has also been
           implicated in cell proliferation and differentiation.
           Krs1 may regulate cell growth arrest and apoptosis in
           response to cellular stress.
          Length = 256

 Score = 28.4 bits (64), Expect = 0.85
 Identities = 24/100 (24%), Positives = 41/100 (41%), Gaps = 26/100 (26%)

Query: 23  LHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPT--P 80
               +  K+D+WS G+T  E   +A  +P             S +H     F+ +P   P
Sbjct: 172 QEIGYNNKADIWSLGITAIE---MAEGKP-----------PYSDIHPMRAIFM-IPNKPP 216

Query: 81  QT-------TKDILDLMNECWKRSPTERPSFTEI--HLFL 111
            T       + +  D + +C  + P ERPS  ++  H F+
Sbjct: 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256


>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine
           Kinase, Cyclin-Dependent protein Kinase 7.
           Serine/Threonine Kinases (STKs), Cyclin-Dependent
           protein Kinase 7 (CDK7) subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The CDK7 subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. CDKs belong to a large family
           of STKs that are regulated by their cognate cyclins.
           Together, they are involved in the control of cell-cycle
           progression, transcription, and neuronal function. CDK7
           plays essential roles in the cell cycle and in
           transcription. It associates with cyclin H and MAT1 and
           acts as a CDK-Activating Kinase (CAK) by phosphorylating
           and activating cell cycle CDKs (CDK1/2/4/6). In the
           brain, it activates CDK5. CDK7 is also a component of
           the general transcription factor TFIIH, which
           phosphorylates the C-terminal domain (CTD) of RNA
           polymerase II when it is bound with unphosphorylated
           DNA, as present in the pre-initiation complex. Following
           phosphorylation, the CTD dissociates from the DNA which
           allows transcription initiation.
          Length = 298

 Score = 28.3 bits (64), Expect = 0.86
 Identities = 21/104 (20%), Positives = 35/104 (33%), Gaps = 25/104 (24%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPY-EGLTDLEVLENISHL-----HADDGEFIYLP 78
           R +    D+WS G    E+L      P+  G +D++ L  I          +      LP
Sbjct: 178 RHYGVGVDMWSVGCIFAELLL---RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234

Query: 79  T----------------PQTTKDILDLMNECWKRSPTERPSFTE 106
                            P  + D LDL+      +P +R +  +
Sbjct: 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278


>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein
           Serine/Threonine Kinase, Never In Mitosis gene A-related
           kinase 4.  Serine/Threonine Kinases (STKs), Never In
           Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The Nek4 subfamily is
           one of a family of 11 different Neks (Nek1-11). The Nek
           family is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Neks are involved in the regulation of
           downstream processes following the activation of Cdc2,
           and many of their functions are cell cycle-related. They
           play critical roles in microtubule dynamics during
           ciliogenesis and mitosis. Nek4 is highly abundant in the
           testis. Its specific function is unknown.
          Length = 257

 Score = 28.0 bits (62), Expect = 1.0
 Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 13/92 (14%)

Query: 16  IFKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFI 75
           +F NK      +  KSDVW+ G  ++E+  L      + +  L V   I      +G+  
Sbjct: 173 LFSNK-----PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRII------EGKLP 220

Query: 76  YLPTPQTTKDILDLMNECWKRSPTERPSFTEI 107
            +P    + ++ +L+     + P +RPS   I
Sbjct: 221 PMPK-DYSPELGELIATMLSKRPEKRPSVKSI 251


>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein
           Serine/Threonine Kinase, 90 kDa ribosomal protein S6
           kinase.  Serine/Threonine Kinases (STKs), 90 kDa
           ribosomal protein S6 kinase (RSK) subfamily, N-terminal
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The RSK subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. RSKs contain an
           N-terminal kinase domain (NTD) from the AGC family and a
           C-terminal kinase domain (CTD) from the CAMK family.
           They are activated by signaling inputs from
           extracellular regulated kinase (ERK) and
           phosphoinositide dependent kinase 1 (PDK1). ERK
           phosphorylates and activates the CTD of RSK, serving as
           a docking site for PDK1, which phosphorylates and
           activates the NTD, which in turn phosphorylates all
           known RSK substrates. RSKs act as downstream effectors
           of mitogen-activated protein kinase (MAPK) and play key
           roles in mitogen-activated cell growth, differentiation,
           and survival. Mammals possess four RSK isoforms (RSK1-4)
           from distinct genes. RSK proteins are also referred to
           as MAP kinase-activated protein kinases (MAPKAPKs),
           p90-RSKs, or p90S6Ks.
          Length = 318

 Score = 28.2 bits (63), Expect = 1.0
 Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 11/78 (14%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQ-TT 83
           R  T  +D WSFGV ++E+  L    P++G    E +  I  L A       L  PQ  +
Sbjct: 173 RGHTQSADWWSFGVLMFEM--LTGSLPFQGKDRKETMTMI--LKAK------LGMPQFLS 222

Query: 84  KDILDLMNECWKRSPTER 101
            +   L+   +KR+P  R
Sbjct: 223 PEAQSLLRALFKRNPANR 240


>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein
           Serine/Threonine Kinase, Novel Protein Kinase C eta.
           Serine/Threonine Kinases (STKs), Novel Protein Kinase C
           (nPKC), eta isoform, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           nPKC subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PKCs are classified into three groups
           (classical, atypical, and novel) depending on their mode
           of activation and the structural characteristics of
           their regulatory domain. nPKCs are calcium-independent,
           but require DAG (1,2-diacylglycerol) and
           phosphatidylserine (PS) for activity. There are four
           nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta
           is predominantly expressed in squamous epithelia, where
           it plays a crucial role in the signaling of cell-type
           specific differentiation. It is also expressed in pro-B
           cells and early-stage thymocytes, and acts as a key
           regulator in early B-cell development. PKC-eta increases
           glioblastoma multiforme (GBM) proliferation and
           resistance to radiation, and is being developed as a
           therapeutic target for the management of GBM.
          Length = 320

 Score = 28.3 bits (63), Expect = 1.1
 Identities = 21/70 (30%), Positives = 37/70 (52%), Gaps = 9/70 (12%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMN 91
           D W+ GV L+E+  L  H P+E   + ++ E I      + E +Y PT   ++D +D++ 
Sbjct: 178 DWWAMGVLLYEM--LCGHAPFEAENEDDLFEAIL-----NDEVVY-PT-WLSQDAVDILK 228

Query: 92  ECWKRSPTER 101
               ++PT R
Sbjct: 229 AFMTKNPTMR 238


>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional.
          Length = 357

 Score = 27.9 bits (62), Expect = 1.2
 Identities = 9/19 (47%), Positives = 16/19 (84%)

Query: 26  KFTTKSDVWSFGVTLWEIL 44
           K+ +K+D+WS G+ L+E+L
Sbjct: 232 KYNSKADIWSAGIVLFEML 250


>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of
           Phototropin-like Protein Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Phototropin-like
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           phototropin-like subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Included in this subfamily
           are plant phototropins and predominantly uncharacterized
           fungal STKs whose catalytic domains resemble the
           phototropin kinase domain. One protein from Neurospora
           crassa is called nrc-2. Phototropins are blue-light
           receptors that control responses such as phototropism,
           stromatal opening, and chloroplast movement in order to
           optimize the photosynthetic efficiency of plants. They
           are light-activated STKs that contain an N-terminal
           photosensory domain and a C-terminal catalytic domain.
           The N-terminal domain contains two LOV (Light, Oxygen or
           Voltage) domains that binds FMN. Photoexcitation of the
           LOV domains results in autophosphorylation at multiple
           sites and activation of the catalytic domain. Neurospora
           crassa nrc-2 plays a role in growth and development by
           controlling entry into the conidiation program.
          Length = 316

 Score = 27.2 bits (61), Expect = 2.2
 Identities = 17/70 (24%), Positives = 31/70 (44%), Gaps = 7/70 (10%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDLMN 91
           D W+ G+ L+E+  L    P++G    E   NI        E  +  +P  +    DL+ 
Sbjct: 214 DWWTLGILLYEM--LYGTTPFKGSNRDETFSNILK-----KEVTFPGSPPVSSSARDLIR 266

Query: 92  ECWKRSPTER 101
           +   + P++R
Sbjct: 267 KLLVKDPSKR 276


>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C.
           Serine/Threonine Kinases (STKs), Classical (or
           Conventional) Protein Kinase C (cPKC) subfamily,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase (PI3K). PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. cPKCs contain a
           calcium-binding C2 region in their regulatory domain.
           There are four cPKC isoforms, named alpha, betaI,
           betaII, and gamma. cPKCs are potent kinases for
           histones, myelin basic protein, and protamine. PKC-gamma
           is mainly expressed in neuronal tissues. It plays a role
           in protection from ischemia.
          Length = 324

 Score = 27.4 bits (61), Expect = 2.2
 Identities = 13/33 (39%), Positives = 22/33 (66%), Gaps = 2/33 (6%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           D W+FGV L+E+  LA   P++G  + E+ ++I
Sbjct: 183 DWWAFGVLLYEM--LAGQPPFDGEDEDELFQSI 213


>gnl|CDD|223895 COG0825, AccA, Acetyl-CoA carboxylase alpha subunit [Lipid
          metabolism].
          Length = 317

 Score = 27.2 bits (61), Expect = 2.6
 Identities = 13/35 (37%), Positives = 17/35 (48%), Gaps = 9/35 (25%)

Query: 38 VTLWEILNLARH--RPYEGLTDLEVLENISHLHAD 70
          +T W+ + LARH  RPY        L+ I  L  D
Sbjct: 54 LTPWQRVQLARHPDRPY-------TLDYIELLFTD 81


>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein
           Serine/Threonine Kinase, cGMP-dependent protein kinase. 
           Serine/Threonine Kinases (STKs), cGMP-dependent protein
           kinase (cGK or PKG) subfamily, catalytic (c) domain.
           STKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine residues on protein
           substrates. The cGK subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Mammals have two cGK isoforms
           from different genes, cGKI and cGKII. cGKI exists as two
           splice variants, cGKI-alpha and cGKI-beta. cGK consists
           of an N-terminal regulatory domain containing a
           dimerization and an autoinhibitory pseudosubstrate
           region, two cGMP-binding domains, and a C-terminal
           catalytic domain. Binding of cGMP to both binding sites
           releases the inhibition of the catalytic center by the
           pseudosubstrate region, allowing autophosphorylation and
           activation of the kinase. cGKI is a  soluble protein
           expressed in all smooth muscles, platelets, cerebellum,
           and kidney. It is also expressed at lower concentrations
           in other tissues. cGKII is a membrane-bound protein that
           is most abundantly expressed in the intestine. It is
           also present in the brain nuclei, adrenal cortex,
           kidney, lung, and prostate. cGKI is involved in the
           regulation of smooth muscle tone, smooth cell
           proliferation, and platelet activation. cGKII plays a
           role in the regulation of secretion, such as renin
           secretion by the kidney and aldosterone secretion by the
           adrenal. It also regulates bone growth and the circadian
           rhythm.
          Length = 262

 Score = 26.8 bits (60), Expect = 2.6
 Identities = 17/73 (23%), Positives = 29/73 (39%), Gaps = 9/73 (12%)

Query: 31  SDVWSFGVTLWEILNLARHRPYEG--LTDLEVLENISHLHADDGEFIYLPTPQTTKDILD 88
            D WS G+ L+E+L      P+       +E+  +I          +  P         D
Sbjct: 173 VDYWSLGILLYELLT--GRPPFGEDDEDPMEIYNDI----LKGNGKLEFPNYIDKAAK-D 225

Query: 89  LMNECWKRSPTER 101
           L+ +  +R+P ER
Sbjct: 226 LIKQLLRRNPEER 238


>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III
           myosin-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs), Class III myosin-like
           subfamily, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           class III myosin-like subfamily is part of a larger
           superfamily that includes the catalytic domains of other
           protein STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. Class III myosins are motor
           proteins with an N-terminal kinase catalytic domain and
           a C-terminal actin-binding motor domain. Class III
           myosins are present in the photoreceptors of
           invertebrates and vertebrates and in the auditory hair
           cells of mammals. The kinase domain of myosin III can
           phosphorylate several cytoskeletal proteins,
           conventional myosin regulatory light chains, and can
           autophosphorylate the C-terminal motor domain. Myosin
           III may play an important role in maintaining the
           structural integrity of photoreceptor cell microvilli.
           It may also function as a cargo carrier during
           light-dependent translocation, in photoreceptor cells,
           of proteins such as transducin and arrestin. The
           Drosophila class III myosin, called NinaC (Neither
           inactivation nor afterpotential protein C), is critical
           in normal adaptation and termination of photoresponse.
           Vertebrates contain two isoforms of class III myosin,
           IIIA and IIIB. This subfamily also includes mammalian
           NIK-like embryo-specific kinase (NESK), Traf2- and
           Nck-interacting kinase (TNIK), mitogen-activated protein
           kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or
           MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in
           some MAPK signaling pathways by activating a MAPK kinase
           kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is
           activated either by a small GTP-binding protein or by an
           adaptor protein, which transmits the signal either
           directly to a MAP3K to start the triple kinase core
           cascade or indirectly through a mediator kinase, a
           MAP4K. MAPK signaling cascades are important in
           mediating cellular responses to extracellular signals.
          Length = 275

 Score = 26.9 bits (60), Expect = 3.2
 Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 24/95 (25%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTT--- 83
           +  +SDVWS G+T  E   LA  +P            +  +H     F     P  T   
Sbjct: 195 YDARSDVWSLGITAIE---LADGKP-----------PLCDMHPMRALFKIPRNPPPTLKS 240

Query: 84  -----KDILDLMNECWKRSPTERPSFTEI--HLFL 111
                K   D ++EC  ++  +RP   E+  H F+
Sbjct: 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275


>gnl|CDD|224494 COG1578, COG1578, Uncharacterized conserved protein [Function
           unknown].
          Length = 285

 Score = 26.9 bits (60), Expect = 3.3
 Identities = 7/32 (21%), Positives = 14/32 (43%)

Query: 80  PQTTKDILDLMNECWKRSPTERPSFTEIHLFL 111
            +   + L L++E +  S     + T IH  +
Sbjct: 30  SRIMSEALKLLSEEYGESAVPAIAGTLIHREV 61


>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein
           Serine/Threonine Kinase, Classical Protein Kinase C
           alpha.  Serine/Threonine Kinases (STKs), Classical
           Protein Kinase C (cPKC) subfamily, alpha isoform,
           catalytic (c) domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The cPKC subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. PKCs are
           classified into three groups (classical, atypical, and
           novel) depending on their mode of activation and the
           structural characteristics of their regulatory domain.
           PKCs undergo three phosphorylations in order to take
           mature forms. In addition, cPKCs depend on calcium, DAG
           (1,2-diacylglycerol), and in most cases,
           phosphatidylserine (PS) for activation. There are four
           cPKC isoforms, named alpha, betaI, betaII, and gamma.
           PKC-alpha is expressed in many tissues and is associated
           with cell proliferation, apoptosis, and cell motility.
           It plays a role in the signaling of the growth factors
           PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha
           have been detected in many transformed cell lines and
           several human tumors. In addition, PKC-alpha is required
           for HER2 dependent breast cancer invasion.
          Length = 323

 Score = 26.5 bits (58), Expect = 4.5
 Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 2/33 (6%)

Query: 32  DVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           D W++GV L+E+  LA   P++G  + E+ ++I
Sbjct: 183 DWWAYGVLLYEM--LAGQPPFDGEDEDELFQSI 213


>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein
           Serine/Threonine Kinase, p21-activated kinase 1.
           Serine/threonine kinases (STKs), p21-activated kinase
           (PAK) 1, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The PAK
           subfamily is part of a larger superfamily that includes
           the catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. PAKs are Rho family GTPase-regulated kinases
           that serve as important mediators in the function of
           Cdc42 (cell division cycle 42) and Rac. PAKs from higher
           eukaryotes are classified into two groups (I and II),
           according to their biochemical and structural features.
           PAK1 belongs to group I. Group I PAKs contain a PBD
           (p21-binding domain) overlapping with an AID
           (autoinhibitory domain), a C-terminal catalytic domain,
           SH3 binding sites and a non-classical SH3 binding site
           for PIX (PAK-interacting exchange factor). PAK1 is
           important in the regulation of many cellular processes
           including cytoskeletal dynamics, cell motility, growth,
           and proliferation. Although PAK1 has been regarded
           mainly as a cytosolic protein, recent reports indicate
           that PAK1 also exists in significant amounts in the
           nucleus, where it is involved in transcription
           modulation and in cell cycle regulatory events. PAK1 is
           also involved in transformation and tumorigenesis. Its
           overexpression, hyperactivation and increased nuclear
           accumulation is correlated to breast cancer invasiveness
           and progression. Nuclear accumulation is also linked to
           tamoxifen resistance in breast cancer cells.
          Length = 296

 Score = 26.2 bits (57), Expect = 5.7
 Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 11/101 (10%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTK 84
           + +  K D+WS G+   E++      PY     L  L    +L A +G    L  P+   
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIE--GEPPYLNENPLRAL----YLIATNGT-PELQNPEKLS 243

Query: 85  DIL-DLMNECWKRSPTERPSFTEIHLFLQRKNLGYVPPMNS 124
            I  D +N C      +R S  E+   LQ + L    P++S
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKEL---LQHQFLKIAKPLSS 281


>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase
           3-like Protein Serine/Threonine Kinases.
           Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
           (MEKK3)-like subfamily, catalytic (c) domain. STKs
           catalyze the transfer of the gamma-phosphoryl group from
           ATP to serine/threonine residues on protein substrates.
           The MEKK3-like subfamily is part of a larger superfamily
           that includes the catalytic domains of other protein
           STKs, protein tyrosine kinases, RIO kinases,
           aminoglycoside phosphotransferase, choline kinase, and
           phosphoinositide 3-kinase. This subfamily is composed of
           MEKK3, MEKK2, and related proteins, all containing an
           N-terminal PB1 domain, which mediates oligomerization,
           and a C-terminal catalytic domain. MEKK2 and MEKK3 are
           mitogen-activated protein kinase (MAPK) kinase kinases
           (MAPKKKs or MKKKs or MAP3Ks), proteins that
           phosphorylate and activate MAPK kinases (MAPKKs or MKKs
           or MAP2Ks), which in turn phosphorylate and activate
           MAPKs during signaling cascades that are important in
           mediating cellular responses to extracellular signals.
           MEKK2 and MEKK3 activate MEK5 (also called MKK5), which
           activates extracellular signal-regulated kinase 5
           (ERK5). The ERK5 cascade plays roles in promoting cell
           proliferation, differentiation, neuronal survival, and
           neuroprotection. MEKK3 plays an essential role in
           embryonic angiogenesis and early heart development.
           MEKK2 and MEKK3 can also activate the MAPKs, c-Jun
           N-terminal kinase (JNK) and p38, through their
           respective MAPKKs.
          Length = 263

 Score = 25.9 bits (57), Expect = 5.8
 Identities = 19/78 (24%), Positives = 33/78 (42%), Gaps = 7/78 (8%)

Query: 30  KSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKDILDL 89
           K+DVWS G T+ E+  L    P+    + E +  I  +         LP    + D  + 
Sbjct: 187 KADVWSVGCTVVEM--LTEKPPW---AEFEAMAAIFKIATQPTNPQ-LP-SHVSPDARNF 239

Query: 90  MNECWKRSPTERPSFTEI 107
           +   +  +  +RPS  E+
Sbjct: 240 LRRTFVENAKKRPSAEEL 257


>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine
           Kinase, Fungal Cyclin-Dependent protein Kinase Bypass
           UAS Requirement 1 and similar proteins.
           Serine/Threonine Kinases (STKs), Bypass UAS Requirement
           1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze
           the transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           BUR1 subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CDKs belong to a large family of STKs that are
           regulated by their cognate cyclins. Together, they are
           involved in the control of cell-cycle progression,
           transcription, and neuronal function. BUR1, also called
           SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK)
           that is functionally equivalent to mammalian CDK9. It
           associates with the cyclin BUR2. BUR genes were
           orginally identified in a genetic screen as factors
           involved in general transcription. The BUR1/BUR2 complex
           phosphorylates the C-terminal domain of RNA polymerase
           II. In addition, this complex regulates histone
           modification by phosporylating Rad6 and mediating the
           association of the Paf1 complex with chromatin.
          Length = 311

 Score = 26.1 bits (58), Expect = 5.8
 Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 4/44 (9%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRP-YEGLTDLEVLENISHL 67
           R++TT  D+W  G    E+      RP  +G +D++ L  I  L
Sbjct: 202 RRYTTAVDIWGIGCVFAEMFT---RRPILQGKSDIDQLHLIFKL 242


>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein
           Kinase, MAP/ERK Kinase 1.  Protein kinases (PKs),
           MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain.
           PKs catalyze the transfer of the gamma-phosphoryl group
           from ATP to serine/threonine or tyrosine residues on
           protein substrates. The MEK subfamily is part of a
           larger superfamily that includes the catalytic domains
           of other protein serine/threonine kinases, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. The mitogen-activated protein (MAP) kinase
           signaling pathways are important mediators of cellular
           responses to extracellular signals. The pathways involve
           a triple kinase core cascade comprising the MAP kinase
           (MAPK), which is phosphorylated and activated by a MAPK
           kinase (MAPKK or MKK), which itself is phosphorylated
           and activated by a MAPK kinase kinase (MAPKKK or MKKK).
           MEK1 is a dual-specificity PK that phosphorylates and
           activates the downstream targets, extracellular
           signal-regulated kinase (ERK) 1 and ERK2, on specific
           threonine and tyrosine residues. The ERK cascade starts
           with extracellular signals including growth factors,
           hormones, and neurotransmitters, which act through
           receptors and ion channels to initiate intracellular
           signaling that leads to the activation at the MAPKKK
           (Raf-1 or MOS) level, which leads to the transmission of
           signals to MEK1, and finally to ERK1/2. The ERK cascade
           plays an important role in cell proliferation,
           differentiation, oncogenic transformation, and cell
           cycle control, as well as in apoptosis and cell survival
           under certain conditions. Gain-of-function mutations in
           genes encoding ERK cascade proteins, including MEK1,
           cause cardiofaciocutaneous (CFC) syndrome, a condition
           leading to multiple congenital anomalies and mental
           retardation in patients. MEK1 also plays a role in cell
           cycle control.
          Length = 333

 Score = 26.1 bits (57), Expect = 6.2
 Identities = 11/42 (26%), Positives = 21/42 (50%), Gaps = 2/42 (4%)

Query: 77  LPTPQTTKDILDLMNECWKRSPTERPSFTE--IHLFLQRKNL 116
           LP+     +  D +N+C  ++P ER    +  +H F++R   
Sbjct: 266 LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307


>gnl|CDD|187563 cd05253, UDP_GE_SDE_e, UDP glucuronic acid epimerase, extended (e)
           SDRs.  This subgroup contains UDP-D-glucuronic acid
           4-epimerase, an extended SDR, which catalyzes the
           conversion of UDP-alpha-D-glucuronic acid to
           UDP-alpha-D-galacturonic acid. This group has the SDR's
           canonical catalytic tetrad and the TGxxGxxG NAD-binding
           motif of the extended SDRs. Extended SDRs are distinct
           from classical SDRs. In addition to the Rossmann fold
           (alpha/beta folding pattern with a central beta-sheet)
           core region typical of all SDRs, extended SDRs have a
           less conserved C-terminal extension of approximately 100
           amino acids. Extended SDRs are a diverse collection of
           proteins, and include isomerases, epimerases,
           oxidoreductases, and lyases; they typically have a
           TGXXGXXG cofactor binding motif. SDRs are a functionally
           diverse family of oxidoreductases that have a single
           domain with a structurally conserved Rossmann fold, an
           NAD(P)(H)-binding region, and a structurally diverse
           C-terminal region. Sequence identity between different
           SDR enzymes is typically in the 15-30% range; they
           catalyze a wide range of activities including the
           metabolism of steroids, cofactors, carbohydrates,
           lipids, aromatic compounds, and amino acids, and act in
           redox sensing. Classical SDRs have an TGXXX[AG]XG
           cofactor binding motif and a YXXXK active site motif,
           with the Tyr residue of the active site motif serving as
           a critical catalytic residue (Tyr-151, human
           15-hydroxyprostaglandin dehydrogenase numbering). In
           addition to the Tyr and Lys, there is often an upstream
           Ser and/or an Asn, contributing to the active site;
           while substrate binding is in the C-terminal region,
           which determines specificity. The standard reaction
           mechanism is a 4-pro-S hydride transfer and proton relay
           involving the conserved Tyr and Lys, a water molecule
           stabilized by Asn, and nicotinamide. Atypical SDRs
           generally lack the catalytic residues characteristic of
           the SDRs, and their glycine-rich NAD(P)-binding motif is
           often different from the forms normally seen in
           classical or extended SDRs. Complex (multidomain) SDRs
           such as ketoreductase domains of fatty acid synthase
           have a GGXGXXG NAD(P)-binding motif and an altered
           active site motif (YXXXN). Fungal type ketoacyl
           reductases have a TGXXXGX(1-2)G NAD(P)-binding motif.
          Length = 332

 Score = 26.1 bits (58), Expect = 6.3
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 12/98 (12%)

Query: 2   DFTNDLMRDLTNG--RIFKNKNSLHRKFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLE 59
           DFT   + D+  G  R        +  +  ++   S     + + N+  + P + +  +E
Sbjct: 217 DFT--YIDDIVEGVVRALDTPAKPNPNWDAEAPDPSTSSAPYRVYNIGNNSPVKLMDFIE 274

Query: 60  VLENISHLHADDGEFIYLP-----TPQTTKDILDLMNE 92
            LE      A   +  YLP      P+T  DI  L   
Sbjct: 275 ALEKALGKKA---KKNYLPMQKGDVPETYADISKLQRL 309


>gnl|CDD|235580 PRK05724, PRK05724, acetyl-CoA carboxylase carboxyltransferase
          subunit alpha; Validated.
          Length = 319

 Score = 25.9 bits (58), Expect = 6.6
 Identities = 9/16 (56%), Positives = 11/16 (68%), Gaps = 2/16 (12%)

Query: 39 TLWEILNLARH--RPY 52
          T W+ + LARH  RPY
Sbjct: 56 TPWQKVQLARHPQRPY 71


>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine
           Kinase, Cyclin-Dependent protein Kinase 10.
           Serine/Threonine Kinases (STKs), Cyclin-dependent
           protein Kinase 10 (CDK10) subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The CDK10 subfamily is
           part of a larger superfamily that includes the catalytic
           domains of other protein STKs, protein tyrosine kinases,
           RIO kinases, aminoglycoside phosphotransferase, choline
           kinase, and phosphoinositide 3-kinase. CDKs belong to a
           large family of STKs that are regulated by their cognate
           cyclins. Together, they are involved in the control of
           cell-cycle progression, transcription, and neuronal
           function. CDK10, also called PISSLRE, is essential for
           cell growth and proliferation, and acts through the G2/M
           phase of the cell cycle. CDK10 has also been identified
           as an important factor in endocrine therapy resistance
           in breast cancer. CDK10 silencing increases the
           transcription of c-RAF and the activation of the p42/p44
           MAPK pathway, which leads to antiestrogen resistance.
           Patients who express low levels of CDK10 relapse early
           on tamoxifen.
          Length = 309

 Score = 25.8 bits (57), Expect = 6.9
 Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 4/53 (7%)

Query: 25  RKFTTKSDVWSFGVTLWEILNLARHRP-YEGLTDLEVLENISHLHADDGEFIY 76
             +TT  D+W+ G  L E+L    H+P   G +++E L+ I  L     E I+
Sbjct: 184 TTYTTAIDMWAVGCILAELL---AHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233


>gnl|CDD|232949 TIGR00382, clpX, endopeptidase Clp ATP-binding regulatory subunit
          (clpX).  A member of the ATP-dependent proteases, ClpX
          has ATP-dependent chaperone activity and is required
          for specific ATP-dependent proteolytic activities
          expressed by ClpPX. The gene is also found to be
          involved in stress tolerance in Bacillus subtilis and
          is essential for the efficient acquisition of genes
          specifying type IA and IB restriction [Protein fate,
          Protein folding and stabilization, Protein fate,
          Degradation of proteins, peptides, and glycopeptides].
          Length = 413

 Score = 25.5 bits (56), Expect = 8.6
 Identities = 9/20 (45%), Positives = 12/20 (60%)

Query: 69 ADDGEFIYLPTPQTTKDILD 88
           ++ E  YLPTP+  K  LD
Sbjct: 57 EEEFELSYLPTPKEIKAHLD 76


>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional.
          Length = 392

 Score = 25.6 bits (56), Expect = 8.8
 Identities = 7/18 (38%), Positives = 13/18 (72%)

Query: 27  FTTKSDVWSFGVTLWEIL 44
           +  K+D+WS G+ L+E+ 
Sbjct: 264 YCAKTDIWSAGLVLFEMS 281


>gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein.  This family includes the
           hamartin protein which is thought to function as a
           tumour suppressor. The hamartin protein interacts with
           the tuberin protein pfam03542. Tuberous sclerosis
           complex (TSC) is an autosomal dominant disorder and is
           characterized by the presence of hamartomas in many
           organs, such as brain, skin, heart, lung, and kidney. It
           is caused by mutation either TSC1 or TSC2 tumour
           suppressor gene. TSC1 encodes a protein, hamartin,
           containing two coiled-coil regions, which have been
           shown to mediate binding to tuberin. The TSC2 gene codes
           for tuberin pfam03542. These two proteins function
           within the same pathway(s) regulating cell cycle, cell
           growth, adhesion, and vesicular trafficking.
          Length = 667

 Score = 25.7 bits (56), Expect = 9.0
 Identities = 10/22 (45%), Positives = 14/22 (63%)

Query: 84  KDILDLMNECWKRSPTERPSFT 105
           K +LD +NEC  + PT  P+ T
Sbjct: 69  KYLLDKLNECLGKPPTRLPTLT 90


>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent
           protein Kinase 9-like Serine/Threonine Kinases.
           Serine/Threonine Kinases (STKs), Cyclin-Dependent
           protein Kinase 9 (CDK9)-like subfamily, catalytic (c)
           domain. STKs catalyze the transfer of the
           gamma-phosphoryl group from ATP to serine/threonine
           residues on protein substrates. The CDK9-like subfamily
           is part of a larger superfamily that includes the
           catalytic domains of other protein STKs, protein
           tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. CDKs belong to a large family of STKs that are
           regulated by their cognate cyclins. Together, they are
           involved in the control of cell-cycle progression,
           transcription, and neuronal function. This subfamily is
           composed of CDK9 and CDK12 from higher eukaryotes, yeast
           BUR1, C-type plant CDKs (CdkC), and similar proteins.
           CDK9, BUR1, and CdkC are functionally equivalent. They
           act as a kinase for the C-terminal domain of RNA
           polymerase II and participate in regulating mutliple
           steps of gene expression including transcription
           elongation and RNA processing. CDK9 and CdkC associate
           with T-type cyclins while BUR1 associates with the
           cyclin BUR2. CDK12 is a unique CDK that contains an
           arginine/serine-rich (RS) domain, which is predominantly
           found in splicing factors. CDK12 interacts with cyclins
           L1 and L2, and participates in regulating transcription
           and alternative splicing.
          Length = 287

 Score = 25.6 bits (57), Expect = 9.1
 Identities = 14/42 (33%), Positives = 22/42 (52%), Gaps = 2/42 (4%)

Query: 26  KFTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENISHL 67
           ++  + D+WS G  L E+        ++G T+LE LE I  L
Sbjct: 178 RYGPEVDMWSVGCILAELFL--GKPIFQGSTELEQLEKIFEL 217


>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain.  It is an
           interaction domain identified as being similar to the
           C-terminal protein kinase catalytic fold (C lobe). Its
           presence at the N terminus of signalling proteins and
           the absence of the active-site residues in the catalytic
           and activation loops suggest that it folds independently
           and is likely to be non-catalytic. The occurrence of
           KIND only in metazoa implies that it has evolved from
           the catalytic protein kinase domain into an interaction
           domain possibly by keeping the substrate-binding
           features.
          Length = 176

 Score = 25.4 bits (56), Expect = 9.2
 Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 11/88 (12%)

Query: 28  TTKSDVWSFGVTLWEILN--LARHRPYEGLTDLEVLENISHLHADDGEFIYLPTPQTTKD 85
           T K+D++S G+TL+E L+  L  +   E    LE+L  ++ + ADD         +    
Sbjct: 82  TEKADIYSLGITLYEALDYELPYNEERELSAILEIL--LNGMPADDPR--DRSNLEGVSA 137

Query: 86  IL---DLMNECWKRSPTERPSFTEIHLF 110
                D M  C  R P  R      H  
Sbjct: 138 ARSFEDFMRLCASRLPQRRE--AANHYL 163


>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal
           Byr2-like MAP Kinase Kinase Kinases.  Serine/threonine
           kinases (STKs), mitogen-activated protein kinase (MAPK)
           kinase kinase (MAPKKK) subfamily, fungal Byr2-like
           proteins, catalytic (c) domain. STKs catalyze the
           transfer of the gamma-phosphoryl group from ATP to
           serine/threonine residues on protein substrates. The
           MAPKKK subfamily is part of a larger superfamily that
           includes the catalytic domains of other protein STKs,
           protein tyrosine kinases, RIO kinases, aminoglycoside
           phosphotransferase, choline kinase, and phosphoinositide
           3-kinase. Members of this group include the MAPKKKs
           Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae
           and Cryptococcus neoformans Ste11, and related proteins.
           They contain an N-terminal SAM (sterile alpha-motif)
           domain, which mediates protein-protein interaction, and
           a C-terminal catalytic domain. MAPKKKs phosphorylate and
           activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which
           in turn phosphorylate and activate MAPKs during
           signaling cascades that are important in mediating
           cellular responses to extracellular signals. Fission
           yeast Byr2 is regulated by Ras1. It responds to
           pheromone signaling and controls mating through the MAPK
           pathway. Budding yeast Ste11 functions in MAPK cascades
           that regulate mating, high osmolarity glycerol, and
           filamentous growth responses.
          Length = 267

 Score = 25.2 bits (55), Expect = 9.8
 Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 2/38 (5%)

Query: 27  FTTKSDVWSFGVTLWEILNLARHRPYEGLTDLEVLENI 64
           +T K+D+WS G  + E+L   +H P+   T L+ +  I
Sbjct: 189 YTRKADIWSLGCLVVEMLT-GKH-PFPDCTQLQAIFKI 224


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.321    0.137    0.430 

Gapped
Lambda     K      H
   0.267   0.0685    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 6,431,681
Number of extensions: 549856
Number of successful extensions: 843
Number of sequences better than 10.0: 1
Number of HSP's gapped: 708
Number of HSP's successfully gapped: 199
Length of query: 124
Length of database: 10,937,602
Length adjustment: 85
Effective length of query: 39
Effective length of database: 7,167,512
Effective search space: 279532968
Effective search space used: 279532968
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (24.3 bits)